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PREFÁCIO 
 
Nesta dissertação são apresentados os resultados do trabalho de investigação desenvolvido 
no Instituto de Medicina Molecular na Faculdade de Medicina de Lisboa da Universidade 
de Lisboa, entre os anos de 2003 e 2008, sob a orientação da Professora Doutora Maria do 
Carmo-Fonseca.  
 
Este trabalho foi desenvolvido para responder à escassez de dados consistentes sobre 
splicing alternativo e está dividido em duas partes. A primeira parte consiste no 
desenvolvimento de um algoritmo flexível e rápido que cria uma base de dados de splicing 
alternativo para qualquer organismo a partir de sequências de transcritos depositadas no 
GenBank, e que fornece informação num formato acessível não só para biólogos, para a 
análise de genes individuais, mas também para tecnologias que permitem a análise de 
milhares de genes em simultâneo.  
 
O trabalho está organizado em quatro capítulos. O primeiro capítulo consiste numa 
introdução onde são abordados os vários aspectos relativos ao splicing, em particular ao 
splicing alternativo, e a outros mecanismos que resultam na variação de transcritos. É 
apresentado o caso particular de alterações no splicing alternativo em distrofia miotónica. A 
área de estudo, relativamente recente, de transcritos que não codificam proteínas, em 
particular os microRNAs, é em seguidas abordada. Por fim é feita uma breve  introdução à 
tecnologia dos microarrays.  
 
A segunda parte do trabalho descreve o método implementado pelo algoritmo  
desenvolvido para gerar uma base de dados de splicing alternativo para 13 modelos de 
organismos do reino animal.  
 
A terceira parte apresenta um estudo estatístico dos dados produzidos, incluindo uma 
análise de exões até agora ignorados, e descreve e discute as várias aplicações de pequena e 
grande escala aos quais os dados produzidos pela base de dados foram sujeitos e que os 
validam. Por fim são tiradas conclusões sobre o sucesso do método e das várias aplicações  
efectuadas com os dados.   
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SUMÁRIO 
Objectivos 
O trabalho apresentado tem como objectivo o desenvolvimento de um algoritmo que gera 
uma base de dados de splicing alternativo e que detecta novos elementos envolvidos em 
splicing alternativo de maneira consistente e reprodutível. Este trabalho foi desenvolvido 
em duas fases. A primeira fase consistiu no desenvolvimento e optimização do algoritmo 
que cria uma base de dados de splicing alternativo para qualquer organismo a partir de 
informação de sequências depositados no GenBank [Mollet et al. 2008].  A segunda foi a 
aplicação dos dados gerados a análises de splicing alternativo de grande e pequena escala 
[Pacheco et al. 2006; Mollet et al. 2006]. 
 
Conceitos Teóricos 
A quantidade fenomenal de sequências depositadas no GenBank todos os anos requer o 
desenvolvimento de algoritmos de triagem e condensação desta informação de modo a que 
esta seja útil ao biólogo. Só para o humano há mais de 8 milhões de sequências de 
transcritos depositadas. Um dos aspectos de enorme interesse é o do splicing alternativo 
que permite a um gene produzir variantes de uma proteína utilizando combinações 
alternativas de exões [Black 2003]. Para além da geração de variantes de proteínas, a 
geração de transcritos não codificantes é um mecanismo importante de regulação da 
expressão genética [Lewis et al. 2003; Blencowe 2006; Graveley 2001; Modrek e Lee 
2002]. Estima-se que cerca de 73% dos cerca de 20,000 genes humanos sofram splicing 
alternativo [Johnson et al. 2003; Kan et al. 2001].  A informação útil retirada de bases de 
dados como o GenBank sobre splicing alternativo terá de ser útil não só para a análise de 
pequena escala, pelo biólogo que se dedica a aspectos específicos de alguns genes, mas 
também deverá ser útil para análises de grande escala, nomeadamente para análises por 
microarray. Os microarrays permitem monitorizar milhares genes em simultâneo num dado 
tecido. A comparação por microarray de dados em células de diferentes tecidos, ou de 
células saudáveis com células doentes, permite detectar os grupos de genes responsáveis 
pelas diferenças. 
 
 
Inês Guerra Mollet                                                                                                                                                  SUMÁRIO 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS 11 
Desenvolvimento do algoritmo 
O algoritmo foi desenvolvido na linguagem Perl interagindo com bases de dados 
construídas em MySQL [Mollet et al. 2008]. Os dados de partida consistem em tabelas de 
alinhamentos de transcritos (mRNA e ETSs) a um genoma pelo programa BLAT [Kent 
2002], retiradas do UCSC Genome Browser [Karolchik et al. 2008].  A qualidade dos 
alinhamentos é analisada pelo programa que procede a uma triagem e à condensação de 
informação repetida. A informação condensada é utilizada para gerar tabelas com todo o 
splicing alternativo existente nos transcritos em relação a cada gene. O programa ainda 
determina a tradução dos transcritos, locais de poliadenilação e informação sobre expressão 
em diferentes tecidos ao nível de isoformas e exões individuais. O resultado consiste numa 
base de dados em MySQL com dez tabelas por genoma, optimizadas de modo a se poder 
fazer todo o tipo de pesquisas. A base de dados foi chamada ExonMine e, em colaboração 
com outros elementos do grupo, foi integrada num servidor no Instituto de Medicina 
Molecular com acesso ao público [http://www.imm.fm.ul.pt/exonmine/]. Os updates são 
gerados de quatro em quatro meses. 
 
Estudo estatístico - Descoberta de novos elementos 
O estudo estatístico dos dados gerados e uma comparação com outras bases de dados, 
revelou que a ExonMine detecta níveis mais altos de splicing alternativo do que qualquer 
outra base de dados. Uma análise dos dados revelou que se detectam mais exões novos, que 
não têm sequência codificante, no humano do que no rato. Sabe-se que transcritos não 
codificiantes estão envolvidos na regulação da expressão de genes e que elementos móveis 
(como novos exões) estão na base da evolução de genes e de genomas em geral. Este 
resultado identifica portanto potenciais elementos que poderão ser fundamentais para se 
decifrar a diferença em termos de regulação genética, entre o humano e outros  organismos 
menos complexos. 
  
Aplicações de grande escala 
Procura de motivos envolvidos na regulação de splicing alternativo 
A base de dados ExonMine foi desenhada de modo a se poderem facilmente fazer procuras 
de elementos regulatórios envolvidos em splicing alternativo (ou mesmo de qualquer 
elemento regulatório a nível de sequência primária). O sucesso deste objectivo foi 
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demonstrado num estudo em que, com base num pequeno algoritmo que questiona a base 
de dados ExonMine, se detectaram, no espaço de umas horas, combinações de elementos 
regulatórios que foram posteriormente validados experimentalmente e publicados [Pacheco 
et al. 2006] pela Doutora Teresa Pacheco. 
 
Construção de um microarray para estudo da Distrofia Muscular 
Em colaboração com o grupo do Doutor Juan Valcárcel (CRG-Centre de Regulació 
Genómica, Barcelona, Spain), a base de dados ExonMine foi utilizada para a construção de 
um microarray especificamente concebido para o estudo de alterações de splicing 
alternativo em distrofia muscular incluindo informação sobre cerca de 400 genes 
específicos de musculo e cerca de 400 factores de splicing.  
 
Análise do microarray comercial ExonArray 1.0 ST e de tiling arrays da 
Affymetrix 
Para aplicações de grande escala a base de dados está a ser utilizada para a análise de 
microarrays produzidos comercialmente pela Affymetrix com cerca de 5.5 milhões de 
sondas e que visam cobrir o genoma inteiro ao nível de um exão. Dados de ‘tiling arrays’ 
de Affymetrix que cobrem o genoma inteiro com uma resoluçao de 5 nucleótidos também 
foram comparados aos dados da ExonMine e são objecto de projectos em curso. 
 
Aplicações de pequena escala 
Análise de variação do splicing na família U2AF  
A diversificação por splicing alternativo da importante família de factores de splicing 
U2AF foi investigada e publicada [Mollet et al. 2006]. Em todos os sete genes analisados 
foram detectados, com base no ExonMine, novas formas de splicing alternativo, com ou 
sem sequência codificante.   
 
Análise de novos elementos na família U2AF35 
Para a família de genes U2AF35 foi feita uma análise ainda mais aprofundada com o 
objectivo de validar as novas isoformas detectadas pelo ExonMine.  Todas a isoformas, 
escolhidas para uma validação experimental, continham novos exões que se encontravam 
em humano mas não em rato, e foram confirmadas por RT-PCR por outros elementos do 
Inês Guerra Mollet                                                                                                                                                  SUMÁRIO 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS 13 
grupo da Professora Doutora Maria Carmo-Fonseca. Para além da validação experimental 
foi ainda feita uma análise do potencial codificante das novas isoformas e da conservação 
dos novos exões noutros genomas. Em dois casos de isoformas contendo novos exões, mas 
sem sequência codificante,  foi feito o estudo da estrutura secundária do mRNA e foi 
detectado potencial para expressão de microRNAs, um dos quais foi confirmado 
experimentalmente por outro elemento do grupo da Professora Doutora Maria Carmo-
Fonseca. 
 
Conclusões 
Neste trabalho não só se desenvolveu e optimizou um método reprodutível e eficaz para 
gerar informação sobre splicing alternativo para qualquer organismo, como também se 
realizaram várias análises que mostram claramente que os objectivos pretendidos foram 
atingidos. Foram detectadas mais variações em splicing alternativo do que em qualquer 
outra base de dados, incluindo formas de splicing alternativo envolvendo novos exões não 
codificantes, até agora ignorados. Algumas das novas formas de splicing alternativo foram 
validadas por elementos do laboratório de Professora Doutora Maria Carmo-Fonseca, e 
foram aplicados os dados à análise de genes em grande escala, nomeadamente para análise 
de motivos envolvidos na regulação do splicing alternativo e na análise de microarrays. 
 
Esta base de dados é além disso um projecto activo e com continuidade, tendo vários 
projectos dependentes dos seus dados em execução, nomeadamente: análise de microarrays 
independentes no laboratório de Professora Doutora Maria do Carmo-Fonseca e em 
colaboração com o laboratório do Doutor Juan Valcárcel (CRG-Centre de Regulació 
Genómica, Barcelona, Spain); análise de splicing alternativo de factores de splicing 
(projecto em execução); e análise de splicing alternativo em factores de coagulação pelo 
grupo de Claire Shovlin (Imperial College, London). A base de dados ExonMine será 
mantida no Instituto de Medicina Molecular da Faculdade de Medicina da Universidade de 
Lisboa. 
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OBJECTIVES 
 
 
One of the difficulties in modern day genomics is that vast amounts of data are being 
generated at a breathtaking rate and biologists need to be able to tap into this information 
with a minimum of effort. This requires the biologist to acquire computational skills in 
order to extract information to meet his/her particular needs.  
 
The objective of this doctorate was the development of an alternative splicing database that 
could be easily updated and which should be structured so as to serve both the biologist, 
focusing on a single gene, and the computational biologist, seeking to do large-scale 
analysis of alternative splicing data. The first phase of the work would consist in the 
development and optimization of a Perl program, which would generate the alternative 
splicing data from BLAT alignments of transcript sequence data deposited in GenBank. 
The second phase of the project would consist in validating the alternative splicing data 
generated in small and large-scale projects in collaboration with members of our lab and 
other labs. Large-scale analysis would consist in genome wide analysis of sequence 
elements involved in the regulation of alternative splicing; using the database to custom 
design microarrays; and for analysis of commercial microarrays aiming at measuring gene 
expression at the level of an exon. Small-scale projects would consist in investigating the 
protein-coding potential of new isoforms and the regulatory potential of non-protein-coding 
isoforms detected by the algorithm and in providing data for RT-PCR validation of these 
isoforms.  
 
Since the data generated would be on a genome wide scale it was intended that this data 
should be shared with the scientific community in order to give it a maximum exposure for 
validation. With this objective in mind a web server was to be established in collaboration 
with other members of the group at the Institute of Molecular Medicine, with open access 
of the database to the public through a friendly interface. 
Inês Guerra Mollet                                                                                                                                                ABSTRACT 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS 15 
ABSTRACT 
 
Background 
Mining current mRNA and EST databases for novel alternatively spliced isoforms is of 
paramount importance for shedding light on the way in which the maturation of RNA is 
used to regulate gene expression. Preliminary observations revealed a tendency for greater 
amounts of potentially non-protein-coding alternative transcripts in human genes than in 
orthologous genes from other organisms. However, many of these isoforms did not appear 
in recently published alternative splicing databases on account of constraints imposed in the 
selection of transcripts. This prompted us to develop a less constrained database with the 
aim of contributing to the identification of the full repertoire of splice variants in the 
transcriptome of different organisms. Given that mechanisms of control of gene expression 
involving non-protein-coding splice variants have been described in a variety of genes, this 
information may be crucial to deciphering more intricate layers of gene regulation in 
complex organisms brought about by alternative splicing. 
 
 
Description 
An algorithm was developed to cluster mRNA and EST BLAT alignments to annotated 
gene regions. Consensus splice sites were the main requirement imposed on the selection of 
transcripts. The method was applied to thirteen model organisms. The alternative splicing 
information generated has been incorporated into a database with clear graphical displays 
representing the splicing patterns and is available from the ExonMine website 
(http://www.imm.fm.ul.pt/exonmine). It incorporates information on constitutive exons, 
poly-A signals, open reading frames and translation, expression specificity of any exon or 
splicing pattern relative to biological source of mRNA/EST, alternative splicing events and 
respective exon and junction sequences for microarray probe design. The ExonMine 
interface also provides several tools to support laboratory validation of splicing patterns. 
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Conclusions 
ExonMine detects a higher percentage of spliced genes and isoforms than currently 
available alternative splicing databases. The analysis reveals a marked increase, in complex 
organisms, of splice variants with either retained introns or incorporating novel exons with 
no apparent protein-coding potential. About 18% of unannotated exons detected in 
ExonMine were found expressed in primary human cells using tiling arrays. Validation of 
some of these results for the U2AF family of splicing factors was successfully performed in 
collaboration with members of the lab revealing primate specific transcripts and an 
alternatively spliced transcript carrying a microRNA. The database was also successfully 
used for genome wide analysis of sequence elements involved in the regulation of 
alternative splicing and for custom alternative splicing microarray design. Matching of 
ExonMine data to a commercial exon microarray platform covering the majority of human 
exons was also performed and will assist in large-scale analysis of alternative splicing data. 
The algorithm developed also provides for easy updatability, taking only 48 hours to 
generate data for the whole human genome and far less time for less complex organisms. In 
conclusion, ExonMine represents a new useful resource for future research on alternative 
splicing and gene regulation. 
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1. INTRODUCTION 
 
The overwhelming amount of biological sequence information now available requires the 
creation of automated procedures for retrieving useful information from databases 
containing vast amounts of data. For the human genome alone over 8 million transcribed 
sequences have been deposited in GenBank [Benson et al. 2007], however only about 
20,000 human genes have so far been identified. The fact that the nematode worm, 
Caenorhabditis elegans, measuring just one millimetre, contains about the same amount of 
genes as the human was initially perplexing [Hodgkin 2001]. However, it is becoming clear 
that, in more complex organisms, mechanism for generating a variety of transcripts from a 
single gene have evolved through alternative transcription initiation, alternative splicing 
and alternative polyadenylation. It has been estimated that, in the human genome, more 
than 73% of genes are alternatively spliced [Johnson et al. 2003; Kan et al. 2001]. 
Alternative splicing is therefore thought to play a dominant role in expanding the proteomic 
complexity encoded in a limited number of genes. Regulation of alternative splicing not 
only produces a dynamic proteome by modulating expression of functionally diverse 
protein isoforms but also regulates gene expression through on/off switches using 
premature termination codons and nonsense-mediated decay [Blencowe 2006; Graveley 
2001; Modrek and Lee 2002; Black 2003]. Alternative splicing events occur in response to 
a wide range of stimuli which can result in changes at the level of the encoded protein, 
through the inclusion, exclusion or variability of particular protein domains [Pacheco et al. 
2004; Schischmanoff et al. 1997]. Altered protein function can result in differential 
expression, activity, and localization of a gene product  [Kwon et al. 1999]. Alternative 
splicing has been shown to play a vital role in a variety of physiological and developmental 
events, ranging from sexual differentiation [Lopez 1998; Elliott and Grellscheid 2006], to 
neuronal functions [Grabowski 2007; Schmucker and Flanagan 2004; Lipscombe 2005], 
neuronal development [Boutz et al. 2007b], immune functions [Lynch 2004], apoptosis in 
mammalian cells [Schwerk and Schulze-Osthoff 2005]; the cell cycle [Blencowe 2003]; and 
also in response to extracellular signals [Pelisch et al. 2005] and the environment [Pleiss et 
al. 2007; Srebrow et al. 2002].  Alternative splicing in untranslated regions i.e. that do not 
affect the reading frame, play an important role in regulation of gene expression [Hughes 
2006]; they can, for example affect translation in the cytoplasm [Gebauer et al. 1998]. The 
study of alternative splicing is also important from a therapeutic point since it has been shown 
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to be associated with many diseased states [Wang and Cooper 2007] including cancer 
[Kalnina et al. 2005].  
 
Although it has also become apparent that many of the alternatively spliced isoforms in a 
gene may not come to produce a protein, post transcriptional regulation through alternative 
splicing constitutes an important mechanism for the control of gene expression [Lewis et 
al. 2003] and lately much attention is being focused on non-protein-coding RNAs 
(ncRNAs) [Strausberg and Levy 2007; Prasanth and Spector 2007]. 
 
The work presented in this thesis consists in the creation of a program, which produces a 
database of alternative splicing patterns in genes from information deposited in GenBank. 
The program is applicable genome wide and its speed allows for easy updating of the 
database. The database is user friendly and informative and has been successfully applied 
to a variety of problems involving alternative splicing, including: microarray design, 
detection of control sequences, detection of microRNAs and cross-species comparison of 
alternative splicing.  In addition to its application a statistical analysis of the output data 
revealed, particularly for higher organisms, a striking number of alternatively spliced exons 
which do not contain open reading frames in frame with known exons and which may play 
an important part in complex layers of gene regulation in higher organisms. 
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1.1. ALTERNATIVE SPLICING 
 
The majority of genes in metazoans are composed of exons separated by intervening 
sequences referred to as introns. Figure 1.1 represents an overview of the steps which take 
place in the process of converting the information encoded in a gene into a protein. Splicing 
is normally thought to occur exclusively in the nucleus; a spliced messenger RNA is then 
transported to the cytoplasm where translation is expected to occur. A gene is encoded in a 
segment of DNA by combinations of four nucleotides two purines, adenosine (A) and 
guanine (G), and two pyrimidines, cytosine (C) and thymine (T). The gene is expressed via 
transcription into a pre-messenger RNA transcript (pre-mRNA), in which only the 
nucleotide base T is replaced by the nucleotide base uridine (U). In order to be translated 
into protein this RNA message must undergo a series of processing reactions, which 
include the removal of introns and joining of exons; and protection of the 5’ and 3’ ends of 
the RNA with a Cap structure and polyadenylation respectively.  
 
The splicing of exons refers to the biochemical reactions which take place on a pre-mRNA 
molecule and result in the excision of an intervening sequence (intron) and concomitant 
splicing of the bordering exons [Sanford and Caceres 2004].  Splicing occurs in defined 
cellular loci [Moen et al. 1995; Misteli 2000]. Alternative splicing refers to this same 
mechanism taking place in the presence of additional splicing factors, which influence the 
choice of splice sites thereby producing alternative combinations of spliced exons. These 
combinations of exons normally occur not by shuffling but in a linear arrangement and can 
be systematized into seven basic types (Figure 1.2). One or more exons may be skipped 
(Figure 1.2A); exons, which can be skipped, are referred to as cassette exons. Cassette 
exons can be mutually exclusive (Figure 1.2B), i.e. never occur together in the same 
isoform. Exons may also be extended at either end through the use of alternative 5’ splice 
sites (Figure 1.2C) or alternative 3’ splice sites (Figure 1.2D). Strictly speaking, alternative 
first exons (Figure 1.2 E) are primarily an issue of the use of alternative transcription 
initiation sites (or alternative promoters) [Tsuritani et al. 2007], however, transcription 
factors can affect alternative splicing through promoter identity and occupation involving 
the recruitment of factors with dual functions in transcription and splicing and the control 
of RNA polymerase II elongation [Kornblihtt 2005; Pagani et al. 2003; Nogués et al. 2002; 
Kadener et al. 2002] furthermore, promoter specific polar effects on alternative splicing 
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have been observed [Fededa et al. 2005]. Alternative terminal exons will be associated with 
alternative polyadenylation signals, although alternative polyadenylation signals may in 
fact occur on the same terminal exon. And finally an intron can be retained in the final 
transcript (Figure 1.2 F). A transcript may however be subject to highly complex 
superimposed patterns of alternative splicing as is shown in (Figure 1.2H). Exons, which 
are always included in the final mRNA, are referred to as ‘constitutive exons’.  
 
Trans-splicing [Horiuchi and Aigaki 2006] (splicing between distinct pre-mRNAs) 
commonly occurs in clusters of genes transcribed polycistronically in unicellular organisms 
and in Caenorhabditis elegans, and has been observed in two Drosophila melanogaster 
genes; in mammals the physiological significance of the rare cases of trans-splicing 
reported in vitro is unclear.                                                                                                             
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Figure 1.1. The diagram represents a gene encoded in a segment of DNA, composed of 3 
exons separated by two intervening sequences, or introns. The gene is expressed via 
transcription into a pre-messenger RNA transcript (pre-mRNA). In order to be translated 
into protein this pre-mRNA must undergo a series of processing reactions, which include 
the removal of introns and concomitant splicing of exons; and protection of the 5’ and 3’ 
ends of the RNA with a Cap structure and polyadenylation respectively.  
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Figure 1.2. Alternative splicing can be systematised into six basic categories A-G. 
However, in reality, not only can there be several distinct alternatively spliced regions in a 
gene, but within a region there can be superimposed patterns of alternative splicing.  H. An 
example of complex alternative splicing occurring in the 4.1R gene [Schischmanoff et al. 
1997] where in addition to a basic alternative 3’ splice site and cassette exons, multiple 
superimposed patterns of alternative splicing are observed in three distinct regions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A –  Cassette Exon B – Mutual exclusion of cassette exons 
C – Alternative 5’ splice site D – Alternative 3’ splice site 
E – Alternative First Exons F – Alternative Terminal Exons 
H – Complex alternative splicing 
G – Intron Retention 
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1.1.1. THE SPLICEOSOME AND THE SPLICING REACTION  
The spliceosome and main consensus sequences 
The basic splicing reaction takes place on a macromolecular assembly called the 
spliceosome, which may be the most complex machine in a cell [Nilsen 2003]. The 
spliceosome is composed of five small nuclear ribonucleoprotein particles (snRNPs) U1, 
U2, U5, U4 and U6, and an array of non-snRNP splicing factors and splicing associated 
factors [Chiara et al. 1996; Jurica and Moore 2003; Zhou et al. 2002].  The 
ribonucleoprotein particles each contain a different small nuclear RNA (snRNA), a 
common RNP core structure composed of seven Sm proteins (E,F,G,D1,D2,D3, and B/B’) 
[Kambach et al. 1999b; Raker et al. 1996; Stark et al. 2001; Urlaub et al. 2001; Walke et 
al. 2001] and additional proteins particular to a given snRNP particle [Will and Lührmann 
2006; Burge et al. 1999;  Kambach et al. 1999a; Will and Lührmann 2001]. The sequence 
of the spliceosomal snRNAs, in particular those regions engaging in base-pairing 
interactions, and to some extent the secondary structures, are highly conserved 
evolutionarily [Guthrie and Patterson 1988; Reddy and Busch 1988, Kiss 2004; Yu et al. 
1999]. In addition to the snRNPs it is estimated that there may be as many as 300 splicing 
factors and splicing associated factors [Rappsilber et al. 2002; Jurica and Moore 2003] 
involved in the splicing reaction, many of which may be tissue specific or may participate 
in other cellular processes. 
 
The snRNPs are recruited concomitantly to the pre-mRNA proceeding through a series of 
stabilization and destabilization reactions [Vilardell and Valcarcel 2007], remodelling 
multiple RNA-RNA ( intra- and inter-snRNA , as well as snRNA – pre-mRNA) [Nilsen 
1998], RNA-protein [Shen and Green 2007] and protein-protein interactions [Corsini et al. 
2007], to generate a catalytically active RNP structure. This process of activation has been 
proposed to take place through an allosteric cascade of interactions [Brow 2002].  
 
The operation of the spliceosome relies on specific sequences encoded in the pre-mRNA at 
the 5’splice site (5’ss), the 3’ splice site (3’ss), the branch point sequence (BPS) which 
carries a conserver A nucleotide, and the polypirimidine tract (Py), all of which direct the 
initial assembly of the spliceosome. The nature of these sequences can influence the 
dynamics of the splicing reaction. The sequence of the Py-tract is highly variable [Singh et 
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al 1995], strong Py-tract being rich in uridines. The major class of introns, called U2-type 
introns have a branch signal consensus yUnAy [Gao et al. 2008] which is quite degenerate, 
where only the U and A seem to be consistently present, and is normally located at about 
40 nucleotides from the 3’ splice site but can also be found at a highly variable position 
relative to the 3’splice site [Gooding et al. 2006]; and have conserved 5’ and 3’ splice site 
sequences |GUR and YAG| in more than 99.9% of cases, or very rarely |GC and YAG|, 
where | represents the splice junction (R=A or G, and Y=U or C). A minor class of introns, 
called U12-type introns  [Tarn and Steitz 1997], carry a very strongly conserved branch 
point sequence (BPS) UCCUUAAC (branch point underlined), equally strongly conserved 
5’ and 3’ splice site sequences, either |AUAUCCUUU and YAC| or more commonly 
|GUAUCCUUU and YAG|, and typically lack a polypyrimidine tract. U12-type introns 
are spliced by a compositionally distinct spliceosome referred to as the minor spliceosome 
[Patel and Steitz 2003; Will and Luhrmann 2005], which has an early evolutionary origin 
[Russell et al. 2006]. 
 
The proportion of all nuclear introns that are spliced by the U12-type spliceosome is 
estimated to be in the order of one in a thousand in vertebrates and lower in other taxa 
[Patel et al 2002]. Both spliceosomes form similar RNA-RNA, RNA-protein interactions 
and exhibit similar protein compositions [Schneider et al. 2002; Will et al. 1999]. The U12-
dependent spliceosome is formed from the U11, U12, U5, and U4atac/U6atac snRNPs, the 
U5 snRNA being common to both spliceosomes [Hall and Padgett 1996; Tarn and Steitz 
1996a, 1996b]. Additional non-snRNP splicing factors are common to both spliceosomes 
[Shen and Green 2007]. The physiological significance of the existence of the two distinct 
spliceosomes is not clear and since genes containing U12-type introns also contain U2-type 
introns, it appears that the U2-type and U12-type spliceosomes can be active in the same 
region of the nucleus, however, splicing of transcripts with U12-type introns has been 
observed in anucleate platelets [Meshorer and Misteli 2005; Denis et al. 2005] and recent 
work indicates that the major and minor spliceosomes may belong to two spatially 
segregated pathways acting on distinct sets of genes; the minor spliceosome being  
preferentially active in the cytoplasm [Cáceres and Misteli 2007], rather than in the 
nucleus, and on genes involved in cell proliferation [König et al. 2007], providing a means 
for nucleus-independent key regulatory events in the control of gene expression. Indeed, 
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many splicing components cycle between the nucleus and the cytoplasm as part of their 
normal life cycle [Cáceres et al. 1998; Yong et al. 2004; Gama-Carvalho et al. 2006]. 
 
 
The splicing reaction 
All nuclear pre-mRNA introns are removed by an identical two-step mechanism involving 
two consecutive trans-esterification reactions (Figure 1.3). In the first step, the 2’- OH 
group of the branch point adenosine sugar carries out a nucleophilic attack on the 
phosphate at the 5’ splice site (Figure 1.3A), which results in the cleavage of the pre-
mRNA at the 5’ splice site, leaving a free 3’- hydroxyl group, and the ligation of the 5’ end 
of the intron to the branch point adenosine. The second step consists in another nucleophilic 
attack, this time by the free 3’- hydroxyl group of the 5’ exon on the phosphate at the 
3’splice site (Figure 1.3B), leading to the ligation of the 5’ and 3’ exons, and concomitant 
release of the intron in the form of a lariat structure. It is notable that the splicing reaction, 
as we know it, can never take place on DNA, it can only take place on RNA because DNA 
does not possess 2’- OH groups on the sugar backbone. 
 
Spliceosome assembly model 
The initial identification of splice sites may take place across an intron or an exon and the 
choice of recognition mechanism is influenced by the size of both exons and introns 
[Sterner et al. 1996]. In mammals, where introns can be several orders of magnitude longer 
than exons, recognition of splice sites appears to take place across an exon, where these, 
being much shorter than introns, serve as a unit of recognition in a process called “exon 
definition” [Berget 1995; Reed 1996; Hoffman and Grabowski 1992; Robberson et al. 
1990], even though the splice sites flanking an exon will not be spliced by the same 
spliceosome. The process of exon definition appears to involve interaction with the carboxy 
terminal domain of RNA polymerase II [Zeng and Berget 2000]. Although some 
observations suggest that the spliceosome exists as a large, preformed entity that engages 
the pre-mRNA as such [Stevens et al. 2002; Das et al. 2000; Maroney et al. 2000; Sergeant 
et al. 2007], studies performed on a variety of systems also show that the major 
spliceosome assembles in a stepwise manner by the ordered interaction of the U1 and U2 
snRNPs and the U4/U6.U5 tri-snRNP with the pre-mRNA (Figure 1.4). This stepwise 
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model has recently been confirmed by studies of co-transcriptional spliceosome assembly 
coupled to 5’ end processing and transcription [Görnemann et al. 2005]. The classic 
representation of spliceosome assembly is pictured to proceed across an intron [Burge et al. 
1999; Will and Lührmann 2006; Brow  2002; Nilsen 2002; Staley and Guthrie 1998], from 
the set of five small nuclear ribonucleoproteins (snRNPs) and numerous accessory proteins, 
through five stages (E, A, B, B* and C) which correspond to the most stable assembly 
intermediates of the human spliceosome that have been detected biochemically. 
Spliceosomal proteins contribute to splice site recognition indirectly by stabilizing snRNA-
pre-RNA  base-pairing interactions; or directly by recognition of the 5’ and 3’ splice sites. 
Recent work has revealed a link between exon definition and an intron-defined spliceosome 
[Sharma et al. 2008].  
 
In the early E, or commitment Complex (Figure 1.4), the U1 snRNP is recruited to the 5’ 
splice site, with the U1 snRNA base pairing with the 5’splice site, an interaction which is 
stabilised by U1 specific proteins (U1-70K and U1-C) as well as members of the SR 
protein family [Will and Lührmann 1997; Rossi et al. 1996; Du and Rosbach 2001, 2002]. 
At this stage, the 3’ splice site elements are bound cooperatively by a special set of proteins 
[Abovich and Rosbash 1997; Berglund et al. 1997, 1998a, 1998b]:  SF1 binds at the 
branch-point; the 65-kDa subunit of the dimeric U2 auxiliary factor (U2AF) binds to the 
polypyrimidine tract and contacts the BPS via its RS domain [Gaur et al. 1995; Valcárcel et 
al. 1996; Kent et al. 2003; Shen and Green 2004; Sickmier et al. 2006]; and, in at least 
some cases, the 35-kDa subunit of U2AF binds directly to the AG dinucleotide at the 
intron/exon junction [Das et al. 2000; Merendino et al. 1999; Wu et al. 1999]. U2AF 
independent formation of this early complex has also been observed in mammals [Kent et 
al. 2005]. It is thought that, at this stage, a molecular bridge involving SR proteins is 
formed between the U1 snRNP at the 5’ splice site and SF1 and U2AF bound to the BPS 
and 3’ splice site [Reed 1996; Boukis et al. 2004]. This complex is joined by the U2 snRNP 
to form the A complex [Dönmez et al. 2004, 2007].  
 
 
In the A Complex (Figure 1.4), or pre-spliceosome, the U2 snRNP apparently displaces 
SF1 and stably associates with the branch point sequence (BPS), with the U2 snRNA base 
pairing with the branch point sequence; an interaction which requires U2AF and is 
facilitated by other heteromeric splicing factors (SF3a and SF3b) which contact the pre-
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mRNA in the vicinity of the branch site [Reed 1996]. The U2 snRNA forms an RNA 
duplex with a bulged adenosine [Berglund et al. 2001] at the branch point (Figure 1.5) 
positioning this adenosine to carry out the nucleophilic attack in the first catalytic step of 
splicing [Query et al. 1994]. The bulged branch point adenosine is directly contacted by a 
subunit of SF3b, namely p14/SF3b14a, which appears to remain associated at least through 
the first step of splicing [Query et al. 1996; Will et al. 2001]. This subunit is thought, in 
higher eukaryotes, to play a central role in the recognition and/or selection of the BPS and 
is likely present at the catalytic core of the spliceosome. However, during enhancer-
dependent spliceosome assembly, RS domains of SR proteins also directly contact the BPS 
at the time of A complex assembly [Shen et al. 2004]. The nature of the molecular bridge 
formed between U1 and U2 snRNPs, bringing together the 5’ and 3’splice sites, has been 
recently studied [Behzadnia et al. 2007] and it appears that it involves base pairing 
interactions between U1 snRNA and U2 snRNA. Non- snRNP DEAD-box protein Prp5 has 
also been implicated in bridging the U1 and U2 snRNPs in the major spliceosome [Xu et al. 
2004]. This complex is joined by the U4/U5/U6 tri-snRNP to form the B complex. 
 
The B Complex [Deckert et al. 2006] (Figure 1.4) carries the pre-assembled U4/U6.U5 tri-
snRNP, which has displaced proteins U2AF65 and U2AF35. This complex undergoes a 
complicated rearrangement of RNA-RNA and RNA-protein interactions leading to the 
destabilization of the U1 and U4 snRNPs to form the catalytically activated B* Complex.  
 
Finally the conversion into the catalytic C Complex takes place, in which the U1 snRNP 
interaction at the 5’ splice site is replaced with the U6 snRNP and the U1 and U4 snRNPs 
are lost from the complex. In this complex the first of the two catalytic steps of splicing 
occurs (Figure 1.4), with the U5 protein Prp8 being implicated in properly positioning the 
5’ splice site within the spliceosome for this first reaction. After the first trans-
esterification, U5 also contacts exon nucleotides just downstream from the 3’ splice site 
and is thought not only to tether the 5’ exon to the spliceosome, but also to align both exons 
for the second catalytic step, interactions that involve several other splicing factors 
[Aronova et al. 2007]. U6 snRNA is also involved in genetic interactions between the 5' 
and 3' splice site consensus sequences during this step [Collins and Guthrie 2001]. After the 
second catalytic step the spliceosome is thought to disassemble and the snRNPs are thought 
to take part in additional rounds of splicing.   
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This stepwise assembly model provides a clear picture of when individual snRNPs are 
stably recruited to the pre-mRNA, and is not necessarily contradictory with the existence of 
a preassembled spliceosome, as the intermediate stages of assembly which have been 
detected are likely to reflect different stabilization/destabilization states of the spliceosomal 
snRNPs and splicing factors with the pre-mRNA.  
 
Many additional non-snRNP spliceosomal proteins are involved in major structural 
rearrangements in the RNA-RNA and RNA-protein and protein-protein networks prior and 
subsequent to the formation of a catalytically active spliceosome [Burge et al. 1999; Will 
and Lührmann 2006; Tycowski et al. 2006; Bartels et al. 2002, 2003; Kuhn et al. 2002; 
Tarn et al. 1993a,b; Makarova et al. 2004; Chen et al. 2002; Chan et al. 2003; Ajuh et al. 
2000; Horowitz et al. 2002; Collins and Guthrie 1999; Graveley 2000]. At least some 300 
proteins have been shown to be implicated in splicing [Jurica and Moore 2003; Chen et al. 
2007; Barbosa-Morais et al. 2006; Gabut et al. 2008; Will and Luhrmann 2006]. These 
include members of the Serine/Arginine (SR) protein family, heterogeneous nuclear 
ribonucleoproteins (hnRNPs), and members of the DEXH/D-box family of RNA 
unwindases/RNPases [Teigelkamp et al. 1994; Staley and Guthrie 1998; Schwer and 
Meszaros 2000; Schwer 2001] and many others, but the precise spliceosomal targets of 
these proteins remain for the most part unclear. In addition, protein modifications, by 
phosphorylation, are thought to contribute to spliceosome dynamics at virtually every step of 
splicing, in particular the phosphorylation of SR proteins [Wang et al. 1999; Wang et al. 
1998; Misteli and Spector 1999; Bollen and Beullens 2002; Lai et al. 2003; Soret and Tazi 
2003; Tazi et al. 1992].  
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Figure 1.3. Details of the two trans-esterification reactions which result in the removal of 
the intron and the concomitant splicing of the flanking exons. A. In the first reaction the 2’- 
OH group of the Branch Point conserved adenosine (A) sugar displaces the 3’- OH group at 
the 5’ splice site. B. In the second transesterification reaction the free 3’- OH group of the 
5’ exon displaces the 3’- OH group at the 3’ splice site. (B stands for any nucleotide base 
A, C, U or G). 
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Figure 1.4. A. Layout of the main splicing signals in an intron and assembly of the main 
components of the spliceosome through the E, A, B, B* and C complexes. The 5’ splice 
site (5’ss) is at the 5’ end of the intron. The 3’ splice site (3’ss) is at the 3’ end of the intron. 
Branch Point Sequence (BPS) with conserved adenosine (A) nucleotide is expected to be 
found 10-20 nt or 18-40nt upstream of the 3’ss in U12 type and U2- type introns 
respectively. The polypyrimidine tract (Py) in U2-type introns lies between the BPS and the 
3’ss but its position and composition are highly variable. 
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Figure 1.4 (cont.) Schematic representation of the two trans-esterification reactions which 
take place on the catalytic C complex (spliceosome components omitted for clarity) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   A          (Py)n           AG 
   A          (Py)n                    AGp 
U
G
p 
U
G
p 
 p + 
1st transesterification 
2nd transesterification 
C Complex reactions  
HO 
  A          (Py)n            AGp 
UGp 
OH 
5’ss 
3’ss 
Inês Guerra Mollet                                                                                                                                       INTRODUCTION 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS 32 
Figure 1.5. Base pairing (indicated by vertical lines) between a messenger RNA (mRNA) 
branch point sequence and the U2snRNA, producing the bulged Adenosine  (A), which is 
involved in the first trans-esterification reaction in splicing. 
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RNA catalysis 
 
Despite its absolute dependence on numerous proteins for catalytic activation, and the fact 
that it is predominantly made up of protein, the spliceosome appears to be an RNA enzyme 
[Nilsen 2000] (or ribozyme) with an active site or sites composed of RNA [Collins and 
Guthrie 2000; Villa et al. 2002; Valadkhan 2005]. Several intermolecular structures formed 
by the pre-mRNA and the U2, U5 and U6 snRNAs exhibit similarities with intramolecular 
structures formed by self-splicing-group II introns supporting the idea that pre-mRNA 
splicing is catalysed by RNA [Madhani and Guthrie 1992; Weiner 1993]. The first step of 
splicing has also been shown to be mediated by a metal ion [Sontheimer 2001], consistent 
with RNA-based catalysis [Sontheimer et al. 1997, Gordon et al. 2000; Yean et al. 2000]. 
Because splicing appears to by catalysed by RNA, a major job of the set of proteins present 
in the C complex will likely be to generate and/or maintain the RNA structures required for 
catalysis. In addition to facilitating the formation of critical RNA-RNA interactions, 
spliceosomal proteins are thought to be the driving force behind the numerous structural 
rearrangements required for the catalytic activity of this dynamic RNP machine. Splicing is 
indeed a very dynamic process, and some functionally important proteins are thought to act 
only transiently with the spliceosome at defined stages.  
 
 
Integration of splicing with other cellular processes 
Pre-mRNA splicing has been shown to be linked spatially and temporally to several other 
cellular processes [Hirose and Manley 2000; Bird et al. 2004, Bird et al. 2005; Aguilera 
2005; Bentley 2005; Moore et al. 2006]. Changes in chromatin structure have been shown 
to affect splicing [Nogués et al. 2002; Sacco-Bubulya and Spector 2002; Batsché et al. 
2006] perhaps because hyperacetylation of core histones facilitates the passage of the 
transcribing polymerase. Promoter structure [Cramer et al. 1997; Kornblihtt 2005], and 
recruitment of transcription factors [Kadener et al. 2001; Nogués et al. 2002] and 
coactivators [Auboeuf et al. 2004] can greatly affect alternative splicing. Interactions 
between polymerase II carboxy terminal domain (CTD) and splicing factors [de la Mata 
and Kornblihtt 2006], the rate of RNA polymerase elongation [Roberts et al. 1998; de la 
Mata 2003; Howe et al. 2003; Fededa et al. 2005], transcription [Kornblihtt et al. 2004; 
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Das et al. 2006; Hicks et al. 2006; Lynch 2006], RNA editing [Laurencikiene et al. 2006], 
capping [Görnemann et al. 2005], polyadenylation [Glover-Cutter et al. 2008] and mRNA 
export [Zhao et al. 2004, Reed and Hurt 2002] have also been shown to affect alternative 
splicing. Furthermore, on completion of the pre-mRNA splicing reaction, the spliceosome 
deposits a set of protein factors 20-24 nucleotides upstream of the exon-exon junction 
referred to as the exon junction complex (EJC) [Kataoka et al 2000; Le Hir et al. 2000a, 
2000b]. The presence of these complexes will shape subsequent events in gene expression. 
These exon junction complexes have been shown to enhance translation [Nott et al. 2004] 
of an mRNA, although they are removed by the translation machinery in the pioneer round 
of translation in the cytoplasm (i.e. the first time the mRNA is used as a template for 
translation into protein). The EJC is also implicated in post-splicing events such as mRNA 
nuclear export and nonsense-mediated mRNA decay (NMD) [Le Hir et al. 2001a, 2001b; 
Maquat 2004] since they will remain on the mRNA if there is a premature stop codon, 
providing a signal to the NMD machinery, which will target mRNA for degradation. 
However, in the event of a premature stop codon, NMD can be inhibited by binding of 
poly(A)-binding protein [Silva et al. 2008]. The interplay of so many factors involved in 
pre-mRNA processing requires us to visualise the integration of these interactions over 
extended lengths of RNA sequences during the process of splicing [Cramer et al. 2001; 
Rigo et al. 2008; Bentley 2002; Maniatis and Reed 2002; Reed 2003; Mc Cracken et al. 
1997].  
 
Given these facts it is not surprising that many proteins related to other cellular processes 
have been detected in spliceosomal complexes [Chen et al. 2007]. For example, drosophila 
Sxl splicing regulator binding to one of its mature mRNA targets can also block translation 
in the cytoplasm [Bashaw and Baker 1997; Kelley et al. 1997; Gebauer et al. 1998]. 
 
However, as some of these proteins have also been documented to function in splicing, they 
may be multifunctional rather than being responsible for linking splicing to other gene 
expression machines. Candidates for mediating these types of interactions are proteins 
containing an arginine-serine (RS or SR) domain, which is present in many proteins 
important for splicing in vertebrates. RS domains are involved in both protein-protein and 
protein-RNA interactions [Manley and Tacke 1996; Tacke and Manley 1999; Sanford et al. 
2005; Das et al. 2007]. Proteins containing RS domains have been shown to be critical in 
both early and late stages of spliceosome assembly in vertebrate cells [Manley and Tacke 
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1996; Valcárcel and Green 1996; Graveley and  Maniatis 1998; Graveley et al. 1999; 
Hertel and Graveley 2005], and the heterogeneous distribution of such proteins in the 
vertebrate nucleus suggests an intimate relationship between splicing and nuclear structure 
[Xing et al. 1993]. SR proteins have also been linked to signal transduction pathways in 
which concerted regulation of alternative splicing and translation is observed in response to 
extracellular signals [Blaustein et al. 2005; Graveley 2005]. An example is the SF2/ASF 
SR protein, which shuttles between the nucleus and the cytoplasm where it is expected to 
perform distinct functions [Sanford et al. 2004]. 
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1.1.2. SPLICING REGULATION AND SPLICING REGULATORY 
ELEMENTS 
Changes in splice site choice are responsible for alternative splicing. It is thought that such 
changes occur mainly during the early stages of spliceosome assembly. Splice site choice can 
be determined at the stage of splice site recognition through exon or intron definition, but 
commitment to alternative splice site choice pairing may occur after initial splice site 
recognition and E complex formation [Lim and Hertel 2004]. There is also evidence of 
regulation of 3’ splice site choice after the first catalytic step [Lallena et al. 2002].   
 
Additional cis-regulatory sequence elements 
The core human splice site motifs, 3’ splice site, 5’ splice site, branch point and 
polypyrimidine tract are too short and degenerate to reliably identify the splice junctions 
even in short introns [Lim and Burge 2001].  The higher level of degeneracy of the splice 
sites and the branch site in the more common U2- type introns, in relation to the U12 – type 
introns, suggests that the former may depend more critically on recognition of additional 
sequences to specify a splice junction [Berget 1995; Black 1995]. Branch point plasticity 
has also been shown to contribute to splicing regulation [Kol et al. 2005]. However, 
whether for U2-type introns or U12-type introns, it is by now fairly well established that, in 
metazoans, for a splice site to be reliably identified, additional mRNA cis-sequence 
elements are necessary [Black 2003]. These additional cis-acting pre-mRNA elements can 
be present on exons or introns. Elements within an exon, which promote or inhibit 
inclusion of that exon, are conventionally classified as exonic splicing enhancers (ESEs) or 
exonic splicing silencers (ESSs) [Blencowe 2000; Smith and Valcárcel 2000; Black 2003; 
Wang and Burge 2008]; many large scale and small scale computational and experimental 
approaches have been dedicated to identifying and compiling ESE and ESS [Chasin 2007; 
Tian and Kole 1995; Tian and Kole 2001; Liu et al. 1998, 2000; Fairbrother et al. 2002; 
Zhang and Chasin 2004; Cartegni et al. 2002; Wang et al. 2004; Wang et al. 2005; Goren 
et al. 2006]. Similarly, elements within an intron, which enhance or inhibit usage of the 
adjacent splice sites or exons, are conventionally classified as intronic splicing enhancers 
(ISEs) or intronic splicing silencers (ISSs), and a few have been identified [Ladd and 
Cooper 2002; McCullough and Berget 1997, 2000; Yeo et al. 2004; Hui et al. 2005; Hung 
et al. 2007; Brudno et al. 2001; Jin et al. 2003; Minovitsky et al. 2005; Nakahata and 
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Kawamoto 2005; Underwood et al. 2005; Jensen et al. 2000; Ule et al. 2003; Matlin et al. 
2005; Wagner et al. 2005; Singh et al. 2006; Kashima et al. 2007].  
 
These cis-acting pre-mRNA elements are typically short and diverse in sequence, most 
seem to bind regulatory proteins, but some can form RNA secondary structures that affect 
splice site recognition [Libri et al. 1991; Liu et al. 1995; Jacquenet et al. 2001; Buratti 2004; 
Hiller et al. 2007]. These elements modulate splicing of both constitutively and 
alternatively spliced exons [Garg 2007]; in fact it is thought that most, if not all exons, 
contain exonic splicing enhancers (ESEs) that stimulate splicing at the adjacent splice sites 
[Schaal and Maniatis 1999; Fairbrother et al. 2002; Cartegni et al. 2003]. Exons without 
these elements are generally not recognized and tend to be excluded from the mature mRNA 
[Wang and Burge 2008]. Silencers seem to play a more predominant role in alternative 
splicing [Fairbrother et al. 2002; Wang et al. 2004; Zhang and Chasin 2004] causing 
intronic sequence around alternatively spliced exons to be more conserved than that around 
constitutive exons [Sorek and Ast 2003]. These regulatory elements normally function by 
recruiting trans-acting splicing factors [Matlin et al. 2005; Chasin 2007]. There can be 
several copies of a particular regulatory element which may function additively by 
increasing the number of factors recruited to it [Huh and Hynes 1994; McCullough and 
Berget 1997; Chou et al. 2000; Wang et al. 2004; Zhang and Chasin 2004; Dominguez and 
Allain 2006]. Different regulatory elements may also function cooperatively to regulate 
alternative splicing [Han et al. 2005; Modafferi and Black 1999]. The context in which 
these cis-acting elements are and the relative concentration of the trans-acting splicing 
regulators will determine the outcome of the splicing reaction [Mabon and Misteli 2005]. 
Certain motifs can even function as silencer or enhancer depending on their location 
[McCullough and Berget 1997; Chen et al. 1999; Hui et al. 2005; Ule et al. 2006; Goren et 
al. 2006]. Although the issue of pre-mRNA secondary structure playing a role in the 
recognition of regulatory elements has been debated [D’Souza and Schellenberg 2002], it 
has been found to be essential in several cases [Hiller et al. 2007; Jensen et al. 2000; Warf 
and Berglund 2007; Donahue et al. 2006]. 
 
Many exonic splicing enhancers function by recruiting SR proteins [Lynch and Maniatis 
1996; Graveley 2000]. SR proteins contain RNA recognition motifs (RRM) that bind to the 
RNA elements; and RS domains that facilitate protein-protein interactions and assembly of 
the spliceosome [Graveley and Maniatis 1998]; in some cases RS domains can also interact 
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with the branch point sequence and the 5’ splice site. 
 
Another large group of proteins, identified by their association with unspliced mRNA 
precursors (also called heterogeneous nuclear RNA, hnRNA), are commonly referred to as 
hnRNP proteins. These are not a single family of related proteins, rather they are 
identitified by their association with RNA in the nucleus. hnRNP proteins contain RNA 
binding domains that can bind to exonic splicing silencers and thereby act as repressors. 
They may also contain inhibitory glycine-rich motifs [Pozzoli and Sironi 2005]. They have 
been shown to function through a wide variety of mechanisms: by blocking interactions 
between spliceosomal snRNPs [Izquierdo et al. 2005; Sharma et al. 2005]; by binding on 
either side of an exon and looping it out; or by displacing snRNP binding [Zhu et al. 2001; 
Nasim et al. 2002].  
 
Examples of alternative splicing mechanisms 
Many examples of regulation of the splicing reaction have been summarized in a number of 
reviews [Black 2003; Konarska and Query 2005; Matlin et al. 2005; Blencowe 2006; House 
and Lynch 2008]. 
 
The simplest known mechanism for altering splice site choice is by direct competition with 
essential splicing factors for RNA binding sites. An example of this mechanism is illustrated 
by the splicing regulator Sxl in drosophila which can promote alternative 3’splice site choice 
is one target pre-mRNA [Crowder 1999; Handa 1999], by competing directly with U2AF for 
its uridine-rich binding site, which coincides with the Py tract, at the 3’ss.  
 
To determine the consequences of the presence of a splicing factor, the location of its binding 
sites has to be taken into account. The same drosophila splicing regulator Sxl, for example, 
can also promote intron retention when its uridine-rich binding site is also present near the 
5’ss of another target pre-mRNA [Förch et al. 2000; Förch et al. 2001], directly competing 
with two other essential splicing factors, TIA-1 and U1snRNP; or it can promote exon 
skipping when its uridine-rich binding sites are present on flanking introns [Lallena et al. 
2002]. 
   
Exonic splicing enhancers can also be composed of repeats [Tian and Maniatis 1992; Lynch 
and Maniatis 1996; Hertel et al. 1996] onto which proteins bind cooperatively through 
protein-protein interactions of RS domains and protein-RNA interactions of RNA-binding 
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domains [Hertel et al. 1997; Smith and Valcarcel 2000; Wang and Manley 1997] forming a 
stabilizing multiprotein enhancer complex which leads to spliceosome assembly and splicing 
of the exon [Zuo and Maniatis 1996; Graveley et al. 2001; Graveley 2000] 
 
Exon definition, being an early event during splicing, can lead to commitment of the exon to 
splicing, therefore this step is critical for splicing regulation and specificity. One example of 
control of alternative splicing at this level is found in the definition of Fas gene exon 6 
which is inhibited by polypyrimidine tract binding protein (PTB/hnRNP I) binding to an 
exonic splicing enhancer sequence which inhibits exon definition complex formation 
causing skipping of Fas exon 6 [Izquierdo et al. 2005]. PTB has also been found to inhibit 
the spliceosome assembly across introns (intron definition) in repressing splicing of the c-
src N1 exon [Sharma et al. 2005]. These two examples illustrate context dependence of cis-
RNA sequence regulatory elements, i.e. the presence of the same trans-acting splicing 
factors can result in different alternative splicing patterns and mechanisms of splicing on 
different substrates depending on the location of the binding site on the RNA.  
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1.1.3. ADDITIONAL SOURCES OF VARIATION 
 
Alternative transcription initiation 
Alternative first exons (or alternative transcription initiation) are primarily an issue of use 
of alternative promoters. It has been estimated that, in human, more than 20% of genes 
have functional alternative promoters [Cooper et al. 2006; Landry et al. 2003] providing 
distinct regulation for alternate isoforms of the same gene.   
 
RNA polymerase II is a multisubunit enzyme that catalyzes the synthesis of mRNA from 
the DNA template. RNA polymerase II promoters are generally viewed as composed of a 
core region and an extended region. The core region of a promoter is defined as the 
minimal stretch of contiguous DNA sequence, encompassing the transcription start site, 
that is sufficient to direct accurate initiation of transcription by the RNA polymerase II 
machinery, [Woychik and Hampsey 2002]. There seem to be two major types of core 
promoters - focused and dispersed [Juven-Gershon et al. 2008]. Focused promoters, which 
are more ancient and widespread throughout nature, will contain either a single 
transcription start site or a distinct cluster of start sites over several nucleotides [Smale and 
Kadonaga 2003].  Dispersed promoters, which, in vertebrates, are more common than 
focused promoters, contain several start sites over 50-100 nucleotides and are typically 
found in CpG islands. Core promoters contain a complex array of sequence motifs, refered 
to as TATA box, INR, DPE, MTE, BRE, DCE, and XCPE1 [Juven-Gershon et al. 2008; 
Smale and Kadonaga 2003; Maston et al. 2006] that specify different mechanisms of 
transcription and responses to enhancers. However, these motifs can occur in various 
combinations and not only have a high degree of degeneracy but there seems to be no 
universally required element within promoters necessary for promoter activity [Cooper et 
al. 2006]. 
 
In addition to the core region there are other specific cis-acting DNA regulatory sequences 
forming the extended promoter upstream and downstream of the transcription start site. 
These sequences regulate RNA polymerase II transcription controlling spatial and temporal 
expression of the downstream gene. They include the proximal promoter, enhancers, 
silencers and boundary/insulator elements [Butler and Kadonaga 2002]. The proximal 
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promoter is the region in the immediate vicinity of the transcription start site (roughly from 
!250 to +250 nt). Enhancers and silencers can be located many kbp from the transcription 
start site and act either to activate or to repress transcription. Boundary/insulator elements 
appear to prevent the spreading of the activating effects of enhancers or the repressive 
effects of silencers or heterochromatin [Butler and Kadonaga 2002]. These elements are 
recognized by both sequence-specific and general transcriptional regulators during 
transcription initiation, and serve to integrate signals from multiple cellular pathways to 
deliver specific, highly regulated expression of a gene [Smale and Kadonaga 2003].  
 
Although much effort has been dedicated to identifying and describing eukaryotic 
promoters [Butler and Kadonaga 2002; Kim et al. 2005a; Cooper et al. 2006; Trinklein et 
al. 2007] and many sequence elements have been identified in subsets of promoters, the 
identification of the true start sites for all human transcripts is far from complete [Cramer 
2007]. 
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Alternative polyadenylation 
The formation of mature mRNAs in vertebrates involves processing of the 3’ untranslated 
region through a coupled reaction involving endonucleolytic cleavage followed by poly(A) 
synthesis 10–30 nt downstream of an AAUAAA or AUUAAA signal sequence. Additional 
U-rich elements upstream and downstream of the hexamer can also be present [Colgan and 
Manley 1997; Legendre and Gautheret 2003] and contribute to the definition of the correct 
cleavage and polyadenylation site. Alternative cleavage site selection for synthesis of 
poly(A) has been experimentaly validated [Moucadel et al. 2007] and shown to vary in 
2.8% of cases [Pauws et al. 2001] and is thought to depend on variation of polyadenylation 
signals. Although the AAUAAA signal is often considered to be present in 90% of the 
mRNAs (and the AUUAAA variant in the other 10%) [Colgan and Manley 1997], alternate 
signals are certainly present in a significant fraction of the 3’ ends. In addition to the two 
signals mentioned above, 10 other patterns of variant polyadenylation signal usage have 
been identified in human [Beaudoing et al. 2000] (Figure 1.6), which could account for 
14.9% of the putative mRNA 3’ ends. All the observed signals are single-base variants of 
the canonical AAUAAA hexamer. This suggests a model where a unique polyadenylation 
machinery is tolerant to a limited level of mutation in its regular signal. Positions 3, 4, and 
6 are highly conserved, while positions 1, 2, and 5 are tolerant to point mutations (Figure 
1.6). Variant signals (including the common AUUAAA) are processed less efficiently than 
the canonical signal and could therefore be selected for regulatory purposes.  
 
A number of studies reveal that at least 50% of genes in mammalian genomes contain 
several polyadenylation sites and mRNAs with different 3'UTR regions can be produced 
from a single gene [Beaudoing et al. 2000; Lee et al. 2007a; Tian et al. 2005]. The choice 
of poly(A) sites may influence the stability, translation efficiency, or localization of an 
mRNA in a tissue- or disease-specific manner [Edwalds-Gilbert et al. 1997; Graber et al. 
1999; Jankovic et al. 1990; van Solinge et al. 1996].  
 
Alternative poly(A) sites are commonly classified into tandem poly(A) sites located on the 
same 3'-exon, and sites located on different exons (including composite exons) formed by 
alternative splicing [Edwalds-Gilbert et al. 1997; Tian  et al. 2005; Yan and Marr 2005]. 
Alternative 3' ends involving different 3' exons may affect the coding sequence and 
therefore have obvious functional consequences. However, the actual functional 
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consequence of tandem poly(A) sites, producing 3' ends that differ solely by the length of 
the 3' UTR, is still largely unknown. The mRNAs with multiple poly(A) sites tend to use 
non-canonical polyadenylation signals (including the common AUUAAA) more often than 
mRNAs with a single poly(A) site [Beaudoing et al. 2000]. Regulation of 3’ end variation 
through alternative poly(A) site usage may be tissue-specific [Beaudoing and Gautheret 
2001; Hu et al. 2005; Zhang et al. 2005]. Recently reports show that alternative 
polyadenylation can also be regulated by genomic imprinting [Wood et al. 2008]. 
 
Alternative polyadenylation patterns have been shown to be conserved in mammals [Ara et 
al. 2006]. Features such as the presence of multiple cleavage sites, distribution of poly (A) 
signal variants and nucleotide composition of flanking regions were reported to be similar 
in human and mouse [Tian  et al. 2005]. All this evidence suggests that alternative 
polyadenylation is a widespread mechanism that contributes to transcript diversity in 
eukaryotes. 
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Figure 1.6 – The 12 putative human polyadenylation signals. The canonical signal 
AAUAAA is thought to be present on 90% of mRNAs. The other 11 variant signals 
observed are single-base variants of the canonical AAUAAA hexamer (single base 
variation highlighted in blue).  Positions conserved in more than 90% of the variants are 
highlighted in yellow [Beaudoing et al. 2000]. Consensus sequence shown below (N = any 
nucleotide). 
1.  AAUAAA  
2.  AUUAAA  
3.  AGUAAA 
4.  UAUAAA 
5.  CAUAAA 
6. GAUAAA 
7.  AAUAUA 
8.  AAUACA 
9.  AAUAGA 
10.  ACUAAA 
11. AAGAAA 
12. AAUGAA 
 NNUANA 
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Alternative translation initiation 
The process of translation initiation of messenger RNAs in eukaryotes is conventionally 
thought to proceed through three steps: binding of a 40S ribosomal subunit-factor complex 
to the capped 5' end of the mRNA, followed by linear migration of the ribosome along the 
mRNA, with translation of the genetic code into protein beginning upon encounter of the 
ribosome with the first AUG codon [Kozak 1989]. However, the context of the AUG codon 
can affect the start of translation [Kozak 1987a; Fekete et al. 2007]. In mammals, the 
optimal consensus sequence, GCCRCCAUGG (R = purine), has been identified as the 
most efficient context for translation initiation [Kozak 1987b, 1989, 1995, 1997].  A less 
favorable context may cause the first AUG codon to be bypassed and the scanning 
mechanism to continue until an AUG codon in a more favorable context for translation 
initiation is found. AUG start codons are designated strong when position -3 is a purine 
base (R shown in bold above) and position +4 is a guanine base (G shown in bold above); 
or weak based on lack of conformity to the consensus sequence at positions -3 and +4 
[Kozak 1987b, 1989, 1995, 1997]. This variation in translation initiation is referred to as 
reinitiation and context-dependent leaky scanning [Kozak 2001, Kozak 2002]. Bifunctional 
mRNAs [Kozak 1986] have also been found where a stop codon is followed closely by a 
start codon and the ribosome reinitiates translation of a second protein from the same 
mRNA.  mRNA secondary structure at the 5’ end has also been shown to affect translation 
initiation at AUG codons within an unfavourable context [Kozak 1990] including initiation 
at non-AUG codons [Kochetov 2007]. Another mechanism of translation has been 
discussed in the literature where it is proposed that the ribosome enters the mRNA not at 
the 5’ capped end but at an internal ribosome entry site (IRES), however, some degree of 
controversy surrounds this proposed mechanism [Fujimura et al. 2008; Kozak 2005].  
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1.1.4. ABBERANT ALTERNATIVE SPLICING IN MYOTONIC 
DYSTROPHY – A CASE STUDY 
 
Myotonic Dystrophy is a multisystemic disorder caused by microsatellite expansions of 
CTG (in DM1) and CCTG (in DM2) repeats in non translated regions of the DMPK and the 
ZNF9 genes respectively [Timchenko 1999]. Although the expansions are located on 
different chromosomes, there appears to be a common pathogenic mechanism involving the 
accumulation of transcripts into discrete nuclear RNA foci containing long tracts of CUG 
or CCUG repeats expressed from the expanded allele, and that these effects are 
independent of the DMPK or ZNF9 locus [Margolis et al. 2006]. The disease is mainly 
characterised by defects in skeletal muscle, but many other tissues and systems are 
involved such as cardiac muscle, brain, eye, and the endocrine system. Some of these 
defects have been traced to misregulation of alternative splicing of a number of genes 
[Kuyumcu-Martinez and Cooper 2006]. At least 20 alternative splicing events are disrupted 
in DM heart, skeletal muscle, or brain tissues [Cooper 2007]. The mechanism by which 
these expanded repeats alter the regulation of pre-mRNA alternative splicing is complex. A 
model of RNA-mediated pathogenesis has recently been propose [Kanadia et al. 2006]. 
Several aspects of this model have been studied in DM1 and are summarised in Figure 1.7. 
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Figure 1.7 
 
 
 
 
 
Figure 1.7 – Summary of some of the complex events which occur in Myotonic Dystrophy 
Type 1 (DM1) as a consequence of expanded CUG repeats in the DMPK gene. CUG 
repeats form a highly stable single-loop hairpin with an extended stem and mRNAs with 
expanded repeats accumulate in nuclear foci [Davis et al. 1997; Napierala and Krzyzosiak 
1997; Kock and Leffert 1998]. These hairpins recruit double stranded CUG binding 
proteins such as MBNL [Mankodi et al. 2001; Miller et al. 2000] and hnRNP H [Kim et al. 
2005b], both of which are involved in the regulation of splicing [Ho et al. 2004]. hnRNP H 
may also be responsible for the nuclear retention of the DMPK transcripts [Kim et al. 
2005b]. Nuclear accumulation of CUG expanded repeats also results in a 2-5x 
overexpression of CUGBP1 activity and retention in the nucleus by some unknown 
mechanism [Timchenko et al. 2001]. However, CUGBP1 does not co-localize 
preferentially with the CUG expanded repeats, but rather binds preferentially to U/G rich 
sequences [Mori et al. 2008]. CUGBP1 is known to regulate at least three of the pre-
mRNAs that are misregulated in DM striated muscle by binding to intronic U/G rich 
regions on these genes; these genes are chlorine channel 1(CLCN1), Insulin Receptor  
(IR), and cardiac Troponin T (cTNT). Aberrant alternative splicing in CLCN1 displays a 
novel exon and intron retentions which introduce a premature stop codon, the absence of 
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this channel being symptomatic of myotonia [Charlet-B  et al. 2002; Mankodi et al. 2002; 
Lueck et al. 2007]. In the Insulin receptor an exon skipping event produces a non-muscle 
lower affinity isoform which results in insulin resistance [Savkur et al. 2001]. And in 
cardiac troponin T the introduction of a novel exon is associated with cardiac conduction 
abnormalities [Philips et al. 1998]. Other genes are also known to suffer aberrant 
alternative splicing in DM1 such as, microtubule-associated protein tau (MAPT) [Leroy et 
al. 2006] in both muscle and brain; myotubularin related protein 1 (MTMR1) [Buj-Bello et 
al. 2002] ; homeobox gene SIX5 [Sato et al. 2002]; and others, but the exact consequences 
of the mis-splicing are not known. Furthermore it has been demonstrated that inappropriate 
splicing patterns of cTNT and IR can be reproduced in normal cells by overexpression of 
CUGBP1 [Timchenko et al. 2004], which strongly suggests that aberrant regulation of 
alternative splicing of these genes in DM1 is, at least in part, a consequence of CUGBP1 
overexpression. However although altered expression of genes post-transcriptionally 
regulated by CUGBP1 are likely to contribute to DM pathogenesis many other factors are 
simultaneously at play: cardiac troponin T is also a target for the splicing factor MBNL 
[Warf and Berglund 2007]; it has also been demonstrated that MBNL and CUGBP splicing 
factors are antagonistic regulators of alternative splicing [Ho et al. 2004] promoting 
opposite splicing patterns for cTNT and IR alternative exons; and that coordinated physical 
and functional interactions between hnRNP H, CUG-BP1 and MBNL1 dictate IR splicing 
in normal and DM1 myoblasts [Paul et al. 2006].  
 
At the translational level, it has also been demonstrated in mice that the overexpression of 
CUGBP1 increases translation of proteins that are required for myogenesis such as MEF2A 
and p21 [Timchenko et al. 2004]. A similar induction of these proteins is observed in DM1 
which diplays increased levels of CUGBP1. Overexpression of MEF2A and p21 may 
inhibit myogenesis and contribute to the deficiency in muscle development observed in 
DM1. A marked reduction of MyoD, a transcription factor required for the differentiation 
of myoblasts during muscle regeneration, is also observed in DM [Amack et al. 2002].  
 
Interestingly in the case of chloride channel 1, ryanodine receptor 1, and 
sarcoplamic/endoplasmic reticulum Ca2+-ATPase 1 aberrant splicing in DM, the actually 
mRNA splice variants are not abnormal, but the normal developmental splicing pattern 
seems to be disrupted, resulting in expression of fetal protein isoforms that are 
inappropriate for adult tissues [Kimura et al 2005; Lin et al. 2006; Dhaenens et al. 2008; 
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Cooper 2007; Ranum and Cooper 2006]. A recent report also reveals the existence of  
MBNL1 fetal isoforms in the DM1 brain [Dhaenens et al. 2008]. The delayed 
differentiation in human myotonic dystrophy myoblasts affects fetal muscle development 
and compromises muscle regeneration in adults [Cooper 2007] . The case of disruption of 
alternative splicing in myotonic dystrophy may have revealed tampering with pathways of 
regulation of developmentally programmed alternative splicing [Pascual et al. 2006], 
involving splicing factors such as hnRNP-H, CUGBP1 and MBNL1. This hypothesis is 
supported by recent work which shows that MBNL1 participates in the post-natal 
remodelling of skeletal muscle by controlling a key set of developmentally regulated 
splicing switches and that sequestration of MBNL1 in DM and consequent failure to 
maintain these splicing transitions, has a pivotal role in muscle pathogenesis of this disease 
[Lin et al. 2006].  
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1.2. NON-PROTEIN-CODING RNA 
 
Noncoding RNA (ncRNA) genes make transcripts that function directly as RNA, rather 
than encoding proteins [Eddy 1999, 2001]. The best known ncRNAs have complex three-
dimensional RNA structures and play roles as catalytic or structural parts of RNA-protein 
machines; examples include transfer RNA, ribosomal RNA, and spliceosomal RNAs. Many 
other ncRNAs, especially many of the recently discovered ones, act in a relatively 
unsophisticated manner by base pairing to a target RNA. This binding can regulate gene 
expression directly (for instance, by sterically occluding a ribosome binding site), or 
provide RNA targeting specificity for a protein-based regulatory or modification 
mechanism: Examples include the micro RNAs (miRNAs) [Ambros 2001; Bartel 2004], E. 
coli translational regulatory RNAs [Wassarman et al. 1999], and small nucleolar RNAs 
(snoRNAs) [Eliceiri 1999; Kiss 2002; Kiss 2001]. In vertebrates snoRNAs are intimately 
involved in alternative splicing regulation [Bazeley et al. 2008]. Hundreds of small 
nucleolar RNAs are processed from pre-mRNA introns [Hirose et al. 2006; Kiss 2006]. 
Other RNA genes include snRNAs (small nuclear RNAs), scRNAs (small cytoplasmic 
RNAs), telomere RNAs, splice leaders and small regulatory RNAs. Some of these, such as 
the snoRNAs are hard to recognize in raw sequence [Hertel et al. 2008], and consequently 
their exact number is unknown. Others, such as the developmental timing regulators lin-4 
and lin-7, are known to perform important biological functions, but their discovery has 
depended entirely on genetic methods [Reinhart et al. 2000]. The number of known RNA 
genes in C. elegans is about 1000. 
 
MicroRNAs 
MicroRNAs constitute a large family of small, approximately 21-nucleotide-long, non-
coding RNAs that have emerged as key post-transcriptional regulators of gene expression 
in metazoans and plants [He and Hannon 2004]. In mammals, microRNAs are predicted to 
control the activity of approximately 30% of all protein-coding genes, and have been 
shown to participate in the regulation of almost every cellular process investigated so far 
[Ambros 2003; Carrington and Ambros 2003; Ambros 2004; Farh et al. 2005; Maroney et 
al. 2006; Nilsen 2007; Wu and Belasco 2008] including cancer [Calin et al. 2006; Esquela-
Kerscher and Slack 2006]. By base pairing to mRNAs, microRNAs mediate translational 
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repression or mRNA degradation [Filipowicz et al. 2008]. Some clustered microRNAs are 
likely to coordinately regulate target genes and specific regulatory relationships appear to 
be conserved between flies and mammals [Grün et al 2005]. 
 
Although biochemical methods [Zhang et al. 2007] have been more successful for 
predicting microRNAs, many bioinformatics tools have been developed to predict 
microRNAs and their targets [Eddy 2002; Rehmsmeier et al. 2004; Legendre et al. 2005; 
Ng Kwang Loong and Mishra 2007]. Although little is known about the transcriptional 
regulation of primary microRNAs (pri-miRNAs), and most metazoan miRNA genes do not 
have the classical signals for polyadenylylation [Ohler et al., 2004], evidence suggests that 
many are transcribed by RNA polymerase II [Bartel 2004] and are therefore capped; some 
however can be transcribed by RNA polymerase III [Bartel 2004; Borchert et al. 2006]. 
Many are located within introns of host genes, including protein-coding genes and non-
coding genes and may therefore be regulated through the host gene promoters. Certain 
miRNAs are clustered in polycistronic transcripts suggesting that these mRNA are 
coordinately regulated [Lagos-Quintana et al. 2003]. The current model for the biogenesis 
of microRNAs is summarized in Figure 1.8 [He and Hannon 2004; Kim 2005]. 
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Figure 1.8. (adapted from [He and Hanon 2004]) 
 
 
 
 
Figure 1.8. Current model for the biogenesis of microRNAs (Figure taken from [He and 
Hannon 2004]). Regardless of their diverse primary sequences and structures, pri-miRNAs 
are processed inside the nucleus, by the RNase III enzyme Drosha, into ~70-nucleotide pre-
miRNAs that consist of an imperfect stem-loop structure [Lee et al. 2003]. Pre-miRNAs are 
transported to the cytoplasm by Exportin 5 [Lund et al. 2004]. In the cytoplasm these 
hairpin precursors are cleaved by Dicer [Hutvagner et al. 2001] into a small, imperfect 
double stranded RNA (dsRNA) duplex (miRNA: miRNA*) that contains both the mature 
miRNA strand and its complementary strand (miRNA*). Dicer also processes long dsRNA 
molecules into small interfering RNA (siRNA) duplexes. Cleavage by Dicer generates 
mature miRNAs that range from 21 to 25 nucleotides, the differences in size possibly 
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resulting from the presence of bulges and mismatches on the pre-miRNA stem. Only one 
strand of the miRNA:miRNA* duplex or the siRNA duplex is selectively assembled into 
the RNA-induced silencing complex (RISC), which subsequently acts on its target by 
translational repression or mRNA cleavage, depending, at least in part, on the level of 
complementarity between the small RNA and its target.  This process is also known as 
post-transcriptional gene silencing (PTGS). 
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1.3. MICROARRAYS 
Microarray technology is a widely used tool which allows the expression levels of 
thousands of genes to be simultaneously monitored [Allison et al. 2006; Schena et al. 1995; 
Schena et al. 1996]. The principle behind microarray analysis is the binding of 
complementary strands of nucleic acids. A microarray consist of a solid support, such as 
glass, plastic or silicon, onto which specific oligonucleotides are tethered in defined 
locations (or spots), by various methods. Each microscopic spot will contain several 
thousand copies of a unique oligonucleotide sequence referred to as a probe. These oligos 
are designed so as to be complementary to transcribed gene sequences as illustrated in 
Figure 1.9. Although transcribed genes are captured as RNA this molecule is less stable 
than DNA and therefore, for these experiments, it is common to transcribe it into cDNA 
which will contain both the sense and the antisence strand.  
 
Figure 1.9. Complimentary binding of a tethered DNA probe to the sample cDNA 
 
  
 
 
 
 
 
 
 
 
 
 
 
Probes can be designed either as the sense strand or the antisense strand. To ensure that 
binding of cDNA to a microarray is indeed specific, probes are designed to comply to 
several requirement such as: low potential for forming hairpins (binding to itself); absence 
of repeats; balanced nucleotide coverage; no secondary binding (binding to other genes); 
and good annealing temperature.  
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In order to visualise the bound cDNA the sample is labelled with a fluorophore, either Cy3, 
which has a fluorescence emission wavelength of 570 nm (green), or Cy5 with a 
fluorescence emission wavelength of 670 nm (red). 
 
A one-colour (or single-channel, or single dye) microarray experiment will use cDNA from 
a single sample. A two-colour (or dual-channel) microarray experiment will simultaneously 
monitor two samples, labelled with different fluorophores, on the same microarray. Once 
the hybridization has taken place the results are viewed by scanning the microarray with a 
laser beam of a defined wavelength. The intensities (or relative intensities) of the 
fluorophore(s) are then used to identify up or down regulated genes. 
 
Oligonucleotide microarrays will normally contain control probes designed to hybridize 
with RNA spike-ins (additional sequences added to the sample). The degree of 
hybridization between the spike-ins and the control probes is used to normalize the data.  
 
A single-channel microarray will normally be analysed either by comparing genes within 
an array or to reference "normalizing" probes used to calibrate data across the entire array, 
or across multiple arrays.  Although twice the amount of arrays are required to compare 
samples within an experiment, single channel arrays allow comparison of data from 
different experiments conducted at different times. A dual-channel microarray can be used 
to compare relative levels of expression in a diseased tissue versus a healthy tissue, for 
example. The advantage of using a dual channel is that only one microarray is needed. 
 
One of the most popular companies producing commercial platforms is Affymetrix which 
has produced microarray platforms monitoring 3’ end expression of genes. Recently 
Affymetrix has produced commercial arrays containing millions of probes which aim at 
covering the entire genome at the scale of an exon [W10; Gardina et al. 2006] rather than 
just monitoring the 3’end of a gene. One such array is the GeneChip® Human Exon 1.0 ST 
array containing approximately 5.5 million probes from a 1.4 millon probe set which can be 
used to interrogate 1 million known and predicted exons. This type of array is naturally 
inviting for the study of alternative splicing as the study of gene expression can be 
monitored at the level of individual isoforms and exons [Okoniewski 2007] 
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2. MATERIALS AND METHODS 
 
2.1. CONSTRUCTION OF THE DATABASE  
2.1.1. DATA SOURCES 
Tables of BLAT alignments [Kent 2002] of RefSeq [Pruitt et al. 2007], mRNAs and 
spliced ESTs to a genome assembly were obtained from the UCSC Genome Browser 
[Karolchik et al. 2008; Karolchik et al. 2004; W6] and loaded into a MySQL database. The 
Perl programming language [Wall et al. 2000] and the Perl::DBI [W1] module were used to 
interface with the MySQL database. BLAT alignments of spliced ESTs taken from UCSC 
Genome Browser have a minimum of 96% base identity with the genomic sequence and 
will only carry introns smaller than 750,000 bases; in addition, such spliced ESTs retrieved 
from UCSC BLAT alignments must have at least one intron of minimum length 32 bases 
with a GT…AG consensus splice site. For the RefSeq alignments the RefFlat UCSC table 
was used to include a gene symbol associated with the alignment. The chromosome 
sequences for the genome assemblies of thirteen model organisms were obtained from the 
UCSC Genome Browser [W6]: human, Homo sapiens; chimp, Pan troglodytes; rhesus, 
Macaca mulatta; mouse, Mus musculus; rat, Rattus norvegicus; cow, Bos taurus; dog, 
Canis lupus familiaris; chicken, Gallus gallus; frog, Xenopus tropicalis; zebrafish, Danio 
rerio; fruit fly, Drosophila melanogaster; nematode worm, Caenorhabditis elegans; and 
sea squirt, Ciona intestinalis. Human ESTs originate from libraries generated from a 
variety of tissue sources (45% from normal tissue, 26% from tumor tissue or cell lines, 2% 
from disease tissue, and 27% with no tissue annotation). 
 
 
2.1.2. DATA PROCESSING 
The genomic region of a gene was determined as that to which all RefSeq BLAT 
alignments associated with a given Entrez GeneID [Maglott et al. 2007] mapped, extended 
to any mRNA or spliced EST with at least one spliced junction in common with the RefSeq 
alignments. For unspliced RefSeq genes all mRNA and spliced EST alignments falling 
within the boundaries of the gene were considered. BLAT alignments consist of a series of 
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aligned blocks separated by gaps of genomic sequence. One would normally expect the 
aligned blocks to correspond to exons and the gaps in the alignment to correspond to 
introns, however, this is not always the case and the following steps are taken to filter out 
data not considered of sufficiently good quality to permit extraction of information on 
alternative splicing. To establish the minimum intron size we looked for the smallest 
RefSeq intron carrying the splice site consensus sequences GT_AG, GC_AG or AT_AC 
and found it to be 30 nt (SupplemetaryTable1.doc). Based on this result, a minimum intron 
size of 30nt was postulated. Two adjacent blocks separated by gaps smaller than 30nt were 
not considered to be reliable introns and were joined into a single block. These small gaps 
can be due to short repeats of variable length in the genomic sequence and the transcript or 
to short stretches of the transcript which the BLAT program did not succeed in aligning due 
to single nucleotide polymorphisms; their occurrence was mostly seen in 5’ and 3’ 
untranslated regions. A record of the sequence and position of all these ‘filled in’ regions 
was kept, including the transcript GenBank accession. Blocks in the BLAT alignment of a 
transcript mRNA or EST are potential exons.  The smallest exon which we have detected in 
RefSeq annotated human genes is 6nt, in the RELN gene, but it is not mapped correctly to 
the genome assembly in UCSC BLAT alignments.  A total of eight blocks with 7nt were 
found in RefSeq genes but of these only one mapped with consensus splice sites in UCSC 
BLAT alignments. A total of nine blocks with 8nt were found in RefSeq genes and, of 
these, seven mapped with consensus splice sites.  There are more than 50 blocks of 9nt in 
RefSeq genes and these map with consensus splice sites in UCSC BLAT alignments, with 
few exceptions. A 9nt block was therefore chosen as a reliable lower threshold to impose 
on the size of blocks. Subsequently, the first two and last two nucleotides of each remaining 
gap in the alignment were analysed for splice site consensus sequences GT...AG, GC...AG, 
or AT...AC in the case of an mRNA source; and GT...AG or GC...AG in the case of an EST 
source. Where a splice site consensus did not exist, or a block was smaller than 9 
nucleotides, an alignment was cut into fragments at the non-consensus junction or on either 
side of the small block respectively. Given that RefSeq sequences are constantly reviewed 
and are here used as reference sequences for a given gene, the program overrides this 
filtering procedure for RefSeq alignments and all of these are accepted regardless of the 
consensus sequence at the splice junction and the size of the aligned blocks. For the above 
set of filtered data the start and end of each alignment was corrected to the nearest known 
spliced junction or, for the terminal regions, to the longest corresponding block, according 
to the set of rules described in the Appendix A. The resulting blocks were considered to 
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correspond to exons and the intervening gaps to introns and each sequence segment was 
numbered and assigned a type as described in Figure 2.1. Thus, only a single EST or 
mRNA is required to support a new exon, provided that 96% of its sequence aligns to the 
genome assembly, that it contains at least one intron with consensus splice sites and has at 
least one splice site in common with a RefSeq annotated exon. No special requirement was 
imposed on first or last exons other than that these must have at least 9nt (the minimum 
block size required) and splice site consensus sequences. Any gaps smaller than 30 nt will 
have been patched up. If a gap greater than 30 nt between the first exon and the next exon 
does not have consensus splice sites the first exon is simply excluded. 
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Figure 2.1 - Nomenclature used to describe the organisation of the gene using the known 
starts and ends of all superimposed exons. The known starts and ends of all superimposed 
exons are used to partition the gene into segments. A. A cut start (cS) followed by an exon 
end (E) is considered a first exon (fe); two consecutive ends (E) is considered a 3' exon 
extension (3e); an end (E) followed by a start (S) is considered an intron; an exon start (S) 
followed by an exon end (E) is considered an exon (e); two consecutive starts (S) is 
considered a 5' exon extension (5e); and an exon start followed by a cut end is considered a 
terminal exon (te). B. Nomenclature used for alternative first exons and alternative terminal 
exons: an end (E) followed by a cut start (cS) is considered an intervening sequence which 
contains only a 5'ss (5i); and a cut end (cE) followed by a start (S) is considered an 
intervening sequence which contains only a 3'ss (3i). C. Nomenclature used for a gene 
containing a single exon:  a cut start (cS) followed by a cut end (cE) is considered a single 
exon (se). 
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Representative set of splicing patterns 
To obtain a representative set of isoforms, the minimal set of longest transcripts covering 
all the collected spliced junctions is retrieved by pattern matching of the various 
combinations of numbered sequence segments. Given that a gene can have several 
thousand ESTs mapping to it, using a representative set of splicing patterns can reduce the 
list of all splicing patterns collected by several orders of magnitude. A reference sequence, 
chosen as the RefSeq transcript with the highest version number and the most recent 
update, is used to number novel exons in relation to it. All the exons in this condensed set 
of isoforms are numbered in relation to a reference sequence as illustrated in Figure 2.5 B.  
 
Alternative Splicing Events 
The representative set of splicing patterns is built into a directed graph object using the Perl 
Graph module [W2] which is used to retrieve a description of all alternative splicing events 
using a generic description of an event as described in Figure 2.2. A region containing 
mutually exclusive exons is described using two or more events (Figure 2.3). Different 
isoforms, however, may carry different combinations of alternative splicing events and the 
alternative splicing events must be viewed in combination with the representative set of 
isoforms. The description of the gene as a succession of segments, as shown in Figure 2.1, 
allows for junctions to be described as a string of characters referred to as the “splice 
string” (Figure 2.4). This string of characters allows us to have additional information, on 
what segments are being skipped, when a region between two exons contains more than 
two splicing patterns  (Figure 2.4). 
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Figure 2.2. Generic description of an alternative splicing event. C1, C2 indicate the 
constitutive exons and A1, A2  are the alternative sequences, either exons or exon 
extensions. Each junction C1,C2 skipping more than a simple intron or containing an intron 
retention is considered as a region of alternative splicing. In the Graph object, A1 is a 
successor of C1 and A2 as a predecessor of C2. Several options are possible for A1 and A2: 
for skipping of a single exon, an alternative 3’ or 5’ splice site or an intron retention, A1 
will be equal to A2 (A1=A2); for alternative first exons there will be no A1; for alternative 
terminal exons there will be no A2; and for other more complex patterns of splicing A1 and 
A2 can be different exons or 3’ or 5’ exons extensions (A1"A2). 
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Figure 2.3. – Mutual exclusion events are described by two or more events of the type “no 
A1” and “no A2” (see generic description of an event in Figure 2.2).  
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Figure 2.4 – Description of complex alternative splicing. In this figure a hypothetical 
complex alternative splicing event is presented, where more than two splicing patterns are 
possible between exons 1 and 2. Boxes indicate exons and the spaces between the boxes 
indicate intervening sequences, or introns. The generic event shown in Figure 2.2 allows 
for an alternative splicing event to be described by comparing two splicing patterns: e.g. 
splicing pattern (1,1B,2) and splicing pattern (1,2)  resulting in the event description 
“Cassette exon 1B”. On the other hand the description of the gene as a succession of 
segments, as shown in Figure 2.1, allows for junctions such as that between exons 1 and 2 
to be described as a string of characters (the splice string) in which the spliced segment 
type characters are in uppercase and the skipped segment type characters are in lowercase. 
In this case the splice string reveals that in the junction (1,2) there are two cassette exons 
and a 5’ extension of exon 2 being skipped.  
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Constitutive exons 
Given the fragmented nature of ESTs, and some mRNAs, used here for mining alternative 
splicing, determination of constitutive exons is not straightforward. Our approach for 
selecting constitutive exons is done by choosing those which are not detected as being 
spliced out in the representative set of isoforms; first or terminal exons will only be marked 
as constitutive if the gene contains a single first or single terminal exon respectively. Exons 
C1 and C2 in Figure 2.2 are only constitutive in relation to the description of a particular 
event; they will not be marked as constitutive if they are spliced out in another event. This 
approach can result in exons upstream and downstream of the reference sequence being 
marked as constitutive, however these can easily be distinguished by the reference 
numbering system (Figure 2.5).  
 
In Figure 2.5 we display a hypothetical gene to illustrate the re-numbering of exons in 
relation to the reference isoform; and a representative set of isoforms with novel, upstream, 
downstream, alternative and constitutive exons colour coded. This representation was used 
as a basis for an automatically generated web graphical display. The description of 
alternative splicing events is provided by comparing pairs of isoforms, however different 
isoforms may carry different combinations of alternative splicing events and the alternative 
splicing events must be viewed in combination with the representative set of isoforms.  
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Figure 2.5 - A. Organization of a hypothetical gene. GenBank accessions for all the 
representative set of isoforms are normally given. Boxes represent exons; exon lengths in 
nucleotides are indicated below each box (blue); intron lengths are indicated in nucleotides 
above in the gaps between the boxes (red). B. Set of determined representative isoforms. A 
reference sequence is chosen from this set and exons can be renumbered in relation to this 
reference sequence. In the reference numbering system upstream exons are preceeded by 
the letter U and downstream exons by the letter W. Novel exons take the number of the 
previous exon succeeded by a capital letter. C. Literal description of alternative splicing 
events. 
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Polyadenylation sites 
Alternative polyadenylation has been shown to be associated to alternative splicing 
[Edwalds-Gilbert et al. 1997]. Polyadelylation sites and their positions in a transcript, based 
on variants of the canonical AAUAAA motif [Beaudoing et al. 2000] are determined for 
the whole transcript of each representative isoform. 
 
Tissue expression 
To determine tissue expression we use the gbCdnaInfo table available from the UCSC 
Table Browser [Karolchik et al. 2004], which associates each accession with various data 
retrieved from the original GenBank record such as: tissue, developmental stage or sex. 
Every mRNA and EST collected for each gene in our database is associated with the 
sequential numbering of exons as exemplified in Figure 2.5. Using simple pattern matching 
the user can determine all the accessions which contain a particular exon, junction or 
splicing pattern and thereby find the corresponding tissue expression information. 
 
Open reading frames 
For information on open reading frames a table is provided with translation of each 
representative isoform starting on the first, second and third nucleotide and then from each 
AUG start codon to the first in-frame stop codon. This allows the user to select individual 
putative proteins from this table. 
 
Orthologs 
Information on orthologs of human genes is also provided. These are obtained by selecting 
BLAT alignments of RefSeq accessions from other organisms to a particular human gene 
locus. These alignments are available from the UCSC Genome Browser. 
 
 
Data for Microarray experiments  
ExonMine also provides data for microarray experiments in the form of tables with all 
junctions (50 nucleotides centered on the junction) and exons involved in alternative 
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splicing events. The information on constitutive exons can also be used for designing or 
analysing alternative splicing microarrays. All information on exons and junctions can be 
referenced back to the original alternative splicing events. This type of information can be 
used either for custom design of alternative splicing microarrays or for relating commercial 
exon array probes to alternative splicing events. Figure 2.6 summarises the steps followed 
in processing the data for a given organism. 
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Figure 2.6 Summary of steps followed in the algorithm to produce ExonMine data for a 
give organism 
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3. RESULTS AND DISCUSSION 
 
3.1. THE EXONMINE DATABASE 
 
3.1.1. STATISTICS 
 
All information collected is stored in a MySQL database structure. Summary of the input 
data used to determine alternative splicing in 13 model organisms and resulting number of 
genes and isoforms detected is described in Table 3.1. Here we show the number of 
alternatively spliced genes measured as the percentage of genes in which more than one 
isoform was detected, this includes intron retentions and transcripts that begin or end in an 
intronic region. For the human genome, for example , 3976715 spliced ESTs were loaded 
into the program and 3851376 (97%) of these were found to share at least one splice site 
with a RefSeq exon and to have at least one intron with consensus splice sites - these are 
referred to as captured or clustered ESTs. A direct comparison of the values in Table 3.1 
can only be done for human, mouse, drosophila and C. elegans, for which we are assuming 
an equivalent coverage of alternative splicing events detected using ESTs (i.e., more than 
95% of spliced ESTs were clustered). For these genomes, the increase in complexity of the 
organisms clearly accompanies the increase in splicing and the increase in alternative 
splicing, as the number of exons per gene increases and as both the number of genes with 
more than one isoform and the number of isoforms per gene rise. ExonMine detected twice 
as many splicing patterns in human than in mouse, with a comparable percentage of ESTs 
clustered, 97% and 96% respectively.  
 
For organisms where more than 95% of spliced ESTs were clustered, we further compared  
the number of splicing patterns, alternative exons and open reading frames (Table 3.2). 
Data from chimp was not included because ESTs and mRNAs used are mainly of human 
origin. The proportional increase observed in different types of splicing patterns, relative to 
C. elegans, is indicated in Table 3.2. We see that the human data contains almost twice the 
amount of splicing patterns as the mouse data with an equivalent percentage of these 
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containing intron retentions (35-36%). The high level of intron retentions detected is most 
likely due to incompletely spliced transcripts. Similar levels of intron retentions have been 
detected in another study of EST transcripts to monitor alternative splicing [Zan et al. 
2002]. A lower percentage of intron retention is observed in the fruit fly (18%) and 
nematode (11%). The proportional increase observed in the number of splicing patterns 
with alternative exons is significant: 30 fold for the human, 13 fold for the mouse and 3 
fold for the fruit fly. Finally, Table 3.2 reveals that human and mouse have significantly 
more splicing patterns where the transcript contains a new exon (i.e. one not annotated by 
RefSeq), greater than 50nt, with no open reading frame in-frame with known exons (i.e. 
exons annotated by RefSeq). The proportional increase observed in the latter, relative to C. 
elegans, is dramatic: 305 fold for the human, 128 fold for the mouse but only 5 fold for the 
fruit fly (the data used to obtain these values is available on request from the ExonMine 
team). This contrasts greatly with the proportional increase observed in the total number of 
splicing patterns with alternative exons. These results are consistent with our premise that 
more complex layers of gene regulation involving putative non-protein-coding transcripts 
containing new exons are likely to exist in general in higher organisms and in particular in 
humans. About 4% (human) and 1.3%(mouse) of these have open reading frames (data not 
shown) which could potentially code for more than 150 amino acid; the possibility of some 
of these transcripts coding for small proteins could also be explored.  
 
 
For human and mouse Table 3.3 shows that the majority of alternative exons captured by 
ExonMine have not been annotated by RefSeq (92% and 94% respectively) with a greater 
percentage of these being new first exons revealing an increased detection of putative 
alternative promoters. In the case of D. melanogaster and C. elegans two thirds of the 
exons captured have been annotated by RefSeq. Of the resulting 24345 new first exons 
(45% of 54515, Table 3.3) detected in the human the April 2008 update of ExonMine, 89% 
are greater than 50nt. 
 
Notwithstanding the fact that the transcript data used by ExonMine to determine alternative 
splicing in chimp is mainly of human origin, the complexity of splicing obtained is very 
close to that of human; the chimp would therefore naturally provide a better model 
organism than the mouse for extrapolation to the human.  
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A manual analysis of the data obtained revealed that alternative splicing involving 
sequences shorter than 20 nucleotides should not be taken for granted. This is due to 
limitations of the BLAT program which does not always succeed in aligning junctions 
containing single nucleotide polymorphisms or exons shorter than 20 nucleotides, 
producing alignments that will appear as alternative splicing but are not. Normally these are 
expected to produce non-consensus splice sites and will be filtered out, but chance may 
produce a consensus splice site in the alignment. We tried to filter out such alignments but 
found that doing so could sometimes remove another valid alternative splicing event in the 
offending transcript and therefore decided instead to include them with this warning. 
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Table 3.1 - Summary of input and output data 
Input data used to determine alternative splicing in each organism and resulting output 
number of genes and splicing patterns detected (April 2008 update). For P. Troglodytes 
both human and chimp mRNAs and ESTs were used. Genome assemblies may contain 
sequenced regions which have not yet been definitively assigned to the complete 
chromosome but are still used in the BLAT mapping process; this can result in a gene being 
assigned both to a chromosome and an unassigned region; on the other hand there may be 
more than one copy of a gene in the genome, this is particularly evident in G. gallus, X. 
tropicalis and D. rerio as the number of genes detected is greater than the number of 
RefSeq sequences used. 
 
 
 
 
Organism 
Genome 
assembly 
Number of 
RefSeq 
transcripts 
Number of 
clustered 
mRNAs 
Number 
of 
clustered 
spliced 
ESTs  
% 
Spliced 
ESTs 
captured 
Number 
of 
Genes 
% 
Genes 
with 
more 
than 
one 
splicing 
pattern 
detected 
Average 
number 
of core 
exons 
per 
gene # 
Average 
number 
of 
splicing 
patterns 
per 
gene 
H. sapiens  hg18  25196 132059 3851376 97 19431 88 14 10.5 
P. troglodytes  panTro2  25656 130388 3722877 97 19750 86 14 9.9 
M. mulatta  rheMac2  466 1031 2603 8 466 23 7 1.5 
M. musculus  mm9  21216 129099 1834467 96 19393 79 11 5.6 
R. norvegicus  rn4  14345 16121 272192 82 14260 56 9 2.5 
C. familiaris  canFam2  873 1109 17352 10 884 39 10 1.8 
B. taurus  bosTau3  9496 13057 654778 78 10052 71 9 3.7 
G. gallus   galGal3  4161 7149 125947 46 4267 71 11 3.3 
X. tropicalis  xenTro2  6837 10588 504015 70 7764 64 9 3.0 
D. rerio  Zv7  12659 18194 697710 81 13647 60 9 2.7 
C. intestinalis  ci2  688 1125 41947 10 736 51 9 2.2 
D. melanogaster  dm3  20714 16676 265263 98 14556 37 5 1.9 
C. elegans  ce4  23121 2279 245458 98 20320 20 6 1.3 
# The number of exons is counted taking into account only the constitutive part of exons and not exon extentions. 
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Table 3.2  - Splicing patterns with intron retentions or with new exons but no open 
reading frames 
The number of splicing patterns where the transcript contains a ‘New Exon’ greater than 
50nt but no open reading frame (orf) in-frame with known exons was determined, 
excluding splicing patterns with intron retentions and splicing to more than one exon 
upstream or downstream of the reference sequence. Percentages (in brackets) are in relation 
to the total number of splicing patterns detected in that organism.  The proportional 
increase in the number of splicing patterns relative to C. elegans is indicated in square 
brackets. 
 
 
 
Organism Genes 
Total no. of 
Splicing 
Patterns 
[value/value for 
C. elegans] 
Splicing Patterns 
with Intron 
Retentions (%  
Total Splicing 
Patterns) 
[value/value for C. 
elegans] 
Splicing Patterns with 
Alternative Exons*  
(%  Total Splicing 
Patterns) [value/value 
for C. elegans] 
No. of splicing patterns 
where transcript contains 
New Exon** >50nt with 
no orf in-frame with 
known exons (% Total 
Splicing Patterns) 
[value/value for C. 
elegans] 
H. sapiens 19431 204556      [8]    74649   (36%)  [26] 118468   (58%)   [30] 30475       (15%)        [305] 
M. musculus 19393   109303       [4] 38632   (35%)  [13] 53210   (49%)   [13] 12805       (12%)        [128] 
D. melanogaster 14556       27391       [1] 4979   (18%)    [2] 10071   (37%)     [3] 526         (2%)            [5] 
C. elegans 20320    26624       [1] 2894   (11%)    [1] 3953   (15%)     [1] 100    (<0.5%)            [1] 
* ‘Alternative Exons’ here refers to exons which do not appear in the reference sequence 
** ‘New Exon’ here refers to an exon which has not been annotated by RefSeq 
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Table 3.3  - Alternative exons determined by ExonMine compared to those annotated 
by RefSeq 
Alternative exons here are counted as those which are spliced out in at least one splicing 
event and do not appear in the reference sequence. First exons (F) are those for which no 3’ 
splice site was detected. Terminal exons (T) are those for which no 5’ splice site was 
detected. Internal exons (I) have both a 3’ splice site and 5’ splice site. First exons and 
terminal exons are counted as alternative if the gene contains more than one first exon or 
more than one terminal exon respectively. 
 
 
 
 
 
 
 
 
 
 
Alternative 
Exons Annotated 
by RefSeq  
Alternative 
Exons not 
annotated by 
RefSeq 
Organism 
Total 
Alternative 
Exons in 
ExonMine 
Alternative 
Exons 
Annotated 
by RefSeq 
% 
F 
% 
I 
% 
T 
Alternative 
Exons not 
annotated by 
RefSeq 
% 
F 
% 
I 
% 
T  
H. sapiens 
59451 4936    (8%) 26 52 22 54515  (92%) 45 35 20 
M. musculus 
27457 1741    (6%) 33 47 20 25716  (94%) 52 28 19 
D. melanogaster 
4408 2991  (68%) 54 37 9 1417  (32%) 53 19 28 
C. elegans 
1477 1043  (71%) 44 44 12 434  (29%) 54 21 25 
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3.1.2. COMPARISON WITH OTHER ALTERNATIVE SPLICING 
DATABASES 
 
Comparison of ExonMine data for the human and mouse with some recently published 
alternative splicing databases (Table 3.4) clearly shows that ExonMine is detecting a 
greater percentage of alternative splicing in protein coding genes: in human ExonMine 
detects 88%, Fast DB [de la Grange et al. 2007] coming second with 78%. A detailed 
comparison of our results for selected human genes with other database revealed the most 
accurate and complete to be Fast DB which provides alternative splicing information based 
on mRNAs and ESTs for the human and mRNAs for the mouse. The increase in alternative 
splicing detected by ExonMine in relation to Fast DB most likely results from the filtering 
process imposed on the transcripts which is less stringent in ExonMine. Fast DB transcripts 
are initially selected by blasting each exon defined by EnsEMBL [W3] against mRNA and 
EST alignments to the genome, whereas ExonMine relies on BLAT alignments and 
requires a transcript to have only one splice site in common with RefSeq transcripts. Global 
percent identity of alignment of transcripts in Fast DB is 98% versus 96% in ExonMine. In 
Fast DB at least 95% of the transcript has to be aligned, it must cover 10% of the genomic 
region, and the ratio of exon and intron lengths in a given transcript cannot exceed three 
times the average ratio of all defined exon and intron lengths; whereas ExonMine cuts 
alignments into fragments at non-consensus junctions and on either side of exons smaller 
than nine nucleotides and recovers any spliced fragments.  As a result of the data selection 
criteria ExonMine succeeds in capturing more than three times the number of ESTs and 
mRNAs than Fast DB (3,983,435 vs. 1,154,554), and almost twice as many as ASTD 
[Stamm et al. 2006] and ECgene [Lee et al. 2007b] (2,018,294 and 2,189,150 respectively). 
In terms of the number of exons detected, ASTD presents a higher number than ExonMine 
(325,692 vs. 311,488) because ASTD exons include all variations of an exon by 3’ and 5’ 
extensions.  
 
Data from ECgene presents a low detection of alternative splicing (43%) and the high 
number of genes detected (49,546 in the human and 43,932 in the mouse) include spliced 
genes with no apparent protein coding potential. ExonMine, however, captured the great 
majority of human spliced ESTs (97%), which suggests a near complete coverage of genes 
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by human RefSeq transcripts and that the overwhelming majority of spliced transcripts 
reside in protein coding loci. ExonMine does, on the other hand, detect a high number of 
non-protein coding spliced isoforms incorporating new exons in relation to the known 
RefSeq annotated exons. This may explain the discrepancy between the number of genes 
detected by ECgene and ExonMine in that the latter may be capturing the transcripts with 
no apparent protein coding potential as being spliced to exons in known protein coding 
genes. 
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Table 3.4 - Comparison of ExonMine results for human and mouse with other 
alternative splicing databases: FastDB [de la Grange et al. 2007], ASAP [Kim et al. 
2007b], ASTD [Stamm et al. 2006] and ECgene [Lee et al. 2007b]. 
 
* In the case of ECgene this count includes spliced non-coding genes many of which may be artefacts but one should not rule out the 
possibility of non-protein coding spliced genes. 
**In the case of ExonMine and ECgene this count includes mRNAs and spliced ESTs; for ASAP II and FastDB this count includes all 
mRNAs and ESTs. 
*** In the case of ExonMine this count includes core exons and exon extensions. 
# In the case of ExonMine this count includes only core exons. 
Human Mouse 
Database Genes* 
% 
Genes 
with 
AS 
mRNAs 
and ESTs 
used** Exons*** 
Internal 
Exons# Genes* 
% 
Genes 
with 
AS 
mRNAs 
and ESTs 
used** Exons*** 
 
Internal 
Exons# 
ExonMine 19,431 88% 3,983,435 311,488 197,572 19,393 79% 1,963,566 240,854 164,607 
FastDB 16,053 78% 1,154,554 201,245 - 13,913 54% 78,170 157,920 - 
ASAP II 22,220 53% - - 129,981 16,404 53% - - 105,260 
ASTD 16,715 68% 2,018,294 325,692 - 16,491 57% 1,229,339 275,612 - 
ECgene 49,546 43% 2,189,150  - - 43,932 40% 1,416,309 - - 
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3.1.3. CONSIDERATIONS ON TRANSCRIPTION INITIATION AND 
TERMINATION 
 
As a result of the procedure followed for clustering mRNAs and ESTs (Appendix A), the 
start and end of transcripts as reported in the original GenBank records have been altered. 
These corrections are normally only of a few nucleotides, and were applied to deal with the 
fragmented nature of the input data. However, if the start or end of the mRNA or EST is 
indeed the start or end of a transcript, the correction applied moves the start or end of the 
transcript further upstream or downstream respectively. In a small number of case, where 
splicing to upstream or downstream exons is observed, a first or terminal exon of a 
representative splicing pattern may come described as an internal exon (type ‘e’). In the 
case of transcription initiation this means that the first exon of a representative splicing 
pattern may not be the actual site of transcription initiation but will include upstream 
promoter sequences. In the case of alternative polyadenylation all polyadenylation signals, 
and variants of the canonical signal, are reported for each representative isoform. However, 
the user is given access to all the raw accession data described, using the same exon 
numbering as that used in the representative isoforms, so that all the variations in the start 
and end of clustered transcripts can be checked. 
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3.1.4. WEB INTERFACE 
 
 
A web interface for public access to the ExonMine data was developed in collaboration 
with Daniel Felício Silva and Ana Rita Grosso at the Institute of Molecular Medicine. It is 
available at [http://www.imm.fm.ul.pt/exonmine] and is supported by clear graphical 
displays of the gene and transcripts. 
 
To query ExonMine, the user selects an organism and enters the Gene Symbol ID, 
GenBank accession or Entrez Gene ID. ExonMine output provides information in both 
graphical and downloadable format. The graphical display is divided in two main parts: one 
with gene organization in terms of exons, exon extensions, introns, and their respective 
length; and the other with the splicing patterns (Figure 3.1). Exons are colour coded 
according to whether they are constitutive, known alternative exons, or new upstream, 
internal or downstream alternative exons (i.e. new exons are not annotated by RefSeq). The 
mRNA and/or EST accessions corresponding to each complete splicing pattern are given. 
For each gene we also provide the orthologue prediction in other organisms. Exon, intron 
and isoform sequences can be downloaded in fasta format. Tab delimited tables can be 
downloaded with information relative to: exons, introns and isoforms (including presence 
of poly-A signals, based on variants of the canonical AATAAA motif [Beaudoing et al. 
2000]) for consideration of alternative polyadenylation [Ara et al. 2006]; start codons with 
neighboring context [Kozak 1987a], stop codons, and translation of all open reading frames 
allowing the user to explore possible variation through reinitiation and context-dependent 
leaky scanning [Kozak 2002], bifunctional mRNAs [Kozak 1986] and the controversial 
internal ribosome entry sites (IRES) [Kozak 2005]. The number and origin of ESTs and 
mRNAs supporting any exon, junction or splicing pattern can be obtained from the 
‘Downloads Options’ by entering the exon number(s) in ‘Tissue distribution in Gene given 
the transcript, junction or exon’. Tissue expression relative to source of mRNA and/or EST 
is based on the gbCdnaInfo Table available from the UCSC Table Browser. Junction 
sequences involved in alternative splicing events for microarray probe design (50 
nucleotide sequences centered on the junction) are also available. 
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The web interface also provides five tools to aid in laboratory validation of individual 
splicing patterns. These tools were developed by Ana Rita Grosso using R language and 
packages RMySQL and seqinr [W5]. An “In silico PCR” tool allows the user to visualize a 
graphical representation of primer location and amplicon length on the relevant splicing 
pattern for a given gene. The user can also verify if the primers cross-amplify transcripts 
from other genes using the second tool. The third tool allows the search for isoform-
specific sequences for primer design given a gene symbol and an isoform. Finally, with an 
input transcript sequence, the user can search for matching isoforms in ExonMine or 
decompose the input transcript sequence into ExonMine exons.  
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Figure 3.1 - Snapshot of the ExonMine graphical display  
A gene is displayed using a succession of adjacent boxes representing exons, exon 
extension and introns in their genomic order. Constitutive and alternative exons are colour-
coded and the length of each sequence is indicated in nucleotides. The genomic assembly 
sequence of each segment can be viewed by clicking on a box.  Splicing patterns are 
displayed below the gene by the relevant boxes. GenBank accessions for each complete 
splicing pattern are given. 
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3.2. EXONMINE APPLIED TO GENOME WIDE ANALYSIS 
 
3.2.1. MINING OF ALTERNATIVE SPLICING SEQUENCE 
REGULATORY ELEMENTS 
 
The usefulness of the ExonMine data produced, in searching for control sequences involved 
in alternative splicing, was demonstrated in a data mining procedure carried out to support 
experiments performed in vitro, on a construct, which revealed the requirement of the small 
subunit of U2AF for the recognition of a weak 3’ splice site [Pacheco et al. 2006].  
 
The construct (Figure 3.2) consisted of a proximal weak 3’ splice site followed by a distal 
strong 3’ splice site with the alternate exon sequence carrying a purine rich exonic splicing 
enhancer. The requirement of U2AF35 for splicing to the proximal weak 3’ splice site had 
been demonstrated by Teresa Pacheco and an analysis of alternative 3’ splice sites in 
existing genes was required to extrapolate this mechanism of alternate 3’ splice site 
selection to known genes.  
 
In purine rich exonic splicing enhancers the presence of the motif GAA has been shown to 
be essential [Aznarez et al. 2003; Liu et al. 1998; Yeakley et al. 1996; Tacke et al. 1998]. 
Following this lead, the alternate region of the exon was considered to house a candidate 
exonic splicing enhancer if it contained at least one GAA motif. The 3’ splice site was 
considered ‘strong’ if it contained at least four consecutive T bases within the 30 
nucleotides upstream of the splice site; and ‘weak’ if it contained no more than two 
consecutive T bases within that region. The alternate exon sequence was also restricted to 
the range 20-350 nucleotides (Figure 3.3 A). The search for candidates was performed 
using a Perl script which queries the ExonMine database taking only 1-2 minutes to scan 
about 270 thousand splicing events in about 19 thousand genes. In addition to returning the 
region of the polypyrimidine tracts and the putative ESE region surrounding a GAA motif, 
the script also returns all tissue information relative to the two alternative splicing patterns. 
This search resulted in 70 potential candidates (Appendix B) from which eight (Figure 3.3 
B) were randomly selected for validation.  
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Figure 3.2 – A. Schematic representation of the minigene construct pyPY consisting of the 
5’ end of Immunoglobulin M (IgM) containing a weak polypyrimidine tract (py) and a 
purine rich exonic splicing enhancer (ESE); and the 3’ end of adenovirus major late 
promoter (AdML) harbouring the second exon and 70 nucleotides upstream containing a 
strong polypyrimidine tract. B. Nucleotide sequence of the construct showing the weak 
(low in consecutive T nucleotides) and strong (high in consecutive T nucleotides) 
polypyrimidine tracts (boxed) and the purine rich exonic splicing enhancer (underlined) 
downstream of the proximal 3’ splice site. Constitutive exon sequences are highlighted in 
green and the alternative exon sequence is highlighted in yellow; AG dinucleotides of the 
proximal and distal 3’ splice sites are highlighted in red. 
 
 
 
 
 B 
 
AGGGAGGTGAATGAGGAGGCTTTGAGAACCTGTGGACCACTGCCTCCACCTTCATCGTCCT
CTTCCTCCTGAGCCTCTTCTACAGCACCACCGTCACCCTGTTCAAGGTAGTATGGTTGTGG
GGCTGAGGACACAGGGCTGGGACAGGGAGTCACCAGTCCTCACTGCCTCTACCTCTACTCC
CTACAAGTGGACAGCAATTCACACTGTCTCTGTCACCTGCAGGTGAAATGACTCTCAGCAT
GGAAGGACAGCAGAGACCAAGAGATTCAAGCTTGCTGCACGTCTAGGGCGCAGTAGTCCAG
GGTTTCCTTGATGATGTCATACTTATCCTGTCCCTTTTTTTTCCACAGCTCGCGGTTGAGG
ACAAACTCTTCGCGGTCTTTCCAGTGGGGGC 
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Figure 3.3 – A. Schematic representation summarising the requirements imposed in the 
searching the ExonMine database for candidate alternative 3’ splice sites containing a 
proximal weak 3’ splice site followed by a distal strong 3’ splice site with the alternative 3’ 
exon extension (3e) harbouring an exonic splicing enhancer. B. Sequences of eight 
candidate endogenous genes selected for further analysis. Intron sequences are in lowercase 
letters; exon sequences are in capital letters. The number of nucleotides between the two 
alternative 3’ sites (AltExSeq) is indicated. 
 
A 
 
 
 
1 2a' 2 
GT_________________AG 
GT________________________________AG 
Weak Pyrimidine  tract  (proximal). A candidate weak pyrimidine tract must contain no 
more than two consecutive Ts in the 30 nucleotides upstream of the 3’ splice site. 
Strong Pyrimidine tract  (distal). A candidate strong pyrimidine tract must contain at least four 
consecutive Ts (TTTT) in the 30 nucleotides upstream of the 3’ splice site. 
ESS (exonic splicing enhancer). A candidate exonic splicing enhancer must contain at least one 
GAA motif in the alternate part of the exon. 
e 3e e 
1_2a' 
i 
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Figure 3.3 (cont.)  
 
B 
 
 
 
 
 
Results, performed by Teresa Pacheco on HeLa cells at the Cell Biology Unit of the 
Institute of Molecular Medicine (Lisbon) and published [Pacheco et al. 2006], confirmed 
the existence of the splicing patterns found in the ExonMine database for four of the eight 
randomly selected candidates: CUEDC1, EIF3S7 (also called EIF3D), MBNL3, and PTK9 
(also called TWF1).  For CUEDC1 and EIF3S7 the major isoform detected in non-treated 
cells corresponded to splicing to the strong distal 3’ splice site and RNAi depletion of 
U2AF35 displayed reduced splicing to the weak 3’ splice site, supporting the requirement 
of the small subunit of U2AF for splicing to the weak 3’ splice site. For MBNL3 and PTK9 
the major isoform detected in non-treated cells corresponded to splicing to the weak 
proximal weak 3’ splice site and RNAi depletion of U2AF35 did not significantly reduce 
splicing to the weak 3’ splice site. The latter result suggest that predominant splicing to a 
weak 3’ splice site depends on additional elements that stimulate splicing to the weak 3’ 
splice site in a U2AF-independent manner. 
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The results published in [Pacheco et al. 2006] were dependent on an ExonMine database 
version based on the human genome assembly hg17 and data downloaded form the UCSC 
Genome Browser in June 2006. When the same analysis was performed on the December 
2007 update of ExonMine, which is based on the human genome assembly hg18, one of the 
eight selected candidates, SRRM2 (for which, incidentally, the predicted splicing patterns 
were not detected in untreated HeLa cells), no longer appeared in the list of candidate 
genes. An analysis of the two ESTs found to display the alternative splicing pattern in the 
December 2007 version of ExonMine revealed BLAT mappings to gene SRRM2 which did 
not display the previously detected splicing pattern. This incident confirms the necessity of 
maintaining stable sets of data for reproducibility of results while simultaneously providing 
for updates at relatively frequent intervals. 
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3.2.2. CUSTOM DESIGN OF AN ALTERNATIVE SPLICING 
MICROARRAY 
 
In collaboration with Juan Valcarcel’s Lab at the 'Centre de Regulació Genòmica' in 
Barcelona, Spain, the ExonMine Database was used to produce a custom designed 
microarray platform for the study of alternative splicing in genes expressed in heart and 
skeletal muscle. The main objective of this project is to find new targuets of misregulation 
of alternative splicing in Myotonic Dystrophy and to identify variations in splicing factor 
concentrations and splicing patterns.  
 
Given that dystrophic muscle seems to display foetal alternative splicing patterns, this 
project offers the opportunity to verify to what extent the patterns of alternative splicing 
vary between genes in myoblasts and those in dystrophic muscle. It may be that in 
Myotonic Dystrophy a mechanism of control of alternative splicing of adult versus foetal 
isoforms is being tampered with. This study may therefore produce insight not just into 
misregulation of alternative splicing in myotonic dystrophy but also into the workings of 
developmentally regulated mechanisms of alternative splicing. 
 
A list of some 10,000 genes expressed in human muscle was obtained from microarray data 
deposited at NCBI in the Gene Expression Omnibus [W4] repository (Series id GSE740) 
[Johnson et al. 2003]. This collection of genes was compared with GNF Expression Atlas 1 
Human Data on Affy U95 Chips avalable on the UCSC Genome Browser for UCSC 
annotated genes (Known Genes). A selection of 2000 genes with matching high values of 
expression in heart and skeletal muscle in both the above mentioned chips was made 
(Supplementary Data File 1). Alternative splicing data produced by ExonMine was 
analysed for these genes and used to custom design of probes for a microarray  
 
Alternative splicing in splicing factors themselves is known to occur. MBNL genes, for 
example, have multiple splice variants, and different protein isoforms may have different 
binding affinities, binding specificities and splicing activities. Therefore, alterations in 
splicing factors at the level of expression and splicing in dystrophic muscle will also be 
monitored. A list of 420 alternative splicing factors and splicing associated factors was 
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compiled from various sources of published [Jurica and Moore 2003] and unpublished data 
supplied by various collaborators. 
 
The selection of alternative splicing events to include in the microarray was made using the 
following criteria: 
1. Exclusion of all intron retention events; 
2. Exclusion of all alternative 3’ and 5’ splice sites involving exon segments shorter 
than 36 nucleotides; 
3. Exclusion of events involving exons upstream or downstream of the reference 
sequence; 
4. Only events described in relation to the reference isoform were included; 
5. Only GT_AG or GC_AG consensus splice sites allowed. 
 
The organization of data in ExonMine allows these selection criteria to be made in a single 
MySQL selection statement: 
mysql> SELECT 
SplID,SeqC1,SeqA1,SeqA2,SeqC2,JunctionOlig_C1A1,SpliceStringOlig_C1A1,SSConsen
susSeq_C1A1,JunctionOlig_A2C2,SpliceStringOlig_A2C2,SSConsensusSeq_A2C2,Juncti
onOlig_C1C2,SpliceStringOlig_C1C2,SSConsensusSeq_C1C2 FROM SplicingEvents 
WHERE ((GeneID = '$GeneID') AND (RefEventDescription NOT REGEXP 'Intron') AND 
(SSConsensusSeq_C1A1 REGEXP 'G[CT].._..AG' OR SSConsensusSeq_C1A1 = '_' OR 
SSConsensusSeq_C1A1 = 'null') AND (SSConsensusSeq_A1C2 REGEXP 'G[CT].._..AG' 
OR SSConsensusSeq_A2C2 = '_' OR SSConsensusSeq_A2C2 = 'null') AND 
(SSConsensusSeq_C1C2 REGEXP 'G[CT].._..AG' OR SSConsensusSeq_C1C2 = '_' OR 
SSConsensusSeq_C1C2 = 'null') AND (SpecialID NOT REGEXP 'N') AND (LengthSeqC1 
>= $MinExonLength OR LengthSeqC1 = 'null') AND (LengthSeqA1 >= $MinExonLength 
OR LengthSeqA1 = 'null') AND (LengthSeqA2 >= $MinExonLength OR LengthSeqA2 = 
'null') AND (LengthSeqC2 >= $MinExonLength OR LengthSeqC2 = 'null') AND 
NOT((SeqC1 REGEXP '[Uu]' AND SeqA1 REGEXP '[Uu]' AND SeqA2 REGEXP '[Uu]' 
AND SeqC2 REGEXP '[Uu]') OR (SeqC1 REGEXP '[Wu]' AND SeqA1 REGEXP '[Wu]' 
AND SeqA2 REGEXP '[Wu]' AND SeqC2 REGEXP '[Wu]')) AND ((RepAcc_C1A1 
REGEXP 'Reference' AND RepAcc_A2C2 REGEXP 'Reference') OR RepAcc_C1C2 
REGEXP 'Reference')  ); 
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For the selected alternative splicing events, exon and junction sequences corresponding to 
exons C1, C2, A1 and A2 (Figure 3.4)  were sent for oligo design to Juan Valcarcel's team 
at the Centre de Regulació Genòmica' in Barcelona, Spain. For the junctions, three  
sequences per junction were sent each of 30 nucleotides: one centered on the junction, and 
the other two each with a one nucleotide shift upstream and downstream. Probes were 
designed using Array Designer 4 (PremierBiosoft commercial software) by Claudia Ben-
dóv. Information on constitutive exons generated by the ExonMine database was used to 
add probes for an additional constitutive exon per gene.  
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Figure 3.4 . Probe design for alternative splicing event.  
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
Given the high number of alternative splicing events detected by ExonMine and due to 
space constraints on the microarray chip, from the list of 2000 muscle genes a subset of 443 
genes. A full description of all alternative splicing events detected in the 443 muscle genes 
and the 420 splicing factors and splicing associated factors is provided in Supplementary 
Data File 2 and 3 respectively. 
 
Agilent microarrays with Inkjet-Deposited Presynthesized Oligos with two sets of  22,000 
spots on a single chip, were ordered: one 22,000 spot array for the muscle specific events 
and the other for the splicing factors. 
 
Visualization of the events on the Genome Browser 
A Perl program was written to produce BED format files from the ExonMine Database 
which allow the representative isoforms and alternative splicing events to be visualised on 
the UCSC Genome Browser. Figure 3.5 shows the result of such a display on the UCSC 
Genome Browser for the gene ABL1. 
 
C1 C2 A1 A2 
C1 A1 A2 C2 
C1 C2 
Not necessarily an intron Not necessarily an intron 
Options: 
A1=A2 
No A1 
No A2 
A1!A2 
 
1x 1x 1x 
10x 10x 
3x 3x 
6x 
1x 
25-30 nt oligos 
60 nt oligos 
10x 10x 
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Figure 3.5. Visualization of alternative splicing events on the UCSC Genome Browser 
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3.2.3. MATCHING DATABASE EVENTS TO AFFYMETRIX HUMAN 
EXON ARRAY 
 
Recently Affymetrix has produced commercial arrays containing probes which aim at 
covering the entire genome at the scale of an exon. One such array is the GeneChip® 
Human Exon 1.0 ST array containing approximately 5.5 million probes from a 1.4 million 
probe set which can be used to interrogate 1 million known and predicted exons. This type 
of array has been extensively used for the study of alternative splicing as gene expression 
can be monitored at the level of individual isoforms and exons [53]. 
 
The set 1.4 million probes from the GeneChip® Human Exon 1.0 ST obtained from the 
UCSC Genome Browser for Human genome assembly hg18, was matched against the 
ExonMine database for human April 2008 update. Table 5 presents a summary statistics of 
the results obtained. Probe selection regions (PSRs) were found to match 19017 genes in 
ExonMine, out of a total of 19431 genes. Of the total of 1409312 PSRs, from the 
GeneChip® Human Exon 1.0 ST, 732157 match ExonMine genes: half of these match 
exons and the other half introns, 210995 PSRs match constitutive exons, 141320 PSRs 
match alternative exons or exon extensions and 108024 PSRs match junctions at the 
boundaries of an exon and an exon extensions or an intron.   
 
An exon sequence may have several probes matching to it; out of a total of 311488 exons 
or exon extensions in ExonMine 252937 are covered by the GeneChip® Human Exon 1.0 
ST probes. Table 5 also shows details of the number of matches to constitutive and 
alternative internal exons (e), first exons (fe), terminal exons (te), single exon genes (se), 
and alternative 3’ (3e) and 5’ (5e) exon extensions.  Every alternative exon in ExonMine is 
linked to at least one splicing pattern and one alternative splicing event. The information on 
constitutive exons in the ExonMine database could be used to determine the level of 
expression of alternative exons by comparing the expression of probes matching each 
alternative exon in the gene against the average expresssion of the constitutive exons in a 
gene within an array, using a formula of the type shown below: 
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where,  
- NC is the number of probes matching constitutive exons in a gene,  
- Ck is the expression level of each probe matching a constitutive exon,  
- NA is the number of probes matching a particular alternative exon, exon extension or 
intron  (A),  
- Aj is the expression level of each probe matching an alternative exon, exon extention or 
intron, and 
- VA is the relative expression of the alternative exon versus the level of expression of the 
constitutive exons in a given gene. A value of  VA  close to 1 would be interpreted as  the 
alternative region being present. 
 
Furthermore, the information on constitutive exons will make comparison of global gene 
expression more accurate by allowing a priori exclusion of probes matching alternative 
exons from the analysis. This data is currently being used in Carmo-Fonseca’s Lab to 
analyse data from experiments performed on this platform. 
 
Detailed analysis of probes in Affymetrix GeneChip® Human Exon 1.0 ST 
Each one of the 1,409,312  probes selection regions (PSR) of the Affymetrix GeneChip® 
Human Exon 1.0 ST corresponds to a region on an exon, an exon extension or an intron 
which ranges from 24-9552nt. For each region one to four 25nt probes are designed giving 
a total of 5.5 million probes on the array.  An example of this design and the relatonship 
with the ExonMine Data alignment is given in Appendix C. 
# Aj 
Ck 
k=1 
# 
j=1 
NC 
VA =  
NA 
1 
 
NA 
1 
 
NC 
MC  = 
MA  = 
Average expression of 
probes on constitutive 
exons from a given gene 
Average expression of 
probes on alternative 
exon, exon extention or 
intron from a given gene 
MA 
 
Mc 
Relative expression of 
probes on alternative 
exon, exon extention or 
intron from a given gene 
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Table 3.5 – Summary statistics of alignment of Affymetrix GeneChip® Human Exon 
1.0 ST array probe selection regions to the ExonMine data 
This analysis was performed using the affyHuEx1 table from UCSC Genome Browser and 
the ExonMine database for the human (April 2008 update). 
 
 
 
 
Description Quantity 
Total affyHuEx1 probes  1,409,312  
AffyHuEx1 probes that match ExonMine genes  732,157  
AffyHuEx1 probes that match ExonMine constitutive exons (type e, fe or te)  210,995  
AffyHuEx1 probes that match ExonMine alternative exons (type e,3e,5e,fe or te)  141,320 
AffyHuEx1 probes that match junctions  108,024  
No. of genes in ExonMine  19,431 
No. of genes from ExonMine that match affiHuEx1 probes  19,017  
Exon sequences in ExonMine (of type e,3e,5e,fe,te or se)  311,488  
Exon sequences in ExonMine that match affiHuEx1 probes 252,937 
AffyHuEx1 probes that match ExonMine exon sequences of type 'e'  206,228  
ExonMine exon sequences of type 'e' that match affyHuEx1 probes 178,353 
ExonMine constitutive exon sequences of type 'e' that match affyHuEx1 probes 131,217 
ExonMine alternative exon sequences of type 'e' that match affyHuEx1 probes 47,136   
AffyHuEx1 probes that match ExonMine exon sequences of type 'fe' 49,264 
ExonMine exon sequences of type 'fe' that match affyHuEx1 probes  30,814  
ExonMine constitutive exon sequences of type 'fe' that match affyHuEx1 probes 6,941 
ExonMine alternative exon sequences of type 'fe' that match affyHuEx1 probes 23,873 
AffyHuEx1 probes that match ExonMine exon sequences of type 'te' 71,152 
ExonMine exon sequences of type 'te' that match affyHuEx1 probes 25,518 
ExonMine constitutive exon sequences of type 'te' that match affyHuEx1 probes 10,873 
ExonMine alternative exon sequences of type 'te' that match affyHuEx1 probes  14,645 
AffyHuEx1 probes that match ExonMine exon sequences of type 'se' 5,734 
ExonMine exon sequences of type 'se' that match affyHuEx1 probes 1,127 
AffyHuEx1 probes that match ExonMine exon sequences of type '3e' 10,565 
ExonMine exon sequences of type '3e' that match affyHuEx1 probes  8,815 
AffyHuEx1 probes that match ExonMine exon sequences of type '5e' 10,321 
ExonMine exon sequences of type '5e' that match affyHuEx1 probes  8,310  
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3.2.4. EXONMINE DATA COMPARED TO HUMAN 
TRANSCRIPTOME PROFILED BY TILING ARRAYS  
 
Results produced by ExonMine were compared to steady-state polyadenylated RNA 
profiles obtained by using tiling arrays over the entire nonrepetitive portion of the human 
genome [Kapranov et al. 2007]. Table 3.6 presents the correlation found between 
ExonMine and the tiling array data for primary human dermal fibroblasts. A total of 
585342 transcribed fragments detect transcripts greater than 200nt. Of these, 393428 
fragments (67%) match 17672 protein-coding gene loci in ExonMine. About 38% of all 
known exons and 18% of new non-coding exons detected in ExonMine were found 
transcribed in primary fibroblasts. In a random selection of 50 of the new exons identified 
in ExonMine and verified in the tiling array data, none were found in Fast DB. Taken 
together these results strengthen the view that the human transcriptome contains even 
greater diversity of splice variants than previously suspected. Noteworthy, 69% of new 
non-coding exons identified in ExonMine are first exons, and the tiling arrays reveal that a 
significant fraction of protein-coding genes produce transcripts that overlap the promoter 
and the first exon and intron regions but do not include most of the other exons [Kapranov 
et al. 2007]. 53% of introns in ExonMine are detected in transcripts, although only 23% of 
these are retained in ExonMine data. Unraveling the potential biological function of such 
novel RNA species will clearly be the focus of future research.  
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Table 3.6  - Matching transcribed fragments from Affymetrix tiling array data from a 
primary cell line of Human Dermal Fibroblasts (HDF) to ExonMine Exons and 
Introns. 
The counting of exons, known exons and new exons includes the constitutive part of an 
exon and  3' or 5' extentions. In the case of non-coding Exons (ncExons) only the 
constitutive part of the exon is counted. A transcribed fragment matching the junction of an 
exon and an intron is counted in both the Exon count and the Intron count. Transfrag 
(transcribed fragment), ncExons (non-coding exons), Known Exons (exons annotated by 
RefSeq), New Exons (exons not annotated by RefSeq), New Retained Introns (retained 
introns not annotated by RefSeq). Tiling array data from GEO Series accession number 
GSE-7576 [Kapranov et al. 2007]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description Quantity 
Total number of long transcribed fragments  585,342 
Genes in ExonMine matching transfrag 17,672 
Transfrag matching Genes in ExonMine 393,428 
Total Genes in ExonMine 19,431 
Exons in ExonMine matching transfrag 103,017 
Transfrag matching Exons in ExonMine 151,802 
Total Exons in ExonMine 311,488 
Known Exons in ExonMine matching transfrag 88,273 
Transfrag matching Known Exons in ExonMine 140,871 
Total Known Exons in ExonMine 230,492 
New Exons in ExonMine matching transfrag 14,744 
Transfrag matching New Exons in ExonMine 16,580 
Total New Exons in ExonMine 80,996 
ncExons in ExonMine matching transfrag 4,260 
Transfrag matching ncExons in ExonMine 5,352 
Total ncExons in ExonMine 23,727 
Introns in ExonMine matching transfrag 133,459 
Transfrag matching Introns in ExonMine 298,321 
Total Introns in ExonMine 251,486 
Retained Introns in ExonMine matching transfrag 31,369 
Transfrag matching Retained Introns in ExonMine 62,799 
Total Retained Introns in ExonMine 55,266 
New Retained Introns in ExonMine matching transfrag 28,299 
Transfrag matching New Retained Introns in ExonMine 52,592 
Total New Retained Introns in ExonMine 49,450 
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3.3. ANALYSIS OF EXONMINE DATA FOR INDIVIDUAL 
GENES 
3.3.1. ALTERNATIVE SPLICING AND DIVERSITY OF HUMAN 
U2AF PROTEINS 
 
Our laboratory has previously reported that human transcripts encoding U2AF
35
 can be 
alternatively spliced giving rise to three different mRNA isoforms called U2AF
35
a, 
U2AF
35
b, and U2AF
35
c [Pacheco et al. 2004]. This discovery raised the question of 
whether additional U2AF genes produce alternatively spliced mRNAs. To date, only two 
CAPER! mRNAs and four CAPER" mRNAs were detected in several human tissues by 
Northern blotting [Dowhan et al. 2005], and a splicing variant of PUF60/FIR was identified 
in colorectal
 
cancers
 
[Matsushita et al. 2006]. This scarcity of data prompted the use 
bioinformatics search strategies to review alternative splicing of U2AF genes. An analysis 
of alternative splicing information obtained from the ExonMine database for the family of 
U2AF
35
 and U2AF
65 
splicing factors was performed and published [Mollet et al. 2006]. 
 
The U2AF
35
 family of proteins is composed of four genes: U2AF
35
 (U2AF1), U2AF
35
-RS1 
(ZRSR1), U2AF
35
-RS2 (ZRSR2) and U2AF
26
 (U2AF1L4) [Shepard et al. 2002]. In the 
U2AF
65
 family there are also four genes: U2AF
65
 (U2AF2), CAPER" (RBM39), CAPER! 
(RBM23), and PUF60 (SIAHBP1). The gene symbol in parenthesis corresponds to the 
official gene symbol used by Entrez Gene [Maglott  et al. 2007] and is the one that appears 
in the ExonMine datababase. 
 
What follows is a detailed discussion of the of the results obtained for each gene, which is 
subsequently summarised in Table 3.7: 
 
For the gene that encodes U2AF
65 
(U2AF2) we found two RefSeq mRNAs 
(NM_001012478.1, NM_007279.2) that reveal one alternative 5'ss at exon 10 which 
extends the exon by 12 nt (Appendix D, Table II.A, Figure II.A). Another mRNA 
(CR609498.1) is a 3’end fragment with a novel intron of 668nt removed, indicated in the 
figure by 12A*, and with no stop codon detected. There is also EST evidence for two novel 
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exons 1A (CD624005.1, CR982513.1) and 5A (CR982513.1, BI909492.1, CA488904.1), 
both of which contain an in-frame stop codon.  
 
For the gene that encodes PUF60 (SIAHBP1) there are two RefSeq sequences 
NM_014281.3 and NM_078480.1 the latter including the novel exon 4A (Appendix D, 
Table II.B, Figure II.B). For each of these isoforms the RefSeq database reports a coding 
sequence running from exon 1 to 11, but the SwissProt database reports a coding sequence 
running from exon 3 to 11. Two other mRNAs BC009734.1 and BC011265.1 which are 
identical to the two RefSeq sequences except for the alternate first exon 1A, do indeed have 
a start codon only on exon 3 and the resulting proteins would therefore correspond to the 
ones reported in SwissProt for the RefSeq isoforms. Two EST fragments (BI915396.1, 
AL522753.3) show an alternative 3’ss at exon 2, which removes only three nucleotides, and 
cause no frame-shift; EST BX397429.2 also uses the alternative 3’ss on exon 2 but the 
alternative first exon 1A moves the start codon to exon 3, and therefore this splicing pattern 
does not affect the coding sequence. Skipping of exon 2 appears in ESTs AL514886.3 and 
BX384203.2 removing 87nt without causing a frame-shift. Another alternative first exon 
2A comes up in mRNA AK055941.1 with a start codon on that same exon producing no 
frame-shift. EST BQ421738.1 uses exons 1A and 1B with a new start codon on exon 1B 
which again does not produce a frame-shift. Substitution of exon 1B by 1C in EST 
BM558085.1 moves the start codon to exon 3. Another combination is found in EST 
BQ956878.1 which uses exons 1 and 1B with the start codon now moving to 1B. A novel 
exon 1D in EST BG115238.1 also contains a start codon on the same exon and produces no 
frame-shift. The fragment EST BE393389.1 has an apparent first exon 4B with a start 
codon on exon 5 which would produce a coding sequence covering all RNA binding 
domains. And finally we found an odd splicing pattern in fragment EST BU170641.1 
which shows sequence 6a”, which previously functioned as an intron, replacing 7a’, leaving 
the latter to function as an intron instead; this substitution adds 6nt to the mRNA and does 
not produce a frameshift. It is interesting to note that none of the alternative splicing 
patterns found removed the RNA binding domains. 
 
The gene that encodes CAPER! (RBM39) is the longest of the genes we are analysing, 
covering about 17 exons (Appendix D, Table II.C, Figure II.C). There are five RefSeq 
variants for this gene, the longest isoforms, NM_184234.1 and NM_004902.2 run from 
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exon 2 through to exon 17 differing only in sequence 13b’ which codes for 6aa. Two other 
isoforms NM_184241.1 and NM_184244.1 contain a premature stop codon in exon 2A and 
another, NM_184237.1, in exon 3C; in these three cases a start codon on exon 7 is used and 
produces two protein sequences, differing only in the sequence 13b’, but which exclude the 
RS domain and include all the known RNA binding domains. The mRNA AL833168.1 
includes exon 13A which introduces a frame shift resulting in a stop codon on exon 14; this 
would produce an isoform which excludes the UHM domain and the Poly-Ala stretch. 
mRNA BC107886.1 contains a known premature stop on exon 2A and two potential 
reading frames from exon 7 to 9A and from exon 10 to 17. Four ESTs (BM468718.1, 
BE816688.1, DA115481.1 and DB027200.1 ) include exon 2A with a premature stop at 
that exon 2A with no other in-frame start codon except on exon 7 for EST BM468718.1; 
the inclusion of exon 3C, skipping of exon 5, inclusion of exon 3B and exclusion of 4a’, in 
the four first ESTs respectively has apparently no effect. The effect of splicing of exon 3A 
to exon 3B in EST AV691154.1 cannot be determined because this fragment has no known 
exons. The fragment EST AL711019.1 includes exon 3B with a premature stop codon on 
that exon. The inclusion of exon 2B in EST CA419145.1 also introduces a stop codon on 
that exon, and the start codon on exon 2B catches exon 3 in the known reading frame but 
encounters another stop codon on exon 3B.  A fragment EST DA372839.1 shows exon 2A 
splicing to exon 2B, but here again there is a premature stop on exon 2B. Novel intron 1A* 
present in ESTs BP352717.1, DB027200.1 and DB264131.1 is in the 5’UTR; the first one 
of these has a putative alternative start on exon 2B after a premature stop on exon 2A; the 
second fragment has a premature stop on exon 2A and no other in-frame strat codon; and 
the third with the known start codon on exon 2 would produce a known coding sequence. A 
novel first exon 12A in EST DA109669.1 contains several start and stop codons, the 
longest orf would code for only 34aa. Alternate first exon 1A in ESTs DB150523.1, 
BG764840.1, DA922841.1 contains a premature stop codon on the same exon; in the 
second case the known start on exon 2 produces a known coding sequence; but in the third 
case there is another premature stop at exon 2A. The EST DA109669.1 showing a novel 
exon 12 A contains stop codons in all reading frames on exon 12A. Likely candidates of 
alternative splicing resulting in variation at the coding level come from the following 
examples: extension of exon 5 by 24 nt (sequence 5a’) in EST BX483043.1 produces no 
frame-shift; evidence of skipping of exon 5, which does not produce a frame-shift, comes 
from ESTs BQ893325.1 and CR995560.1; skipping of exon 10 in EST BQ954122.1 would 
remove a known RNA binding domain containing an RNP1 motif;  inclusion of novel 
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exons 11A and 11B in EST BM983358.1 or just 1B in EST BE933146.1 produces a 
putative in-frame orf. EST BI117009.1 shows a further extention  13a’ of 35nt to the 
sequences 13b’,13 which would introduce a stop codon on this very extension excluding 
the UHM domain; exclusion of sequence 6a’ in EST BU075848.1 removes only 3nt coding 
for a serine residue; inclusion of sequence 2a” of 18 nt in EST DB023865.1 does not 
produce a frame-shift.  
 
The gene that encodes CAPER" (RBM23) contains about 13 exons (Appendix D, Table 
II.D, Figure II.D). Here there is one RefSeq sequence NM_018107.3 which has a coding 
sequence from exon 2 to exon 13, two other mRNAs (CR595426.1, BX161440.1) differ 
only in the skipping of exon 5 and the inclusion of exon 3B respectively; skipping of exon 
5 will affect the RNA binding domain RRM1 and inclusion of exon 3B will add RS amino 
acids to the RS domain already known to be coded for by exon 4. One other complete 
mRNA sequence is known, AL834198.1, which includes exon 9A and subsequent intron 
retention; exon 9A contains a stop codon affecting the coding sequence at the RNA binding 
domain RRM2 and excludes the poly-Alanine stretch further downstream. EST 
BM712633.1 also shows inclusion of exon 9A but without the subsequent intron retention. 
Two ESTs, DA675412.1 and BG033916.1, give evidence of inclusion of exon 3B with 
exclusion of exon 5, which produces no frame-shift and is therefore a likely candidate for a 
novel splicing pattern. Six other ESTs with various splicing patterns at the 5’end of the 
gene were found that result in premature stop codons: DA821789.1 at exon 3A; 
DB164369.1, BM464794.1 and DA145418.1 at exon 3B; and BI823680.1 and DB166416.1 
at exon 4. One EST fragment (DA117163.1) includes a novel exon 1C which carries a 
putative novel start codon. Another putative novel start codon is found in ESTs 
DA311282.1, BQ707907.1 and BQ071908.1 on exon 1Ea’. Other combinations of exons in 
the 5’ UTR are found on ESTs AA324737.1, DA856230.1, CD692273.1 and BP356833.1 
all of which have a start codon on exon 2.  Splicing of exon 1 to 1A in EST AA633094.1 
would equally be a 5’UTR pattern. There is also evidence of a novel intron in EST 
BX388764.2 which would remove the poly-Alanine stretch. Exclusion of exon 2 which 
contains the known start codon occurs in several ESTs: in EST BI915247.1 this produces a 
stop codon in exon 3, and in ESTs DA299707.1, DA026292.1, CN483101.1, CX165727.1 
and mRNA BC106012.1 the stop codon occurs on exon 6; the only other in-frame start 
codon is on exon 6 for the ESTs and exon 8 for the mRNA. The EST 3’end fragment 
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BE269289.1 reveals exclusion of sequence 8a’ which would produce a stop codon on exon 
9.  
 
For the gene that encodes U2AF
35 
(U2AF1) there are three RefSeq mRNAs that 
correspond to the previously identified isoforms U2AF
35
a (NM_006758 ), U2AF
35
b 
(NM_001025203 ), and U2AF
35
c (NM_001025204 ), as described in Pacheco et al 2004. 
NM_006758 and NM_001025203 reveal alternate inclusion of exons 2A and 3 (Appendix 
D, Table II.E, Figure II.E). Consequently, the protein isoform U2AF
35
b differs from 
U2AF
35
a in only 7 amino acid residues located at the atypical RNA recognition motif 
(UHM) involved in dimerization with U2AF
65
. However, biochemical experiments indicate 
that this substitution does not abolish the ability of U2AF
35
b to interact with U2AF
65
. 
U2AF
35
a is 9- to 18-fold more abundant than U2AF
35
b, with distinct tissue-specific patterns 
of expression [Pacheco et al 2004]. RefSeq mRNA NM_001025204 (corresponding to 
U2AF
35
c) includes both exons 2A and 3 resulting in a premature stop codon in exon 3. 
Accordingly, experimental evidence indicates that the resulting mRNA is targeted to 
nonsense-mediated decay [Pacheco et al 2004]. However, an in-frame start codon in exon 4 
would give rise to a coding sequence in the C-Terminal covering the RNA binding domain, 
a Zn-finger, the RS domain and the poly-Gly repeat. Additionally, EST BG612658 shows 
an alternate exon 2B in place of exons 2A and 3; this novel exon introduces a premature 
stop codon, however, a start codon exist on exon 2 with orf to exon 8, exons 3-8 being in-
frame - this would produce a protein with a novel N-Terminal. In EST BE736536 there is 
an apparent novel first exon 1A containing several start codons; all, however, have a 
corresponding stop codon on the same exon.  
 
For the gene that encodes U2AF
26 
 (U2AF1L4) there are two RefSeq sequences, 
NM_144987.2 and NM_001040425.1, the latter  differing only from the former by the 
inclusion of sequence 4a” extending exon 4 by 58nt at its 3’end (Appendix D, Table II.F, 
Figure II.F). This produces a change of frame which codes for a protein containing a Zn-
finger which is not present in isoform NM_144987.2. An EST (BE856544.1) reveals two 
novel exon 2A and 2B which do not produce a frame-shift.  
 
Inclusion of novel sequences 2Ab’,2A in ESTs BM696851.1, BM970675.1 and 
AW274826.1 introduces a stop codon in exon 3, followed closely by a putative start codon 
on the same exon with a known stop codon on exon 6; the first two ESTs produce a known 
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coding sequence; but the third EST in this set skips both sequences 4a” and  6a’. In the case 
of EST DB127360.1 skiping of sequence 2a’ introduces a premature stop codon in exon 3, 
and as in the case of EST AW274826.1 there is skipping of both exons 4a” and 6a’ and a 
coding sequence going from exon 3 to 6.  
 
In ESTs BU628789.1 and AA455588.1 inclusion of exon 2A produces a premature stop 
codon on exon 2A followed closely by a start codon on exon 3 with open reading frame all 
the way to exon 6. Other patterns of splicing at the 5’end revealed in ESTs BI770029.1, 
BC010865.1, BG481735.1 and W51842.1 produce premature stop codons in sequences 
2Aa’, 2Ab’ or 2A. Inclusion of novel exons 5A and 5B in EST BU608847.1 would 
produces a frame shift with a stop codon on exon 6a’. Finally, two more ESTs, 
DB338076.1 and BF821614.1, include sequence 5Ba’ in addition to 5A and 5B which 
introduces a stop codon at this new sequence 5Ba’. 
 
For the gene that encodes U2AF
35
-RS2 (ZRSR2) there is only one complete RefSeq 
sequence, NM_005089.2 (Appendix D, Table II.G, Figure II.G). Although there is mRNA 
and EST evidence (BC065719.1, DA173194.1, DA383795.1, CN289520.1, BE619312.1) 
for several patterns of splicing at the 5’ end, all contain premature stop codons. Two novel 
first exons, 1A and 2A appear in ESTs DA261525.1 and CA425173.1 respectively; the 
latter also shows skipping of exon 6, however neither contains an open reading frame 
which includes known exons of this gene. 
 
In conclusion, our analysis revealed that, with a single exception, all genes coding for 
U2AF proteins can be alternatively spliced. The exception is the U2AF
35
-RS1 gene, which 
is devoid of introns. Many alternatively spliced mRNA isoforms are predicted to contain 
premature stop codons and are therefore expected to be targeted for degradation, thus 
contributing to regulate level of expression of the encoded protein [Lareau et al. 2004]. 
Additionally, we found evidence for several alternatively spliced mRNAs that could 
generate functional protein isoforms (see Table 3.7). Unraveling the roles played by these 
putative new human proteins awaits further experimentation. 
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Table 3.7. Predicted number of mRNA isoforms generated by alternative splicing of the 
U2AF family of genes. An alternatively spliced mRNA isoform was considered confirmed 
if its corresponding protein sequence is annotated in RefSeq or SwissProt databases. A 
splicing pattern observed in an mRNA or EST was predicted to produce a premature coding 
sequence termination if it contained an inframe stop codon within an internal exon. For the 
predicted patterns of splicing there is redundance in the number of accessions shown due to 
the fragmented nature of ESTs and some mRNAs.  The information in this table is a 
summary of the more extended description presented in Appendix D. 
Protein 
(Gene 
Symbol) 
Confirmed mRNA 
isoforms  
(Accessions) 
Predicted splicing patterns 
producing a premature stop 
codon  
(Accessions) 
 
Predicted splicing patterns of 
candidates for putative novel 
protein  
(Accessions) 
 
U2AF65 
(U2AF2) 
2  
 (NM_007279.2, 
NM_001012478.1) 
2  
 (CD624005.1, CR982513.1, 
CA488904.1) 
2  
 (CR609498.1, BI909492.1) 
PUF60 
(SIAHBP1) 
4  
 (NM_014281.3, 
NM_078480.1, 
BC009734.1, BC011265.1) 
0 10  
 (BI915396.1, AL522753.3, 
AL514886.3, BX384203.2, 
AK055941.1, BQ421738.1, 
BQ956878.1, BG115238.1, 
BE393389.1, BU170641.1) 
CAPER" 
(RNPC2) 
5  
 (NM_184234.1, 
NM_004902.2, 
NM_184241.1, 
NM_184244.1, 
NM_184237.1) 
5  
 (NM_184241.1, 
NM_184244.1, NM_184237.1, 
BC107886.1, BM468718.1, 
BE816688.1, DA115481.1, 
AL711019.1, CA419145.1, 
DA372839.1, BP352717.1, 
DB027200.1, DB150523.1, 
BG764840.1, DA922841.1, 
AW993266.1, AL513896.3) 
10  
(BC107886.1, AL833168.1, 
BP352717.1, BX483043.1, 
BQ893325.1, CR995560.1, 
BQ954122.1, BE933146.1, 
BM983358.1, BU075848.1, 
DB023865.1) 
 
 
 
CAPER! 
(RBM23) 
4 
  (NM_018107.3, 
CR595426.1, BX161440.1, 
AL834198.1)  
10 
  (DA821789.1, DB164369.1, 
BM464794.1, DA145418.1, 
BI823680.1, DB166416.1, 
AA633094.1, BI915247.1, 
DA299707.1, DA026292.1, 
CN483101.1, CX165727.1, 
BC106012.1) 
8  
 (DA675412.1, BG033916.1, 
DA117163.1, DA311282.1, 
BQ707907.1, BQ071908.1, 
BX388764.2, BI915247.1, 
DA299707.1, DA026292.1, 
CN483101.1, 
CX165727.1,BC106012.1) 
U2AF35 
(U2AF1) 
3  
 (NM_006758.2, 
NM_001025203.1, 
NM_001025204.1) 
2 
 (NM_001025204.1, 
BE736536.1)  
1 
 (BG612658.1)  
U2AF26 
(U2AF1L4) 
2  
 (NM_144987.2, 
NM_001040425.1) 
6   
(BM696851.1, BM970675.1, 
AW274826.1, DB127360.1, 
BU628789.1, AA455588.1, 
BI770029.1, BC010865.1, 
BG481735.1, W51842.1) 
6  
 (BE856544.1, BM696851.1, 
BM970675.1, AW274826.1, 
DB127360.1, BU628789.1, 
AA455588.1, BU608847.1, 
DB338076.1, BF821614.1) 
U2AF35R2 
(U2AF1L2) 
1 
 (NM_005089.2) 
6  
 (BC065719.1, DA173194.1, 
DA383795.1, CN289520.1, 
BE619312.1, DA261525.1, 
CA425173.1) 
0 
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3.3.2. VALIDATION OF ALTERNATIVE SPLICING IN U2AF35 
FAMILY OF SPLICING FACTORS 
 
The results of the previous analysis of the U2AF family of proteins revealed new putative 
protein-coding transcripts and non-protein-coding transcripts in the human. As a follow-up 
of the bioinformatic analysis, and in order to weed out possible artifacts, a more detailed 
analysis of a number of new transcripts and a study of the extent of conservation of 
alternative splicing patterns across six model organisms (H. sapiens, M. musculus, D. rerio, 
G. gallus, D. melanogaster and C. elegans) was performed for the three members of the 
family of genes of the small subunit of U2AF, namely U2AF
35
(U2AF1), 
U2AF
26
(U2AF1L4) and U2AF
35
-RS2(ZRSR2). This family of proteins have in common a 
central UHM domian (U2AF homology motif) flanked by zinc fingers and a terminal 
Arginine/Serine rich domain (RS domain) except in the case of U2AF
26 
where the RS 
domain is missing. Each UHM [Kielkopf et al. 2004] domain includes: an eight-residue 
RNA binding motif RNP1 (ribonucleoprotein 1) with consensus [RK]-G-[FY]-[GA]-[FY]-
[ILV]-X-[FY]; a six amino acid RNA binding motif RNP2 (ribonucleoprotein 2) with 
consensus [ILV]-[FY]-[ILV]-X-N-L; and a protein interaction motif of the type RXF, 
where X is any amino acid. 
 
Of these three genes C. elegans possesses only an orthologue of U2AF
35
 , called 
Y116A8C.35, with no alternative splicing; this gene contains four exons with an intronic 
division which does not match that of vertebrates. In D. melanogaster we find an 
orthologue for U2AF
35 
called U2af38 with only one intron, corresponding to the first intron 
found in vertebrates, but no alternative splicing was detected. This would indicate that 
Arthropods and Nematodes diverged prior to the division of this gene into exons (see 
phylogeny of animal model organisms in Appendix E).  
 
D. melanogaster also has an orthologue of U2AF
35
-RS2 composed of 5 exons. This gene 
has only a 26% sequence similarity to the human ortholog and the position of the introns 
does not correspond to that found in vertebrates. Two isoforms are known (accession 
NM_135013.2 and NM_175962.1) and no other alternative splicing was detected by 
ExonMine.  
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For the four vertebrates studied the division into exons of the orthologues of these three 
genes is conserved and the layout of exons in these genes is presented in Figure 3.6. The 
work that follows consists in a more detailed study and validation of selected alternatively 
spliced transcripts which are present in human but not in the other vertebrate model 
organisms considered. This work was done in collaboration with two other members of 
Carmo Fonseca’s lab, Joana Borlido and Sandra Martins.  
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Figure 3.6. – Diagram showing the layout of the exons determined by ExonMine for 
vertebrate orthologues of A. U2AF
35
(U2AF1), B. U2AF
26
 (U2AF1L4) and C. U2AF
35
-RS2 
(ZRSR2):  H. sapiens (H), M. musculus (M), D. rerio (Z), G. gallus (G). Boxes represent 
exons and these have been numbered above the boxes. Exon lengths in nucleotides are 
indicated below each box. Intron lengths are indicated in nucleotides above each diagram in 
the gaps between the boxes. Known protein domains, motifs are shown: the UHM domain 
composed of motifs RNP1, RNP2 and RWF; zinc finger motifs of type CCCH (Zn-f), 
Arginine /Serine rich domain (RS); and poly glycine stretch (Poly-Gly). The RNA binding 
domain has a secondary structure containing alpha-helices (!) and beta-sheets (") with the 
pattern and conventional numbering "1 !A "2 "3 !B "4. The exons which have been 
described as belonging to a protein coding gene by RefSeq or SwissProt have been 
coloured grey. Boxes with diagonal pattern indicate exons not annotated by RefSeq which 
were confirmed by RT-PCR. The size of the boxes, representing exons, and the intervals 
between then, representing intervening sequences, are not to scale. For Chicken and 
Zebrafish U2AF
35
-RS2 (ZRSR2) no RefSeq gene was available and the results are based on 
mRNA and EST sequences clustered by ExonMine using gene loci defined by GenScan 
genes chr1_25.193 (chicken) and chr11_3.36/ chr11_3.27 (duplicated gene in zebrafish). In 
the case of the zebrafish duplicated gene U2AF
35
-RS2(ZRSR2) the exons in the region 
between exons 4 and 7 could not be determined by ExonMine with sufficient precision 
from the existing EST and mRNA data; the size of exons determined for this duplicated 
gene are identical and where differences exist in intron sizes these have been indicated for 
chr11_3.36/ chr11_3.27 respectively.  
 
*Duplicated gene with slight variations at the intron level. The region between exons 4 and 
7 is not covered with sufficient confidence by mRNA and EST information for the 
ExonMine program to detect exons 5 and 6, but a manual analysis of the sequence between 
exons 4 and 7 revealed the existence of sequences identical to the missing exons 5 and 6.
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     148                             88                                                                67              50            99                  134                93            347                    
      80                              88             57             67                               67             50             99                134                 93           2828 
  1                                 2                               2A                              3               4               5                    6                   7               8 
    136                             88                              67                              67             50              99                134                 93            275 
 1                                 2                                                                  3               4                5                   6                   7                8 
    156           457            88                              67             38              67             50             99                134                 93            294 
5’end 
Figure 3.6 A - U2AF
35
(U2AF1) orthologs 
  266          2325                  2882                    751             57          4709          157           649                     91           1221 
1             1A              2                                2A            2B             3                4               5                   6                   7               8 
 
 
 
  Zn-f                           RNP2                        RNP2                         RNP1        RWF           Zn-f            RS, Poly-Gly 
                                       !1              "              !1              "A           !2,!3         "B,!4 
 
 
H 
 
 
 
 
 
M 
 
 
 
 
 
G 
 
 
 
 
 
Z 
 
         3586                            2410                           789                  2751           79             350                   87            647 
         1489                    216            2387                   792                 3301          610          1200                   329          2551 
  1                                 2              2A            2B                               3               4               5                   6                    7               8 
 
 
 
          935                                              89                                     1712          1074         2599                  211          4708 
3’end 
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Figure 3.6 - B. U2AF
26
(U2AF1L4) orthologs 
   1                  2a’  2           2Aa’,2Ab’, 2A            2B               3                        4      4a”           5              5A          5Ba',5B            6a’    6    6a”      W1a’, W1 
  94                25  63          243    46     67             50               99                      76     58            96              50             3    51            184   224    6            5    127 
 
 
 
 
 
 
 
 
 
 
5’ end 
3’ end 
     135               143                             85                69                 177                        107           463            87                  351                        1161 
 
 
 
 
 
 
 
 
  Zn-f                            RNP2                            RNP1                RWF             Zn-f   
                                         !1              "A             !2,!3                 "B,!4                                                            "                     "                 RS 
H 
 
 
 
 
 
 
 
 
M 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1   1a” 1b”        2a’  2                             3             4   4a”           5    5a”                  6                   7                                                               8                    W1         W2  W2a”      W3 
123                     310                    85                 71                     79                      95                                 296                                            367          206                  80 
 
 
 
 
 
 
 
 
49  50  9           25  63                            67            20  30           99    93                 134                 96                                                            1287                188           292   66          380 
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Figure 3.6 - C. U2AF
35
-RS2 (ZRSR2) orthologs 
 
5’end 3’end 
Glu-rich Glu-rich Zn-f    RNP1      RNP2     RWY    Zn-f   RS 
37            131               5041          3621               255            634           1734         314           4035         928           6358         2696         1564         2414 
  
 
    273                      160           69    80           196           11   71            431           680           109            87             39            119           214            56            110            611 
1 
H 
 
 
 
 
 
M 
 
 
 
 
 
G 
 
 
 
 
Z* 
 
 
   1     1A’     1B’                                     2                                   3                                                    4               5               6               7                8               9              10             11 
 
 
 
 
 
5       107                   287                              1362                                          1989                           717         3344          808           5946         2925          703          2340     
 90     56       146                                   80                                 82                                                 109            87             39            119            214           56             110         1523 
 
   1                       1A           2a’   2              2A           3a’   3              3A           3B              4               5               6               7               8               9               10             11 
   1                                                2                                    3                                                    4               5              6                7               8                9              10             11 
 199                                               80                                 97                                                 109            87             39            116            214            56            110           678 
                  1767                              128                                            267                         327          2226         1601         5020          2256          183          672 
 161                                               80                                 73                                                 109                                             116            214            56            110           553 
                  96                                 326                                          88                                         2355/2360                 1159/1170     185            90       4602/4482 
    1                                                  2                                   3                                                    4                                                 7              8                9              10             11 
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Validation of novel U2AF
35
 transcripts 
In U2AF
35
 there are two transcripts containing exons not present in mouse, chicken or 
zebrafish. These are: an EST containing exon 2B, which contains exon 1 through to exon 8 
(1,2,2B,4,5,6,7,8), with GenBank accession BG612658.1; and another EST containing a 
novel first exon 1A, which only goes as far as exon 4 (1A,2,3,4), with Genbank accession 
BE736536.1.   
The former transcript (BG612658.1), containing exon 2B, was experimentaly validated by 
members of Carmo Fonseca’s Lab (Figure 3.11). The open reading frame spans exons 2 to 
8, but known exon 2 is in a new reading frame. Figure 3.7.A shows a secondary structure 
prediction of this novel region which is predicted to fold into a helical motif covering 13 
amino acids.  This transcript is therefore expected to generate a new U2AF
35
 isoform with a 
new N-terminal motif.   
The latter transcript (BE736536.1), containing novel first exon 1A, was found to have no 
open reading frames in frame with known exons. Exon 1A is also rather large, covering 437 
nucleotides, (that is about half the size of the full U2AF
35
 transcript) and the transcript 
reveals splicing of exon 1A to known exons 2, 3 and 4. This kind of exon falls into the 
large category of novel non-coding exons (ncExons) examined in the previous section (see 
Table 3.2). There are 6 start codons on this exon with corresponding premature stop codons 
on the same exon. It is therefore not likely to produce a novel isoform of U2AF
35
. 
However, this exon contains two predicted overlaping open reading frames (orfs) with 
upstream start codons only 4 nucleotides apart , which would code for 93 and 92 amino 
acid respectively (Figure 2.7. B). A secondary structure analysis of the translated orfs 
reveals one with three alpha helices and the other with one extended alpha helix covering 
34 amino acids. Exon 1A was found to be conserved in two other primates (chimp and 
rhesus) but not on mouse.  Figure 3.7.C  shows the extent of conservation of the translation 
of the first open reading frame. This analysis indicates that this exon may be unique to 
primates. Although this transcript may not produce a novel U2AF
35
 isoform it may be 
involved in a regulatory pathway which is unique to primates, or it may code for a small 
protein unique to primates as there is a poly(A) signal hexamer (AATAAA) on exon 2. 
Inês Guerra Mollet                                                                                                                  RESULTS AND DISCUSSION 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS                                    111 
Figure 3.7. A.  Secondary structure prediction of amino acid sequences obtained from open 
reading frame on the U2AF
35
 transcript containing the novel exon 2B (BG612658). Spliced 
exons validated by RT-PCR are underlined (see Figure 3.11). The open reading frame 
spans exons 2 to 8 (highlighted in bold green), but known exon 2 is in a new reading frame. 
B. Secondary structure prediction of amino acid sequences obtained from open reading 
frame on the U2AF35 transcript containing the novel first exon 1A (BE736536). The 
sequence shown is extended upstream to the first methionine residues found. Two open 
reading frames exists that cover exon 1A: the first contains three short !-helices and the 
second one extended !-helix covering 34 amino acids. Amino acid secondary structure 
predictions were made with Scratch Protein Predictor SSpro8 [Pollastri et al. 2002; Cheng 
et al. 2005; W7] and coloured and annotated manually; H=alpha-helix, E=extended strand, 
T=Beta turn, S=Bend region, C=random coil. C. Conservation in primates (human, chimp 
and rhesus) of the translation of the 1
st
 orf derived from human exon 1A of U2AF
35
 present 
in EST BE736536. The alignment was performed using the program MULTALIN [Corpet 
1988].  
A. Variant d  (BG612658.1,  EST)    Exons: 1,2,2B,4,5,6,7,8 
(exon2)METGALGCTINRRLAS(exon2B)TESQLKHLPEAAG(exon4)…………………known orf 
(exon2)CCCHCEEEEHHHHHHH(exon2B)HHHHHHTCTTTCC(exon4)…………………known orf 
 
B.  (BE736536.1,  EST)     Exons: 1A,2,3,4 
1
st
 orf    
MNGVSFRGAAAELSPALG(exon1A)SGLADRPTSGPPSRRLPEAASSRAESCLEHPGLLDVDTFVPTFGCECPVEQALVPASPVFSRLSN 
CCCEEEHHHHHHHCHHTT(exon1A)TTCCCSCCCSCCCCCCCHHHHHHHHHHHHCTTCCCCCEECCCECCCCCHHEEECCCCHHHHHHHT 
 
LGS(STOP) 
TCC(STOP) 
 
2
nd
 orf 
MGSLFGAPRPSFLRPWG(exon1A)PDWLIARRPGLRVADSRKPPRAALKVAWSIRAFWTWTRLFQLSAVNVLSSKLWYQPRQYSVAY 
CCCETCCCCCCGCCCTC(exon1A)CHEHHEECTTCEEECTSSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHECCCCEEEEE 
 
LT(STOP) 
EC(STOP) 
C.  
                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
Human        MNGVSFRGAAAELSPALGSGLADRPTSGPPSRRLPEAASSRAESCLEHPGLLDVDTFVPT 
Chimp        MNGASFRGAAAELSPALGSGLADRPTSGPPSRRLPEAASSRAESCLEHPGLLDVDTFAPT 
Rhesus       MNGASFRGAAAELSPALRPGLADRPTSGPPSRQLPEAASSDAESCLEHPGLFDVDTFTPT 
Consensus    MNGaSFRGAAAELSPALgsGLADRPTSGPPSRrLPEAASSrAESCLEHPGLlDVDTF PT 
Prim.cons.   MNGASFRGAAAELSPALGSGLADRPTSGPPSRRLPEAASSRAESCLEHPGLLDVDTF3PT 
 
                     70        80 
                      |         | 
Humanx0      FGCECPVEQALVPASPVFSRLSNLGS 
Chimpx1      FGCECPVEQALVPASPVFSRLSNLGS 
Rhesus       LSCECPVSNKLWYQPCQYSVTYLT-- 
Consensus    fgCECPVe#aLvpaspv%Srlsnlgs                                   
Prim.cons.   FGCECPVEQALVPASPVFSRLSNLGS 
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Validation of novel U2AF
26
 transcripts 
The U2AF
26 
gene may be unique to mammals as it has been found in rat, cow and pig as 
well mouse and human but there is no evidence of it in the genomes of birds, amphibians or 
fish [Mollet et al. 2006]; it is thought to have occurred as a duplication of U2AF
35
 when the 
mammalian lineage was already established. However, in human, the annotated gene for 
U2AF
26
 lacks exons 3 and 4, which are present in the mouse ortholog. Exon 3 contains the 
RNP2 motif and exon 4 contains a large part of an alpha helix A, both these motifs forming 
part of the canonical UHM motif in the mouse orthologue. The crystal structure of the 
U2AF
65
- U2AF
35
 heterodimer has revealed that, when phosphorylated, this helix can 
present a highly negatively charged face which could provide for interaction with other 
splicing factors [Kielkopf et al. 2001].  The absence of these two exons in the known 
human isoform is therefore certain to affect RNA-protein interactions. ExonMine does 
however detect these “missing exons” shown in Figure 3.6B as exons 2A and 2B for the 
human gene. The length of exons 2A and 2B in the human is identical to the mouse 
U2AF26 ortholog and the U2AF35 homolog and the translated sequence contains the 
expected protein motifs as indicated on Figure 3.6B and Figure 3.8. The transcripts 
detected by ExonMine, however, are either incomplete (Appendix F) or include splicing to 
5’ extentions to exon 2A which are not seen in any other ortholog or homolog, and it would 
be important to validate alternative splicing to these exons.  
 
 
Figure 3.8 – Variation in RNP2 motif in U2AF35 and U2AF26 (RNP2 motif highlighted in 
Red) 
 
human U2AF35 (exon 3)    TIALLNIYRNPQNSSQSADGLR 
                         ||   ||||||||| | ||| 
human U2AF35 (exon 2B)   TILIQNIYRNPQNSAQTADGSH 
                         ||   |||||||| |||||||| 
human U2AF26 (exon 2A)   TIVLLNLYRNPQNTAQTADGSH 
                         |||||||||||||||||||||| 
mouse U2AF26 (exon 3)    TIVLLNLYRNPQNTAQTADGSH 
 
 
In addition to this difference between mouse and human U2AF26, in the human, the 
RefSeq annotation describes a 3’ extention of exon 4 (4a”) which changes the reading 
frame of the 3’ end of the transcript which will now code for the expected second zinc 
Inês Guerra Mollet                                                                                                                  RESULTS AND DISCUSSION 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS                                    113 
finger and teminal RS domain not present in the translation of the transcript skipping 4a” 
(see Appendix F for details).  
 
Two new exons, 5A and 5B, not found in mouse, were detected in human. Exon 5B has an 
alternative 5’ extention of 3 nucleotides which is indicated as 5Ba’. Two  splicing patterns 
containing these exons were confirmed by RT-PCR (variants 3 and 4 in Figure 3.11). 
ExonMine tables containing information on open reading frames show that variant 3 has its 
first start codon at position 29 with a good neighboring Kozak consensus AGUAUGG but 
a stop at position 47. However there is a second start codon at position 46 with a 
neighbouring Kozak consensus GAGAUGA,  and an open reading frame extending all the 
way to exon  6a’ (Figure 3.10 A). The predicted secondary structure of the translation of 
this reading frame reveals an extended alpha helix covering the novel exons 5A and 5B. A 
search for similar protein sequences with Mpsrch [http://www.ebi.ac.uk/MPsrch/] reveals 
an interesting match to serine threonine-protein kinase for exon 5A (Figure 3.9). Variant 4 
(Figure 3.11) contains the extention 5Ba’ which introduces a stop codon just before exon 
5B (Figure 3.10B), otherwise the translation is as for variant 3.  The putative proteins are 
very short and may not be real, however, validation by RT-PCR confirms that these 
splicing patterns exist and these isoforms should be considered, if not for novel protein 
fuction, for involvement in the regulation of the expression of this gene.  
 
 
 
Figure 3.9 – Translation of U2AF26 Exon 5A (highlighted cian) matches a 
Serine/threonine kinase. Search made with Mpsrch [W9]. 
 
 
ID   NEK5_HUMAN              Reviewed;         708 AA. 
DE   Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (NimA-related 
DE   protein kinase 5). 
 
  DB  1;  Score     115;  Match 81.2%;  QryMatch 39.8%;  Pred. No. 2.36e-05; 
  Matches    13;  Conservative    3;  Mismatches   0;  Indels   0;  Gaps   0; 
 
          ***.*.***.****** 
Db    534 WSAMARSWLTATSASQ 549 
Qy      1 wsakaqswlsatsasq 16      
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Figure 3.10 -  Secondary structure prediction of amino acid sequences obtained from open 
reading frame on the U2AF
26
 transcript containing the novel exons 5A, 5Ba’and 5B. Exons 
included in open reading frame are highlighted in bold green. Spliced exons validaded by 
RT-PCR are underlined (see Figure 3.10). A. Variant 3 (BU608847.1). B. Variant 4 
(DB338076.1). Amino acid secondary structure predictions were made with Scratch Protein 
Predictor SSpro8 [Pollastri et al. 2002; Cheng et al. 2005; W7] and coloured and annotated 
manually; H=!-helix, E=extended strand, T=Beta turn, S=Bend region, C=random coil. 
 
 
A. Variant 3 (BU608847.1)  
 
Exons:    2Ab',2A,3,4,5,5A,5B,6a',6          (129 amino acids) 
(3)MNVCDNLGDHLVGNVYVK(4)FRREEDGERAVAELSNRWFNGQAVHG(5)NVPEVASATSCICGPFPRTSRGSSMGGDPGAG 
(3)CCEEHHHHHHEEEEEEEE(4)EEECTTHHHHHHHHTTCEETSCEEEE(5)EECCCCCHHHHECCCCCTCCCCCCCTCCTTCC 
 
(5A)WSAKAQSWLSATSASQR(5B)WGFTTLASLVSNSGPQV(6a’)TPEVPYWPPSPREEPSVFP(STOP) 
(5A)HHHHHHHHHHHHHHHHH(5B)HTHHHHHHHHHTTSCCC(6a’)CCCCCCCCCCCCCCCCCCC(STOP) 
 
 
 
 
 
 
B. Variant 4 (DB338076.1) 
 
Exons: 2A,3,4,5,5A,5Ba',5B,6                 (92 amino acids)   
(3)MNVCDNLGDHLVGNVYVK(4)FRREEDGERAVAELSNRWFNGQAVHG(5)NVPEVASATSCICGPFPRTSRGSSMGGDPGAG 
(3)CCEEHHHHHHEEEEEEEE(4)EEECTTHHHHHHHHTTCEETSCEEEE(5)EECCCCCHHHHECCCCCTCCCCCCCTCCTTCC 
 
(5A)WSAKAQSWLSATSASQ(5Ba’)(STOP) 
(5A)HHHHHHHHHHHHHCCC(5Ba’)(STOP) 
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Figure 3.11. A. Total human cDNA of known and predicted U2AF
35
(U2AF1), 
U2AF
26
(U2AF1L4) and U2AF
35
-RS2(ZRSR2) alternatively spliced mRNA isoforms 
validated by quantitative real time reverse transcriptase-PCR. Variants (RT-PCR covers 
bold underlined exons):  U2AF
35 
variant a (NM_006758.2 has exons 1,2,3,4,5,6,7,8), 
U2AF
35 
variant b (NM_001025203.1 has exons 1,2,2A,4,5,6,7,8) and U2AF
35 
variant d 
(BG612658.1 has exons 1,2,2B,4,5,6,7,8); U2AF
26
 variant 1 (NM_001040425.1 has exons 
1,2a',2,3,4,4a",5,6a',6), U2AF
26
 variant 2 (NM_144987.2 has exons 1,2a',2,3,4,5,6a',6), 
U2AF
26
 variant 3 (BU608847.1 has exons 2Ab',2A,3,4,5,5A,5B,6a',6) and U2AF
26
 variant 
4 (DB338076.1 has exons 2A,3,4,5,5A,5Ba',5B,6); U2AF
35
R2 (NM_005089.2 has exons 
1,2,3a',3,4,5,6,7,8,9,10,11), U2AF
35
R2 CA (DA261525.1 has exons 1A,2,3,4,5,7), 
U2AF
35
R2 DA (CA425173.1 has exons 2A,3a',3,4). The experimental validation was 
performed by Joana Borlido, methods detailed in Appendix G.  
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Validation of novel U2AF
35
-RS2 transcripts 
For U2AF
35
-RS2 the expression of two exons, of 160 and 196 nucleotides, which do not 
have any open reading frames in frame with known exons, were validated by RT-PCR by 
Joano Borlido (variants indicated as DA and CA in Figure 3.11). These were found in 
transcripts DA261525.1 with exons (1A,2,3,4,5,7), and CA425173.1 with exons 
(2A,3a',3,4), both of which contain a putative poly(A) signal on exon 4 (Figure 3.14 and 
Figure 3.15). ExonMine data on open reading frames shows that the first two open reading 
frames on these transcripts contain premature stop codons. The putative peptides would 
have 16 and 55 amino acids for the former, and 12 and 35 amino acids for the latter, which 
is indeed very short and are not likely to be real.  
 
Using BLAT we find that Exon 1A  maps well to the Chimp, Orangutan and Rhesus 
genome assemblies on orthologous gene U2AF35-RS2 (Figure 3.12), but does not map to 
the orthologous gene on Mouse, or other mammal model organisms. Similarly Exon 2A 
maps to Orangutan and Rhesus ortholog of U2AF35-RS2 (Figure 3.13) but a match was not 
found on the chimp ortholog although matches were found on other genes. This is an 
indication that this exon may be a mobile element [Kazazian 2004]. Mobile elements are 
transposable sequences which have shaped the evolution of genes and genomes of both 
plants and animals. A match for exon 2A was not found on ortholog of U2AF35-RS2 in 
Mouse or other mammal model organisms. 
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Figure 3.12 – BLAT alignment of Exon1A from Human, to Chimp and Rhesus ortholog 
of  U2AF35-RS2 gene. Matches shown in blue.  
 
Exon 1A (DA261525.1 ) mapping to Chimp Genomic chrX on gene U2AF35-RS2 : 
ccgagaaacc aaggtaagct ccgtacgggg agatgagcag gcgagcgggc  15773473 
CGATCGTGGG CATGGAGGAT GTGGTGGCAG GAAGAAAAGA GAAGCTGGGC  15773523 
CAAGCTAAGT GAGCCACCGC GGCAGCTCCA TTCCTTCCTG GTGCGCGCCC  15773573 
TGGTGCCCTC CCCGGACTTG CACGGGCGGC TGTGGCTCAG GCAAGCGAGG  15773623 
AGAGGATCAG gttggcggat ggagaagaac tgtctgggag tgggaggatg  15773673 
 
Exon 1A (DA261525.1 ) mapping to Orangutan Genomic chrX on gene U2AF35-RS2 : 
cagagaaacc aaggtaagct ccgtacgggg agatgagcag gcaagtgggc  15760311 
CGATCGTGGG CATGGAGGAT GTGGTGGCAG GAAGAAAAGA GAAGCTGGGC  15760361 
CAAGCTAAGT GAGCCACCGC GGCAGCTCCA TTCCTTCCTG GTGCGCGCcC  15760411 
TGGTGCCCTC CCCGGACTTG CACGGGCGGC TGTGGgCTCA GGCAAGCGAG  15760461 
GAGAGGATCA Ggttggcgga tggagaagaa ctgtctggga gtgggaggat  15760511 
 
Exon 1A (DA261525.1 ) mapping to Rhesus Genomic chrX  on gene U2AF35-RS2: 
cagagaaacc aaggtaagct ccgtacgggg agatgagcag gcaagcgggc  13550981 
CGATCGTGGG CATGGAGGAT GTGGTGGCAG cAAGAAAAGg GAAGCTaGGC  13551031 
CAAGCTAAGT GAGCCACCGC GGCAGCTCgA TTCCTTCCTG GTGCGCGCCC  13551081 
TGGTcCCCTC CCCGGACTTt CACGGGCGGC TGTGGgCTCA GGCAAGCGAG  13551131 
GAGAGGATCA Ggttggcgga tggagaagaa ctgccgtctg gaagtcggag  13551181 
 
Figure 3.13 – BLAT alignment of Exon 2A, from Human, to Orangutan and Rhesus 
ortholog of U2AF35-RS2 gene. Matches shown in blue. 
 
Exon 2A (CA425173.1) mapping to Orangutan Genomic chrX on gene U2AF35-RS2 : 
tcaatgattt tcttttttgt tttgttttgt tttgtttttt ttgagatgga  15765809 
GTCTTGCTCT GTCGCCCAGG CTGGAGTGCA GTGGCATGAA CTCGGCTCAC  15765859 
TGCAACCTCC GCCTaCCGGG TTcAAGCAAT TCTCCTGCCT CAGCCTCCAG  15765909 
AGTAGcTGGG ATTACAGACA CGCACCACCG CGCCCaGCCA TCATGACTTT  15765959 
TCTCTGCTTC TTGAGAGCAC TTCCcGCATC aCTAGTCGCA CTTTGTgtga  15766009 
gtctcatgat gttattcaag gtttaccatt ttgtagtaaa cacaatgaaa  15766059 
 
Exon 2A (CA425173.1) mapping to Rhesus Genomic chrX on gene U2AF35-RS2 : 
ctcaatgatt ttcttttctt tctttctttt attttatttt ttgagacaga  13556085 
GTCTTGCTCT GTtGCCCAGG CTGGAGTGCA GTGGCATGAA CTCGGCTCAC  13556135 
TGCAACCTCC GCCTCCCaGG TTcAAGCAgT TCTCCTGCCT CAGCCTCCct  13556185 
AGTAGcTGGa ATTACAGgCg tGCACCACac tGCCCGGtCA TCATGACTTT  13556235 
TCTCTGCTTC TTGAGAGCAC TTCCAGCATC aCTAGTtgca ttttgtgtga  13556285 
gtctcatgat gttattcaag gtttaccatt ttgtagtaaa cacgatgaaa  13556335 
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To explore the RNA sequence of these exons, a secondary structure analysis was peformed 
using the sfold program [W8]. Exon 1A is predicted to form a secondary structure 
containing a hairpin which could code for a microRNA (Figure 3.14). Based on this 
hypothesis, Francisco Enguita from Carmo-Fonseca’s Lab attempted to validate this 
microRNA and preliminary experimental results showed that this exon may in fact be 
coding for a microRNA.   
 
The transcript carrying exon 2A is also predicted to form a stable hairpin, but in this case 
the region which folds into a hairpin covers a spliced junction (Figure 3.15). This hairpin 
was not validated experimentally as a microRNA coding sequence. 
 
The analysis of novel exon 1A and 2A in only preliminary but it opens a new avenue to 
explore the possibility that other novel exons in known protein coding genes, which do not 
contain open reading frames covering other known exons in the gene, may be coding for 
microRNAs, and that some may be unique to the primate lineage.  
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Figure 3.14 – A. U2AF35-RS2 spliced exons 1A,2,3,4,5,7 (DA261525.1) and putative 
Poly(A) signal AATAAA on exon 4. Sequence forming a stable hairpin highlighted in red 
covers nucleotides 14 to 102 of the transcript. B. RNA secondary structure, of nucleotides 1 
to 160nt of transcript, produced by sfold program [W8]. Stable hairpin circled in red.   
 
A. 
CGATCGTGGGCATGGAGGATGTGGTGGCAGGAAGAAAAGAGAAGCTGGGC 
CAAGCTAAGTGAGCCACCGCGGCAGCTCCATTCCTTCCTGGTGCGCGCTC 
TGGTGCCCTCCCCGGACTTGCACGGGCGGCTGTGGCTCAGGCAAGCGAGG 
AGAGGATCAGCCACAAAAAGTACAGGGCCGCCCTGAAGAAGGAGAAACGA 
AAGAAACGTCGGCAGGAACTTGCTCGACTGAGAGACTCAGAAGGAGGAAG 
AGGAGGACACTTTTATTGAAGAACAACAACTAGAAGAAGAGAAGCTATTG 
GAAAGAGAGAGGCAAAGATTACATGAGGAGTGGTTGCTAAGAGAGCAGAA 
GGCACAAGAAGAATTCAGAATAAAGAAGGAAAAGGAAGAGGCGGCTAAAA 
AACGGCAAGAAGAACAAGAGAGAAAGTTAAAGGAACAATGGGAAGAACAG 
CAGAGGAAAGAGAGAGAAGAGGAGGAGCAGAAACGACAGGAGAAGAAAGA 
AAAAGAGTTGGAAAATGGTACCACATGGCAAAACCCAGAACCACCCGTGG 
ATTTCAGAGTAATGGAGAAGGATCGAGCTAATTGTCCCTTCTACAGTAAA 
ACAGGAGCTTGCAGATTTGGAGATAG 
 
B. 14-102nt (putative microRNA hairpin) 
 
Inês Guerra Mollet                                                                                                                  RESULTS AND DISCUSSION 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS                                    120 
Figure 3.15 – A. U2AF35-RS2 spliced exons 2A,3a',3,4 (CA425173.1, EST) and putative 
Poly(A) signal AATAAA on exon 4. Sequence forming a stable hairpin highlighted in green 
covers nucleotides 145 to 221 of the transcript. B. RNA secondary structure nucleotides 
125 to 225nt of transcript produced by sfold program [W8]. Stable hairpin circled in green. 
A. 
GTCTTGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCATGAACTCGGCTCAC 
TGCAACCTCCGCCTCCCGGGTTGAAGCAATTCTCCTGCCTCAGCCTCCAG 
AGTAGTTGGGATTACAGACACGCACCACCGCGCCCGGCCATCATGACTTT 
TCTCTGCTTCTTGAGAGCACTTCCAGCATCGCTAGTCGCACTTTGTGACT 
CTCACAGAAGGAGGAAGAGGAGGACACTTTTATTGAAGAACAACAACTAG 
AAGAAGAGAAGCTATTGGAAAGAGAGAGGCAAAGATTACATGAGGAGTGG 
TTGCTAAGAGAGCAGAAGGCACAAGAAGAATTCAGAATAAAGAAGGAAAA 
GGAAGAGGCGGCTAAAAAACGGCAAGAAGAACAAGAG  
 
B. 145-221nt (putative microRNA hairpin)  
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4. CONCLUSIONS 
 
Novelty 
By imposing fewer constraints on the selection of transcripts, ExonMine produces a high 
level of clustering of spliced EST data to a given gene. The method succeeds in capturing a 
greater number of transcripts and detecting a higher percentage of spliced genes and 
isoforms when compared with other recently published alternative splicing databases. 
ExonMine provides a minimal set of isoforms representing all splicing patterns found but 
also provides the user with all the raw data for each gene. The discrimination of all exons, 
present in all input GenBank transcripts used in the clustering, allows the user to backtrack 
to the original experimental conditions including tissue expression of each transcript. A 
statistical analysis of our output data also revealed a marked increase, in complex 
organisms, of splice variants incorporating intron retentions or novel exons with no 
apparent protein-coding potential. A significant number of these match transcription data 
from tiling arrays. Several lines of evidence indicate that post-transcriptional regulation 
through alternative splicing involving non-protein coding transcripts may constitute an 
important mechanism for the control of gene expression [Lewis et al. 2005; Hughes 2006]. 
Mechanisms of this nature include regulated unproductive splicing and translation (RUST) 
[Lewis et al. 2005] and nonsense mediated decay (NMD) [Lareau et al. 2007; Grellscheid 
and Smith 2006]. Such splice variants may form an integral part of regulatory pathways 
built into more intricate layers of gene regulation in humans. Deciphering complex pathways 
of gene regulation in higher organisms involving non-protein-coding splicing patterns will 
expand our knowledge of the regulatory role of alternatively spliced untranslated regions.  
 
Validation 
Validation of data produced by the ExonMine program has confirmed the utility of this 
resource. The ease with which mining of control sequences, associated with alternative 
splicing events, was performed to validate experimental models [Pacheco et al. 2006] 
reveals the versatility of ExonMine. Cross species analysis of ExonMine data for the U2AF 
family of alternative splicing factors has given insight into the evolution of functions 
brought about by alternative splicing in this set of genes [Mollet et al. 2007]. A selection of 
novel isoforms detected in ExonMine for the U2AF35 family of splicing factors was 
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validated experimentally by members of Carmo-Fonseca’s lab. A transcript from U2AF35, 
including a novel exon which does not have an open reading frame in-frame with known 
exons, was found to be conserved in primates but not in mouse. Another non-coding 
transcript in U2AF35_RS2, which was validated by members of Carmo-Fonseca’s lab, was 
found to contain a potential microRNA hairpin. A recent study done in plants suggest that 
the number of microRNAs in a system is a crucial factor in determining the complexity of 
that system as it is associated with more complex expression patterns in the target genes 
[Takuno and Innan 2008], surely an identical case could be made for animal systems. Our 
results show that the new information mined by ExonMine is not spurious and seems to 
confirm our premise that more complex layers of gene regulation, involving apparently 
non-protein-coding transcripts, exist in humans.  
 
Potential for large-scale analysis 
ExonMine data has been used for custom design of an alternative splicing array designed to 
monitor alterations in alternative splicing in myotonic dystrophy. On the other hand, the 
good correlation obtained between ExonMine data and both Affymetrix tiling array data 
and the commercial exon microarray platform, which covers the majority of exons in 
human, could allow large scale analysis of alternative splicing to be performed. The 
MySQL structure of the data has also provided a resource for easy large-scale analysis of 
regulatory sequences elements involved in alternative splicing [Pacheco et al. 2006].  
 
Plasticity of algorithm 
The algorithm has currently been applied using RefSeq and EntrezGeneIDs as a means to 
identify the locus and exons of a particular gene, and used a particular level of filtering of 
EST and mRNA data in order to weed out determination of false alternative splicing events 
which occur due to incorrect or incomplete BLAT mapping of transcripts to the genome 
assembly. This algorithm does however present a high level of plasticity and could be 
applied to any set of gene predictions. The level of filtering of mRNAs and ESTs is also 
open to easy manipulation at several levels: minimum exon or intron size allowed; number 
of bases in the cDNA unmapped by the BLAT program due to single nucleotide 
polymorphism; number of n bases in the mRNA and EST allowed; and the splice site 
consensus sequences allowed. The algorithm can also be applied to gene predictions when a 
RefSeq annotation is not available and this was successfully done in an analysis of chicken 
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and zebrafish orthologs of human U2AF
35
-RS2 - this provides a means for manoeuvring 
into new territory. 
 
Cross Species Genomics 
Certain mechanisms of gene expression display a high degree of conservation across all 
organisms. For example, mRNA translation by the ribosome follows a set of rules that is 
essentially invariant in all known organisms. On the other hand, although many elements of 
pre-mRNA processing are conserved, the rules governing RNA splicing clearly differ 
between different groups of eukaryotes. In addition, the rules for splicing appear to be 
significantly more complex than those for translation, involving presence of multiple 
degenerate motifs occurring with appropriate spacing in the transcript. Information on 
alternative splicing in orthologous genes (i.e. identical genes found in different organisms) 
is a fundamental tool not only for establishing the common ground in regulation of gene 
expression through alternative splicing across several species but more importantly for 
singling out what distinguishes more complex organisms from less complex ones and 
thereby broadening the road to deciphering the intricate layers of gene regulation in human. 
The cross species analysis and validation of alternative splicing patterns detected by 
ExonMine in the U2AF35 family of splicing factors revealed elements which seem to be 
unique to primates.  
 
Updatability 
We stress that the objective of ExonMine is not to give a near perfect description of 
alternative splicing but rather to mine as much alternative splicing information as possible 
from the vast amounts of transcript sequence deposited in GenBank. Given the rate at 
which novel sequence data is deposited in GenBank on a daily basis, the issue of easy 
updatability is a great asset (48 hours for the human data and less time for less complex 
genomes). On the other hand it is important to provide stable sets of data which can be 
referenced in the process of validation or ongoing work and a four month gap between 
updates has been settled on, allowing nonetheless continued access to previous updates.  
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Future work 
The objectives of this project have been attained. The datasets made available through 
ExonMine are part of an actively growing project which will involve continuous inclusion 
of novel information relating to alternative splicing, such as splicing control sequences, 
tissue-specific splicing events and disease-associated splicing defects. For model organisms 
which have not been extensively covered by RefSeq, or have no such gene annotation, 
future work will include the application of the ExonMine algorithm by defining gene loci 
using gene predictions rather than RefSeq transcripts, and ESTs from closely related 
organisms. Further work is currently being undertaken in several independent projects at 
the level of microarray analysis and at the level of validation of individual alternative 
splicing events. It is hoped that this resource will continue to support work in validation and 
functional analysis of alternative splicing information both on the scale of a single gene and 
by using genome-wide technologies. 
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Appendix A - Rules followed to adjust the ends of transcript BLAT 
alignments 
Figure I. Rules followed to adjust the ends of transcript BLAT alignments 
This figure describes in detail the adjustments made to transcript BLAT alignments taking 
into account information from all superimposed alignments of mRNAs and ESTs, that is, 
the rules followed for adjusting the start (cS – cut Start) and the end (cE – cut End) of each 
alignment to the nearest known start of an exon (S) or end of an exon (E). Figure I. A. For 
a cS lying between a  known exon start S and a known exon end E on the same exon the cS 
is extended to the position of S. When no isoform contains both S and E the program looks 
at the other cE and cS in the region between S and E: if the first cS is downstream of the 
last cE then cS is extended to the position of the first cS (Case 1); if the first cS is upstream 
of the last cE (Case 2) or there are no cE between S and E (Case 3) then cS is extended to 
the position of  S. B. For a cS lying between a known exon end E and a known exon start S, 
the cS is aligned to the position of S if |S-cS|<9nt or to position E otherwise. C. For a cS 
lying between two known exon starts S1 and S2 the cS is extended upstream to the position 
S1. D. For a cS lying between two known exon ends E1 and E2: if E2 has a known start S 
then cS is extended upstream to the position E1 otherwise cS is extended to the furthest 
upstream cS lying between E1 and E2 (first cS). E. For a cE lying between an S and an E on 
the same exon the cE is extended to the position of E. When no isoform contains both S and 
E the program looks at the other cE and cS in the region between S and E: if the first cS is 
downstream of the last cE, then, cE is extended to the position of the last cE (Case 1); if the 
first cS is upstream of the last cE (Case 2) or there are no cS in the region between S and E 
(Case 3) then cE is extended to the position of E. F. For a cE lying between an E and an S 
the cE is aligned to the position of E if |cE-E|<9nt or to position S otherwise. G. For a cE 
lying between two known exon ends E1 and E2 the cE is aligned with E2. H. For a cE lying 
between two known exon starts S1 and S2: if S1 has an known end E then cE in extended to 
the position of S2 otherwise cE is extended to the furthest downstream cE lying between S1 
and S2 (last cE). 
 
 
 
 
 
 
Figure I.  
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Figure I. (cont.) 
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Case 2 
Case 3 
E S 
cS S E 
cS 
C 
B 
S1 S2 
cS 
S2 E S1 
cS E 
E1 E2 
cS 
Case 1. If E2 has a start S then  cS = E1 
  
Case 2. If  E2 has no start S then  cS = first cS 
E1 E2 S 
cS 
E2 
 
E1 S 
first cS 
E2 
 
E2 
cS 
D  
E 
cS E 
S1 S2 
cE 
Case 1 
Case 2 
If |S-cS|<9nt then cS=S 
Else cS=E 
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S E 
cE S E 
S cE 
When at least one transcript contains both S and E  (E is a successor of  S) 
When no transcript contains both S and E (E is not a successor of S) 
E  
Case 1 
Case 2 
Case 3 
S E last cE first cS 
S cE 
S cE 
S 
E 
last cE 
first cS 
S cE 
S 
E 
E S 
cE 
F  
S E 
cE 
E1 E2 
cE 
G  
E1 E2 
S 
cE S 
S1 S2 
cE 
H 
S2 
E S1 
cE 
Case 1. If S1 has end E then  cE = S2 
Case 2 If S1 has no end E then  cE = last cE 
S2 
E 
S1 
cE 
last cE 
E1 E2 S 
cE S 
cS 
Case 1 
Case 2 
If |cE-E|<9nt then cE=E 
Else cE=S 
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Appendix B - List of candidates for validation 
 
Table I. Candidate genes containing alternative 3’ splice sites (3’ss) carrying a weak 
proximal polypyrimidine tract and a strong distal polypyrimidine tract and with the 
alternative exon extention containing a putative exonic splicing enhancer.  
 
 
  
 
 
 
 
 
Gene 
Symbol Chr Strand 
Position 
5'ss 
Position 
proximal 
3'ss 
Position 
distal 3'ss 
Length 
Alternate 
Sequence 
Accession for 
Isoform with 
proximal 3'ss 
Accession for 
Isoform with 
distal 3'ss 
ADA chr20 - 42682354 42682000 42681902 98 BX414292 NM_000022 
downstream 
of APOC1 chr19 + 50122130 50122707 50122892 185 AV645786 DA638554 
ARHGEF19 chr1 - 16276560 16274375 16274341 34 NM_153213 AL137736 
ARMCX4 chrX + 100593144 100594216 100594365 149 NM_152583 CR595436 
ATXN7L2 chr1 + 109741881 109742182 109742278 96 AK090460 NM_153340 
BCL2L14 chr12 + 12135050 12138712 12138865 153 NM_030766 NM_138723 
BCNP1 chr19 + 17504197 17505334 17505396 62 DA951184 NM_173544 
BIRC4BP chr17 + 6599694 6600034 6600085 51 DA430788 BX649188 
BMP4 chr14 - 53489744 53488697 53488644 53 NM_001202 BE877424 
C18orf8 chr18 + 19364259 19364349 19364473 124 NM_013326 AL526305 
C22orf18 chr22 - 40666417 40665893 40665808 85 BM045658 NM_001002876 
CAD chr2 + 27373751 27373850 27373937 87 NM_004341 BG821112 
CUEDC1 chr17 - 53298834 53295717 53295645 72 BI335053 NM_017949 
DMTF1 chr7 + 86459947 86462006 86462059 53 AB209230 NM_021145 
DNAJB13 chr11 + 73354944 73356909 73357038 129 BU859152 NM_153614 
ECE1 chr1 - 21307649 21305622 21305460 162 BQ942755 NM_001397 
ECM2 chr9 - 92359524 92357040 92356974 66 NM_001393 BC105958 
EIF3S7 chr22 - 35232050 35231715 35231547 166 AI302828 NM_003753 
FAM24B chr10 - 124605151 124600056 124600026 30 NM_152644 BU602099 
FBXO2 chr1 - 11648354 11647848 11647750 98 DA054667 BI545439 
NAT11 chr11 + 63469983 63470773 63470999 226 DA731067 NM_024771 
TTLL13 chr15 + 88601958 88602274 88602419 145 NM_001029964 BC052201 
FRMD1 chr6 - 168286603 168286365 168286067 298 AK125963 NM_024919 
GANC chr15 + 40390336 40393372 40393570 198 BM541471 AK074330 
HDAC7A chr12 - 46478158 46477549 46477477 72 NM_015401 CR983547 
KIAA0100 chr17 - 23984694 23984546 23984474 72 NM_014680 BU158839 
KIAA0913 chr10 + 75227369 75227545 75227700 155 NM_015037 AL133662 
LAD1 chr1 - 198083859 198083590 198083524 66 BG980318 NM_005558 
LEPREL2 chr12 + 6811339 6812854 6813017 163 BI756620 NM_014262 
LOC153684 chr5 + 43079426 43080252 43080302 50 BC101382 AK002146 
LOC155060 chr7 + 148422515 148423170 148423360 190 AK098351 BC041610 
LOC203427 chrX + 118322546 118325914 118326035 121 AL590525 NM_145305 
LOC348180 chr16 + 87305604 87305970 87306183 213 BC063512 NM_001012759 
LOC374395 chr11 + 62311575 62313071 62313235 164 NM_199337 BU197210 
Inês Guerra Mollet                                                                                                                                             APPENDICES 
GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS                                    130 
 
 
 
 
 Table I (continued) 
 
Gene 
Symbol Chr Strand 
Position 
5'ss 
Position 
proximal 
3'ss 
Position 
distal 3'ss 
Length 
Alternate 
Sequence 
Accession for 
Isoform with 
proximal 3'ss 
Accession for 
Isoform with 
distal 3'ss 
Upstream of 
LPIN1 chr2 + 11772216 11772915 11773022 107 CR593993 AK000417 
MBNL3 chrX - 131250410 131246374 131246269 105 NM_018388 NM_133486 
MET chr7 + 115992625 115993342 115993396 54 J02958 NM_000245 
LIMD2 chr17 - 59130120 59130030 59129910 120 NM_030576 BE793757 
MGC42174 chr2 + 233026089 233026356 233026429 73 CR598716 AL834174 
NFRKB chr11 - 129260540 129259987 129259951 36 NM_006165 BC063280 
TTLL13 chr15 + 88601958 88602274 88602419 145 NM_001029964 BC052201 
PAX4 chr7 - 126845950 126845853 126845681 172 BC107149 NM_006193 
PBEF1 chr7 - 105519938 105519378 105519328 50 DA295479 DA338663 
PEA15 chr1 + 156988385 156989891 156989996 105 DA736151 AK095879 
PEG3 chr19 - 62029568 62027921 62027694 227 NM_006210 BP219205 
PON3 chr7 - 94646136 94641490 94641451 39 AV660101 NM_000940 
PPP1R13L chr19 - 50577625 50575326 50575024 302 NM_006663 BM716707 
PTK9 chr12 - 42486291 42486072 42485955 117 BP354520 BC022344 
PYGO2 chr1 - 151747023 151746661 151746575 86 DA739729 NM_138300 
RAG2 chr11 - 36576228 36573393 36573321 72 DB137123 DB143931 
RBPSUHL chr20 + 43376619 43378241 43378336 95 NM_014276 BI964057 
RIMS3 chr1 - 40800159 40782607 40782527 80 NM_014747 BC003103 
RNF31 chr14 + 23689937 23690180 23690348 168 NM_017999 AK122711 
SEC13L1 chr3 - 10320710 10318058 10317831 227 NM_030673 CR623402 
SERPINA6 chr14 - 93859357 93850925 93850757 168 BU935177 NM_001756 
SGIP1 chr1 + 66873197 66881977 66882199 222 BM666838 BM689588 
SLCO1C1 chr12 + 20740008 20740950 20741032 82 DA345251 DA142363 
SLCO4A1 chr20 + 60769707 60769809 60769955 143 NM_016354 CR616855 
SMOC2 chr6 + 168762908 168766322 168766355 33 NM_022138 BC047583 
ZNF343 chr20 - 2429302 2422690 2422648 42 NM_024325 CD702168 
SPATA1 chr1 + 84684122 84684360 84684581 221 AW204186, BM055177 
SPP2 chr2 + 234760667 234767489 234767669 180 NM_006944 AV681865 
SRRM2 chr16 + 2761051 2761123 2761371 248 AI376062 AA703497 
TCP1 chr6 - 160179186 160177463 160177440 23 BU508560 NM_001008897 
TM2D2 chr8 - 38972889 38972470 38972369 101 NM_031940 DA114767 
TOR3A chr1 + 175783179 175783511 175783732 221 BX374780 NM_022371 
ZNF124 chr1 - 243661191 243649210 243649156 54 BG257604 NM_003431 
ZNF124 chr1 - 243648349 243646746 243646550 186 BC099661 NM_003431 
ZNF177 chr19 + 9351815 9352265 9352344 79 U37251 BP260204 
ZNF300 chr5 - 150263619 150263138 150262937 201 DA739710 NM_052860 
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Appendix C - Matching AffyHumanExon1.0 ST probes to ExonMine exons 
 
Entry from table matching a Affymetrix GeneChip® Human Exon 1.0 ST Probe Selection Region (PSR). In the case shown below, the region 
where the probes are designed is 84nt long (segment highlighted in grey below), this is the PSR and the ID of this region is 3231391. 
 
ProbeSetID   chr    strand   Start    End       PSRLength     score  GeneID   SegmentID   SegmentType   Constitutive 
3231391   | chr10 | +      | 170747 | 170830 |      84       |  900  | 9976   | 163579    |     3e     |     A   
 
 
Entry from Table Exon(ExonID=163579)matching the above Affymetrix GeneChip® Human Exon 1.0 ST Probe (ProbeSetID = 3231391)
           
  ExonID   GeneID  ExonNum  RefExonNum   Constitutive   ExonType   Known   Length   chr    strand  Start    End                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
| 163579 |  9976 | 2a"    | 1a"        | A            | 3e       | Known |  106   | chr10 | +    | 170727 | 170832 |  
 
Affymetrix designs one to four 25nt probes in the this region.The probes for Probe Selection Region (PSR) 3231391 of Human Exon 1.0 ST 
(design date Dec 2004) the probes are 
 
Probe 
TCCACACATGCACTCCGTATCCACA 
TGTTGGAGCATATTCCTCTGTCTCC 
CCTCTATCCGAAATTTGTTGGAGCA 
TCCCCACGTCCTGTCTTCGGCGCCT 
 
Reverse Complement sequences  for ProbeSetID=3231391 
TGTGGATACGGAGTGCATGTGTGGA 
GGAGACAGAGGAATATGCTCCAACA 
TGCTCCAACAAATTTCGGATAGAGG 
AGGCGCCGAAGACAGGACGTGGGGA 
 
Exon Sequence for ExonID=163579 
                                          GGAGACAGAGGAATATGCTCCAACA            AGGCGCCGAAGACAGGACGTGGGGA 
GTACGTAGCCTTCACGTGTGTGTGGATACGGAGTGCATGTGTGGAGACAGAGGAATATGCTCCAACAAATTTCGGATAGAGGCGCCGAAGACAGGACGTGGGGAAG 
                    TGTGGATACGGAGTGCATGTGTGGA          TGCTCCAACAAATTTCGGATAGAGG                                                                                                                                                                                                                                                                                                                                                    
Here the probe sequence is the antisense strand 
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Appendix D - Full set of data supporting Table 3.6 
Figure II - Predicted mRNA isoforms for genes encoding the U2AF family of proteins. For each gene, a table indicates GenBank accessions and 
corresponding exons according to BLAT mappings; chromosome positions are for genome assembly hg17. The gene names are followed by 
official gene symbol in parenthesis used by Entrez Gene. Confirmed mRNA isoforms are highlighted in yellow; the count of predicted splicing 
patterns producing a premature stop codon are highlighted in cian; the count of predicted splicing patterns of candidates for putative novel 
protein are highlighted in magenta. Transcripts carrying extensive intron retentions with no open reading frames were excluded. Coding 
sequence is indicated as ‘complete’ if a complete known protein is reported in RefSeq or SwissProt databases; or ‘putative’ for other mRNAs or 
ESTs where an in-frame coding sequence was found. Unknown open reading frames are also indicated. The exon on which the Start or Stop 
codon is found is indicated with the respective genomic position. A diagram of the exon structure of each gene is depicted below the 
corresponding table. Numbers below the exons represent exon length in nucleotides, and numbers above represent the intron length in 
nucleotides; junction consensus other than GT_AG is indicated; also indicated are the exons which code for known protein domains. 
 
Abreviations: cds – coding sequence, aa – amino acids,  mRNA – messenger RNA,  EST – expressed sequence tag, RRM – RNA recognition 
motif, Zn-finger – zinc finger domain 
#  Position of first nucleotide of Start codon. 
##  Position of first nucleotide after Stop codon 
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Protein 
(Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in isoform  
( orf in bold) 
 
 
Accession 
 
Status of cds (length of 
cds in aa), protein 
Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2,3,4,5,6,7,8,9,10,10a",11,12,12A*,12A' NM_007279.2 (RefSeq) 
complete (475aa), 
NP_009210.1, P26368 1 (60858282) 12A* (60877246) 
1,2,3,4,5,6,7,8,9,10,11,12,12A*,12A' NM_001012478.1 (RefSeq) 
complete (471aa), 
NP_001012496.1, Q96HC5 1 (60858282) 12A* (60877246) 
9,10,11,12,12A'                                 1 CR609498.1 (mRNA)  putative fragment (191aa) no start no stop 
1,1A,2,3,4,5,6                                    1 CD624005.1 (EST) premature stop (52aa) 1 (60858282) 1A (60862149) 
1,1A,2,3,4,5,5A                                 (1) CR982513.1 (EST)  premature stop (52aa) 1 (60858282) 1A (60862149) 
5A,6,7,8,9                                          2 BI909492.1 (EST)  putative fragment (151aa) 6 (60865685) no stop 
U2AF
65
 (U2AF2)  
chr19: 
60857188-
60877934 
'+' strand 
3,4,5,5A,6,7                                       2 CA488904.1 (EST)  premature stop (100aa) no start 5A (60864951) 
Table II.A 
1 1A 2 3 4 5 5A 6 7 8 9 10    10a" 11 
12A* 
12 12A' 
1104 120 136 45 104 152 60 117 139 80 123 87     12 249 21  
3708 228 831 294 418 581 671 987 4762 83 290 262 4241 668 
93 
 GC_AG GC_AG 
RS 
RRM1 RRM2 UHM 
5’end 3’end 
U2AF65   (U2AF2) 
Figure II.A 
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in isoform 
( orf in bold) 
 
Accession 
Status of cds (length of 
cds in aa), protein 
Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2a',2,3,4,5,6,7a',7,8,9,10,11 
NM_014281.3 
(RefSeq) complete (542aa), NP_055096.2 1 (144983461) 11 (144970677) 
1,2a',2,3,4,5,6,7a',7,8,9,10,11 idem complete (499aa), Q96D94 3 (144976053) 11 (144970677) 
1,2a',2,3,4,4A,5,6,7a',7,8,9,10,11 
 NM_078480.1 
(RefSeq) complete (559aa), NP_510965.1  1 (144983461) 11 (144970677) 
1,2a',2,3,4,4A,5,6,7a',7,8,9,10,11 idem complete (516aa), Q969E7 3 (144976053) 11 (144970677) 
1A,2a',2,3,4,5,6,7a',7,8,9,10,11 BC009734.1 (mRNA) complete (499aa), Q96D94 3 (144976053) 11 (144970677) 
1A,2a',2,3,4,4A,5,6,7a',7,8,9,10,11 BC011265.1 (mRNA) complete (516aa), Q969E7 3 (144976053) 11 (144970677) 
1,2,3,4,5,6,7a',7,8                              1 BI915396.1 (EST) putative fragment (318aa) 1 (144983461) no stop 
1,2,3,4,4A,5,6,7a',7,8                         2 AL522753.3 (EST) putative fragment (335aa) 1 (144983461) no stop 
1A,2,3,4,5,6,7a',7,8           known cds  BX397429.2 (EST) putative fragment (276aa) 3 (144976053) no stop 
1,3,4,5,6,7a',7,8,9                              3 AL514886.3 (EST) putative fragment (335aa) 1 (144983461) no stop 
1,3,4,4A,5,6,7a',7,8                           4 BX384203.2 (EST) putative fragment (307aa) 1 (144983461) no stop 
2A,3,4,4A,5,6,7a',7,8,9,10                 5 AK055941.1 (mRNA) putative fragment (449aa) 2A (144976721) no stop 
1A,1B,2a',2,3,4,5,6,7a',7                   6 BQ421738.1 (EST) putative fragment (292aa) 1B (144981677) no stop 
1A,1C,2a',2,3,4,4A,5,6,7a',7 known cds BM558085.1 (EST) putative fragment (229aa) 3 (144976053) no stop 
1,1B,2a',2,3,4,4A,5,6                         7 BQ956878.1 (EST) putative fragment (238aa) 1B (144981677) no stop 
1D,2a',2,3,4,4A                                  8 BG115238.1 (EST) putative fragment (141aa) 1D (144979054) no stop 
4B,5,6,7a'                                           9 BE393389.1 (EST) putative fragment (119aa) 5 (144972692) no stop 
PUF60 (SIAHBP1) 
chr8:144,970,535-
144,983,525 
'-' strand 
 
 
 
 
 
 
5,6,6a",7,8,9                                      10 BU170641.1 (EST) putative fragment (270aa) 5 (144972692) no stop 
Table II.B 
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PUF60   (SIAHBP1) 
1              1A             1B              1C             1D           2a’    2             2A               3               4              4A              4B               5               6      6a”     7a’    7                8                9              10              11 
  107            120            152             139          343            3     84             797             96              90             51               79             162            93     117   102   112            191            136            236           472 
    176         1447           217            1888          298               1030          572             131            880           1628          424              87                                         79            125            185             90 
5’end 3’end 
Poly-Ala 
UHM 
RRM1 RRM2 
Figure II.B 
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in isoform 
(orf in bold) 
 
Accession 
 
Status of cds (length 
of cds in aa), protein 
Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,1A*,1A',2,3,4a',4,5,6a',6,7,8,9,10,11,12,13b',13,14,15,16,17 
NM_184234.1 
(RefSeq) 
complete (530aa), 
NP_909122.1, Q14498-1 2 (33792210) 17 (33755816) 
1,1A*,1A',2,3,4a',4,5,6a',6,7,8,9,10,11,12,13,14,15,16,17 
NM_004902.2 
(RefSeq) 
complete (524aa), 
NP_004893.1, Q14498-2 2 (33792210) 17 (33755816) 
1,1A*,1A',2,2A,3,4a',4,5,6a',6,7,8,9,10,11,12,13,14,15,16,17           1 
NM_184241.1 
(RefSeq) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A*,1A',2,2A,3,4a',4,5,6a',6,7,8,9,10,11,12,13,14,15,16,17 idem 
complete (367aa), 
NP_909129.1, Q6N037 7 (33776436) 17 (33755816) 
1,1A*,1A',2,2A,3,4a',4,5,6a',6,7,8,9,10,11,12,13b',13,14,15,16,17  (1) 
NM_184244.1 
(RefSeq) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A*,1A',2,2A,3,4a',4,5,6a',6,7,8,9,10,11,12,13b',13,14,15,16,17 idem 
complete (373aa), 
NP_909132.1, Q5QP20 7 (33776436) 17 (33755816) 
1,1A*,1A',2,3,3C,4a',4,5,6a',6,7,8,9,10,11,12,13b',13,14,15,16,17   2 
NM_184237.1 
(RefSeq) premature stop (47aa) 2 (33792210) 3C (33785550) 
1,1A*,1A',2,3,3C,4a',4,5,6a',6,7,8,9,10,11,12,13b',13,14,15,16,17 idem 
complete (373aa), 
NP_909125.1 7 (33776436) 17 (33755816) 
1A',2,3,4a',4,5,6a',6,7,8,9,10,11,12,13,13A,14,15,16,17                    1 AL833168.1 (mRNA) putative (423aa) 2 (33792210) 14 (33758525) 
1A',2,2A,3,4a',4,5,6a',6,7,8,9,9A,10,11,12,13b',13,14,15,16,17       (1) BC107886.1 (mRNA) premature stop (40aa) 2 (33792210) 2A (33791861) 
1A',2,2A,3,4a',4,5,6a',6,7,8,9,9A,10,11,12,13b',13,14,15,16,17          2 idem putative (132aa) 7 (33776436) 9A (33771893) 
1A',2,2A,3,4a',4,5,6a',6,7,8,9,9A,10,11,12,13b',13,14,15,16,17       idem putative (249aa) 10 (33768123) 17 (33755816) 
1A',2,2A,3,3C,4a',4,5,6a',6,7,8                                                          (1) BM468718.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
2,2A,3,4a',4,6                                                                                    (1) BE816688.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A*,1A',2,2A,3,3B                                                                         (1) DA115481.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
3A,3B AV691154.1 (EST) unknown (77aa) 3A (33787895) 3B (33786230) 
1A',2,3,3B                                                                                          3 AL711019.1 (EST) premature stop (95aa) 2 (33792210) 3B (33786230) 
1A',2,2B,3,3B                                                                                     4 CA419145.1 (EST) premature stop (62aa) 2 (33792210) 2B (33790745) 
CAPER! (RNPC2) 
chr20:33,754,944-
33,793,607 
'-' strand 
 
 
 
 
 
 
 
 
 
1A',2,2B,3,3B idem unknown (90aa) 2B (33790764) 3B (33786230) 
Table II.C 
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in 
isoform 
(orf in bold) 
Accession 
 
Status of cds (length of cds in 
aa), protein Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,1A*,1A',2,2A,2B          (1)   DA372839.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A',2,2A,2B,3               (1) BP352717.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A',2,2A,2B,3                 3 idem putative alternative start 2B (33790764) no stop 
1,1A',2,2A,3,4a',4,5          (1) DB027200.1 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
1,1A',2,3,4a',4,5,6a',6 DB264131.1 (EST) known cds (NM_184234.1, NM_004902.2) 2 (33792210) no stop 
3,4a',4,5a',5,6a',6,7          4 BX483043.1 (EST) putative in-frame fragment (169aa) no start no stop 
1A',2,3,4a',4,6a',6,7,8       5 BQ893325.1 (EST) putative fragment (207aa) 2 (33792210) no stop 
4,6a',6,7,8,9,10,11,12       (5) CR995560.1 (EST) putative in-frame fragment (334aa) no start no stop 
6,7,8,9,11,12                     6 BQ954122.1 (EST) putative in-frame fragment (247aa) no start no stop 
11B,12,13,14,15                7 BE933146.1 (EST) putative in-frame fragment (137aa) no start no stop 
7,8,9,10,11,11A,11B          8 BM983358.1 (EST) putative in-frame fragment (255aa) no start no stop 
1A,1Aa",2,2a",2a"_2A,2A    5 DB150523.1 (EST) premature stop (23aa) 1A (33792947) 1A (33792875) 
1A,2,3,4a',4,5,6a',6,7         (5) BG764840.1 (EST) premature stop (23aa) 1A (33792947) 1A (33792875) 
1A,2,3,4a',4,5,6a',6,7 idem known cds (178aa) 2 (33792210) no stop 
1A,2,2A,3,4a',4,5             (5)  DA922841.1 (EST) premature stop (23aa) 1A (33792947) 1A (33792875) 
1A,2,2A,3,4a',4,5            (1) idem premature stop (40aa) 2 (33792210) 2A (33791861) 
12,13a',13b',13,14,15,16,17 BI117009.1 (EST) putative fragment no start 13a' (33760610) 
1A',2,3,4a',4,5,6,7,8            9 BU075848.1 (EST) putative fragment (288aa) 2 (33792210) no stop 
2A,3,4a',4,5,6,7               (1)? AW993266.1 (EST) premature stop no start 2A (33791861) 
1,1A*,1A',2,2a",3,4a',4       10 DB023865.1 (EST) putative fragment (104aa) 2 (33792210) no stop 
12A,13 DA109669.1 (EST) unknown (34aa) 12A (33761820) 12A (33761715) 
(cont.) 
CAPER! (RNPC2) 
chr20:33,754,944-
33,793,607 
'-' strand 
 
 
 
 
 
 
 
 
 
 
1A',2,2A,3,4,5,6a',6          (1) AL513896.3 (EST) premature stop (40aa) 2 (33792210) 2A (33791861) 
Table II.C  (cont.) 
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 1    1A*   1A’          1A  1Aa”         2   2a”           2A             2B               3              3A             3B             3C           4a’    4           5a’    5             6a’  6                7                8               
5’end 
3’end 
Poly-Ala 
RRM1 
RRM2 UHM 
RS 
   58            173            139   26          64    18            73            155              50             129            541             72            3   192          24    66             3    51            118            153 
    9               9A              10             11            11A            11B            12             12A        13a’ 13b’  13       13A             14              15              16              17 
138          89               66              205            26              114            78             284           35  18   33             53              82            106             79              973 
131          314                574                  208          977             375           2326          1431         283           2050              2389               96                  4156           315             2692 
     1137          3708          2350          327            424            197           2452           973                     1231          738           1789          478             86 
CAPER!  (RNPC2) 
Figure II.C  
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in isoform 
(orf in bold) 
 
Accession 
Status of cds (length 
of cds in aa), protein 
Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2,3,4,5,6,7a',7,7a",8a',8,9,10,11,11A*,11A',12,13 
NM_018107.3 
(RefSeq) 
complete (424aa), 
NP_060577.2; (423aa), 
Q86U06-2 2 (22450442) 13 (22440778) 
1,2,3,4,6,7a',7,7a",8a',8,9,10,11,11A*,11A',12,13 
CR595426.1 
(mRNA) complete (405aa), Q86U06-4 2 (22450442) 13 (22440778) 
1,2,3,3B,4,5,6,7a',7,7a",8a',8,9,10,11,11A*,11A',12,13 
BX161440.1 
(mRNA) complete (439aa), Q86U06-1 2 (22450442) 13 (22440778) 
1,2,3,3B,4,5,6,7a',7,7a",8a',8,9,9A,9A_10,10,11,11A*,11A',12,13 
AL834198.1 
(mRNA) complete (419aa), Q86U06-3 2 (22450442) 9A (22443209) 
1,2,3,3B,4,6                                                                                1 DA675412.1 (EST) putative fragment (173aa) 2 (22450442) no stop 
      3,3B,4,6,7a',7,7a",8a',8                                                       (1) BG033916.1 (EST) 
putative in-frame fragment 
(248aa) no start no stop 
1,2,3,3A                                                                                      1 DA821789.1 (EST) premature stop (91aa) 2 (22450442) 3A (22447692) 
1,2,3,3Ba',3B,4                                                                           2 DB164369.1 (EST) premature stop (73aa) 2 (22450442) 3B (22447405) 
1,2,3B,4,5,6,7a',7,7a"                                                                 3 BM464794.1 (EST) premature stop (29aa) 2 (22450442) 3B (22447405) 
1,2,3B,4,6,7a'                                                                            (3) DA145418.1 (EST) premature stop (29aa) 2 (22450442) 3B (22447405) 
1,2,4,6,7a',7,7a",8a',8                                                                 4 BI823680.1 (EST) premature stop (23aa) 2 (22450442) 4 (22445411) 
1,2,4,5,6,7a',7,7a",8a',8                                                              4 DB166416.1 (EST) premature stop (23aa) 2 (22450442) 4 (22445411) 
1,1C,2,3,4                                                                                  2 DA117163.1 (EST) putative fragment (135aa) 1C (22456120) no stop 
1,1Ea',1E,2,3,3B,4                                                                    3 DA311282.1 (EST) putative fragment (177aa) 1Ea' (22452894) no stop 
   1Ea',1E,2,3,4,5,6,7a',7,7a",8a',8                                           4 BQ707907.1 (EST) putative fragment (316aa) 1Ea' (22452894) no stop 
1,1Ea',1E,2,3,4,5,6                                                                  (4)          BQ071908.1 (EST) putative fragment (219aa) 1Ea' (22452894) no stop 
1B,2,3 AA324737.1 (EST) 
putative fragment, known cds 
(59aa) 2 (22450442) no stop 
CAPER" (RBM23) 
chr14:22,439,816-
22,458,214 
'-' strand 
 
 
 
 
 
 
 
 
 
1,1D,1E,2,3,3B DA856230.1 (EST) 
putative fragment, known 
cds(75aa) 2 (22450442) no stop 
Table II.D 
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in isoform 
Accession Status of cds (length of cds in aa), 
protein Accession 
Start codon 
Exon (chr 
postion)# 
Stop codon 
Exon (chr 
position)## 
1,1E,2,3 CD692273.1 (EST) putative fragment, known cds(59aa) 2 (22450442) no stop 
1,1G,2,3,4 BP356833.1 (EST) putative fragment, known cds(117aa) 2 (22450442) no stop 
11,11A'                                                             5 BX388764.2 (EST) putative fragment (19aa) no start no stop 
1,1A                                                                 5 AA633094.1 (EST) premature stop (76aa) 1 (22458231) 1A (22456804) 
1,3,4,6,7a',7,7a",8a',8                                      6 BI915247.1 (EST) premature stop (62aa) 1 (22458231) 3 (22448639) 
1,3,4,6,7a',7,7a",8a',8                                      6 idem 
putative fragment, new start, known cds 
(62aa) 6 (22444447) no stop 
1,3B,4,5,6,7a',7                                               7 DA299707.1 (EST) unknown orf (159aa) 1 (22458231) 6 (22444482) 
1,3B,4,5,6,7a',7                                               (6) idem 
putative fragment, new start, known cds 
(57aa) 6 (22444447) no stop 
1,4,6,7a',7,7a"                                                  8 DA026292.1 (EST) unknown orf (125aa) 1 (22458231) 6 (22444482) 
1,4,6,7a',7,7a"                                                (6) idem 
putative fragment, new start, known cds 
(63aa) 6 (22444447) no stop 
1,4,5,6,7a',7,8a',8                                             9 CN483101.1 (EST) unknown orf (143aa) 1 (22458231) 6 (22444482) 
1,4,5,6,7a',7,8a',8                                             7 idem putative fragment, new start (103aa) 6 (22444447) no stop 
1,4,5,6,7a',7,7a",8a',8,9                                   (9) CX165727.1 (EST) unknown orf (143aa) 1 (22458231) 6 (22444482) 
1,4,5,6,7a',7,7a",8a',8,9                                 (6) idem 
putative fragment, new start, known cds 
(140aa) 6 (22444447) no stop 
1,3B,4,6,7,7a",8a',8,9,10,11,11A*,11A',12,13    10 BC106012.1 (mRNA) unknown orf (141aa) 1 (22458231) 6 (22444482) 
1,3B,4,6,7,7a",8a',8,9,10,11,11A*,11A',12,13    8 idem 
putative fragment, new start, known cds 
(189aa) 8 (22444037) 13 (22440778) 
7a",8,9,10,11,11A*,11A',12,13 BE269289.1 (EST) putative fragment (59aa) no start 9 (22443356) 
7a",8,9,10,11,11A*,11A',12,13 idem 
putative fragment, new start, known cds 
(189aa) 8 (22444037) 13 (22440778) 
(cont.) 
 CAPER" (RBM23) 
chr14:22,439,816-
22,458,214 
'-' strand 
 
 
 
 
 
 
 
9A,10,11,11A*,11A',12 BM712633.1 (EST) putative fragment  no start 9A (22443209) 
Table II.D   (cont.) 
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 1             1A              1B             1C           1D            1Ea’  1E            1F             2                 3               3A        3Ba’  3B             4                 5               6              7a’   7   7a”     
5’end 
3’end 
RRM1 
RRM2 
RS 
  204           239             78             139            102           24    98            118            76              113            209          19    48            174             54             118           52    85   16 
8a’   8                9               9A              10             11    11A*  11A’          12             13   
  4   134             66             196            196              21              39             70            1088  
 1196              7              312         3011             69                  1820          382          1732          742           132                 1964           535            152              89                      81   
548              70            1612            87               60               96            80 
CAPER" (RBM23) 
RS 
Poly-Ala 
Figure II.D 
Inês Guerra Mollet                                                                                                                                                                                                                                                               APPENDICES 
 GENOME WIDE MINING OF ALTERNATIVE SPLICING IN METAZOAN MODEL ORGANISMS                                                                                                                        142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein(Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in 
isoform 
(orf in bold) 
 
Accession 
 
Status of cds (length of cds 
in aa), protein Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2,3,4,5,6,7,8 NM_006758.2 (RefSeq) 
complete (240aa), NP_006749.1 , 
Q01081 1 (43400673) 8 (43386280) 
1,2,2A,4,5,6,7,8 NM_001025203.1 (RefSeq) complete (240aa), Q69YM7 1 (43400673) 8 (43386280) 
1,2,2A,3,4,5,6,7,8     1 NM_001025204.1 (RefSeq)  premature stop 1 (43400673) 3 (43393669) 
1,2,2A,3,4,5,6,7,8 idem complete (167aa), Q71RF1 4 (43388902) 8 (43386280) 
1,2,2B,4,5,6,7,8        1 BG612658.1 (EST) putative (202aa) 2 (43397540) 8 (43386280) 
U2AF
35
 (U2AF1) 
chr21: 43386096-
43400798 
'-' strand 
1A,2,3,4                     2    BE736536.1 (EST)                   premature stop 1A (43400225) 1A (43400168) 
5’end 3’end 
UHM 
 Zn-finger-CCCH 
       Zn-finger-CCCH 
1 1A 2 2A
A 
2B 3 4 5 6     7  8 
156 457 88 67 38 67 50 99 134 93 
266 2325 2882 751 57 4709  649 91 1221 
294 
RS-domain 
Poly-Gly 
U2AF35 (U2AF1) 
Table II.E 
Table II.F 
Figure II.E 
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Protein (Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in 
isoform (coding exons 
in bold) 
 
Accession 
Status of cds (length of cds in aa), 
protein Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2a',2,3,4,5,6a',6 NM_144987.2(RefSeq) complete (202aa), NP_659424.2, Q8WU68 1  (40928132) 6 (40925338) 
1,2a',2,3,4,4a",5,6a',6 
NM_001040425.1 
(RefSeq) complete (181aa), NP_001035515.1 , Q56UU3 1  (40928132) 6a' (40925459) 
2A,2B,3,4,5,6a',6                  1 BE856544.1 (EST) putative fragment (197aa) no start 6 (40925338) 
1,2a',2,2Ab',2A,3,4,5,6a'      1 BM696851.1 (EST) premature stop (97aa) 1  (40928132) 3 (40927113) 
1,2a',2,2Ab',2A,3,4,5,6a'        2 idem putative fragment (129aa) 3 (40927117) no stop 
2,2Ab',2A,3,4,5,6a',6           (1) BM970675.1 (EST) premature stop no start 3 (40927113) 
2,2Ab',2A,3,4,5,6a',6            (2) idem putative, known cds (143aa) 3 (40927117) 6 (40925338) 
2,2Ab',2A,3,4,5,6                (1) AW274826.1 (EST) premature stop no start 3 (40927113) 
2,2Ab',2A,3,4,5,6                   3 idem putative (80aa) 3 (40927117) 6 (40925343) 
1,2,3,4,5,6                             2 DB127360.1 (EST) premature stop (51aa) 1  (40928132) 3 (40927113) 
1,2,3,4,5,6                            (3) idem putative (80aa) 3 (40927117) 6 (40925343) 
2,2A,3,4,4a",5,6a',6             3 BU628789.1 (EST) premature stop no start 2A (40927364) 
2,2A,3,4,4a",5,6a',6              4 idem putative (122aa) 3 (40927117) 6a' (40925459) 
2,2A,3,4,5,6a'                       (3) AA455588.1 (EST) premature stop no start 2A (40927364) 
2,2A,3,4,5,6a'                       (2) idem putative fragment (129aa) 3 (40927117) no stop 
1,2,2Aa',2Ab',2A,2A_2B         4 BI770029.1 (EST) premature stop (95aa) 1  (40928132) 2Aa' (40927541) 
1,2,2Ab',2A,3,3_4,4,5,6a',6    5 BC010865.1 (mRNA) premature stop (39aa) 1  (40928132) 2Ab' (40927466) 
1,2Ab',2A,3                            6 BG481735.1 (EST) premature stop (18aa) 1  (40928132) 2Ab' (40927466) 
1,2,2A,3,3_4,4,4a"             (3)? W51842.1 (EST) premature stop (37aa) 1  (40928132) 2A (40927426) 
2Ab',2A,3,4,5,5A,5B,6a',6     5 BU608847.1 (EST) putative (129aa) 3 (40927117) 6a’ (40925481) 
2A,3,4,5,5A,5Ba',5B,6          6 DB338076.1 (EST) putative (92aa) 3 (40927117) 5Ba' (40925946) 
U2AF
26
 (U2AF1L4) 
chr19:40925185-
40928187 
'-' strand 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4,5,5A,5Ba',5B,6a'              (6) BF821614.1 (EST) putative fragment no start 5Ba' (40925946) 
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1 2a'   2 2Aa'  2Ab'  2A 5 6a’    6 5A 5Ba'  5B 
94 25   63 243    46   67        76     58 96 50 3       51 184 
135 143 204 177 107 463 87 351 
  4       4a” 3
  
2B  
50 99 
69 
Zn-finger-CCCH 
UHM 
5’ end 3’ end 
224 
U2AF26   (U2AF1L4) 
       Zn-finger-CCCH 
Figure II.F 
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Protein 
(Gene 
symbol) 
Chr position  
Strand 
 
Order of exons in 
isoform  
(orf in bold) 
 
Accession 
 
Status of cds 
(length of cds in 
aa), protein 
Accession 
 
Start codon 
Exon (chr 
postion)# 
 
Stop codon 
Exon (chr 
position)## 
 
1,2,3a',3,4,5,6,7,8,9,10,11 NM_005089.2 (RefSeq) 
complete (482aa), 
NP_005080.1 , Q15696 1 (15568275) 11 (15601022) 
1,2,3a',3,3B                     1 BC065719.1 (mRNA) premature stop (147aa) 1 (15568275) 3B (15579294) 
1,2,3a',3,3A                     2 DA173194.1 (EST) premature stop (81aa) 1 (15568275) 3A (15578031) 
1,2,3,3A                          3 DA383795.1 (EST) premature stop (49aa) 1 (15568275) 3 (15577691) 
1,2,3,4,5,6,7,8                (3) CN289520.1 (EST) premature stop (49aa) 1 (15568275) 3 (15577691) 
1,2a',2,3a',3,4                 4 BE619312.1 (EST) premature stop (24aa) 1 (15568275) 2a' (15568678) 
1A,2,3,4,5,7                    5 DA261525.1 (EST) unknown (12aa) 1A (15568364) 1A (15568415) 
U2AF
35
-RS2 
(U2AF1L2) 
chrX:15568024-
15601078 
'+' strand 
2A,3a',3,4                       6 CA425173.1 (EST) unknown (16aa) 2A (15573869) 2A (15573908) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II.G  
1 1A 2a'    2 2A
A 
3a'    3 3B 4 5 6     7  8 
273 160 69    80 196 11    71 680 109 87 39 119 
37 131 5041 3621 255 1734 314 4035 928 6358 
214 
9 
2696 
56 
10 
1564 
110 
11 
2414 
530 
3A 
431 
634 
5’end 3’end 
Poly-Glu Poly-Glu 
Zn-finger-CCCH 
UHM 
Zn-finger-CCCH 
RS 
U2AF
35
-RS2   (U2AF1L2) 
Figure II.G  
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Appendix E – Phylogeny of animal model organisms 
 
Figure taken from “Hedges, S.B. (2002). The origin and evolution of model organisms. 
Nat Rev Genet. 3, 838-849”. 
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Appendix F - Cross species analysis of U2AF35 family 
 
Splicing patterns detected across four vertebrate model organisms for the U2AF small 
subunit family of splicing factors: Table A. U2AF
35
(U2AF1), Table B. U2AF
26
 (U2AF1L4) 
and Table C. U2AF
35
-RS2 (ZRSR2). Longest open reading frame is indicated on the 
splicing pattern in bold. Splicing patterns confirmed by RT-PCR by Joana Borlibo are 
indicated in color and underlined (see Appendix G). Introns are highlighted in yellow. 
 
Table A - U2AF
35
(U2AF1) 
 
Organism - Gene name 
Chr position 
Strand (Assembly) 
Splicing pattern 
(orf in bold) mRNA  Accession 
1,2,3,4,5,6,7,8 NM_006758.2 (RefSeq) 
1,2,2A,4,5,6,7,8 NM_001025203.1 (RefSeq) 
1,2,2A,3,4,5,6,7,8 NM_001025204.1 (RefSeq)  
1,2,2B,4,5,6,7,8 BG612658.1 (EST) 
1A,2,3,4 BE736536.1 (EST)                   
1A_2,2,2A,3,4 BM827141.1 (EST) 
1A_2,2,3,4,5,6,7,8 AF370386.1 (mRNA) 
1,2,2_2A,2A,2A_2B,2B,2B_3,3,4,5,6,7,8 BC032521.2 (mRNA) 
1,2,2A,2A_2B,2B,2B_3,3 AL832665.1 (mRNA) 
4,4_5,5,5_6,6,7,8 BC013786.1 (mRNA) 
3_4,4,5,6 DA936986.1 (EST) 
3_4,4,4_5,5,5_6,6,7,8 BC013786.1 (mRNA) 
Human - U2AF1 
chr21: 43386135-43400785 
'-' strand (hg18) 
 
 
 
 
 
 
 
3_4,4,4_5,5,5_6,6,7,7_8,8 AK098266.1 (mRNA) 
1,2,3,4,5, 6,7,8 NM_024187.3 (RefSeq) 
1,2,2A,4,5,6,7,8 CA977261.1 (EST) 
1,2,2A,3,4,5,6,7,8 CX236600.1 (EST) 
1,4,5,6,7,8 AV476937.1 (EST) 
1,2,2A,2A_3 CN669619.1 (EST) 
3_4,4,5,6,7 CA978127.1 (EST) 
Mouse - U2af1 
chr17:31784025-31795838 
'-' strand (mm9) 
 
 
 
1,2,2_2A   CB524928.1 (EST) 
1,2,3,4,5,6,7,8 NM_204655.2 (RefSeq) 
1,2,2B,4,5,6,7,8 BU111430.1 (EST) 
1,2,2B,3,4,5,6,7,8 BU240246.1 (EST) 
1,2,2A,2B,3,4,5,6,7,8 AJ291765.1 (mRNA) 
1,2,2A,3,4,5,6,7 BM491388.1 (EST) 
Chicken - U2AF1 
chr1:113163827-113180264 
'-' strand (galGal3) 
 
 
1,2,2A,2B,4,5,6,7,8 BU318632.1 (EST) 
Zebrafish - u2af1 
 chr9:4449663-4462013 
 '-' strand (Zv6) 1,2,3,4,5,6,7,8, NM_177479.2 (RefSeq) 
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Table B - U2AF
26
 (U2AF1L4) 
Organism - Gene name 
Chr position 
Strand (Assembly) 
Splicing pattern 
(orf in bold) mRNA  Accession 
1,2a',2,3,4,5,6a',6      (zf,UHM) NM_144987.2(RefSeq) 
1,2a',2,3,4,4a",5,6a',6      (zf,UHM,zf,RS) change of 
frame after 4a” NM_001040425.1 (RefSeq) 
2A,2B,3,4,5,6a',6 BE856544.1 (EST) 
1,2a',2,2Ab',2A,3,4,5,6a',6 BM696851.1 (EST) 
1,2,2Ab',2A,3,3_4,4,5,6a',6    BC010865.1 (mRNA) 
2,2Ab',2A,3,4,5,6 AW274826.1 (EST) 
1,2,3,4,5,6 DB127360.1 (EST) 
   2,2A,3,4,4a",5,6a',6 BU628789.1 (EST) 
1,2,2A,3,3_4,4,4a"    W51842.1 (EST) 
2,2A,3,4,5,6a' AA455588.1 (EST) 
1,2,2Aa',2Ab',2A,2A_2B    BI770029.1 (EST) 
1,2a',2,2Aa',2Ab',2A,2A_2B,2B,3,4,5,6a',6   BC062474.1 (mRNA) 
1,2Ab',2A,3 BG481735.1 (EST) 
2Ab',2A,3,4,5,5A,5B,6a',6 BU608847.1 (EST) 
2A,3,4,5,5A,5Ba',5B,6 DB338076.1 (EST) 
4,5,5A,5Ba',5B,6a'  BF821614.1 (EST) 
1,2,2Ab',2A,3,4,4a",5,5A,5A_5Ba',5Ba',5B,6a',6   AY461582.1 (mRNA) 
4,5,6,W1 AA845716.1 (EST) 
Human - U2AF1L4 
chr19:40925137-40928182 
'-' strand (hg18) 
 
 
 
 
 
 
 
 
 
 
 
4,5,6,6a",W1a',W1 AA713510.1 (EST) 
1,1a",2a',2,3,4,4a",5,6,7,8 NM_170760.3 (RefSeq) 
   1a",2a',2,3,4,4a",5,6,7,8,W1,W2,W3 BC031744.1 (mRNA) 
1,1a",2a',2,3,4,4a",5,6,7,8,W1,W1_W2,W2,W2a",W3   AK160974.1 (mRNA) 
1,1a",2a',2,3,4,4a",4a"_5,5    BY303250.1 (EST) 
    1a",2a',2,3,4,4a",4a"_5,5,5a",5a"_6,6    BI152717.1 (EST) 
    1a",2a',2,3,4,4a",5,5a",5a"_6,6    AA185455.1 (EST) 
1a",2a',2,3,4,4a",5,5a",6,7,8,W1,W2,W2a",W3 BC057315.1 (mRNA) 
1b"_2a',2a',2,3,4,4a",5,6,7,8   DV647783.1 (EST) 
1,1a",2a',2,3,4,4a",5,6,8 BI790606.1 (EST) 
1,1a",2a',2,3,4,5,6,7 DV060266.1 (EST) 
1,2,3,4,4a",5,6,7,8 CF105709.1 (EST) 
1,2,3,4,4a",5,5a",5a"_6,6    BE372653.1 (EST) 
1,2a',2,3,4,4a",5,5a",5a"_6,6,7    CN713072.1 (EST) 
1,2a',2,3,4,4a",5,6,8 BY709622.1 (EST) 
   1a",2,3,4,4a",5,6,7 BE850892.1 (EST) 
1,1a",2,3,4,4a",5,6 BY276709.1 (EST) 
1,1a",2,3,4,4a",5,5a",5a"_6,6    CN832960.1 (EST) 
1,1a",2,3,4,4a",4a"_5,5,5a",5a"_6,6,7,8    DV062015.1 (EST) 
2_3,3,4,4a",5,5a",5a"_6,6  BI247514.1 (EST) 
2_3,3,4,4a",5,6   CJ167056.1 (EST) 
   1a",1b",1b"_2a',2a',2,3,4,4a",4a"_5,5,5a"    BM944609.1 (EST) 
   1a",1b",2a',2,3,4,4a",5,6,7,8 BE570340.1 (EST) 
1,1a",1b",2a',2,3,4,4a",5,6 BC051477.1 (mRNA) 
1,1a",1b",1b"_2a',2a',2,3,4,4a",4a"_5,5,6   BG863348.1 (EST) 
1a",1b",2,3,4,4a",5,8 AV481891.1 (EST) 
1a",1b",1b"_2a',2a',2,3,4,4a",5,8    CK020700.1 (EST) 
Mouse - U2af1l4 
chr7:31347032-31352981 
'+' strand (mm9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1a",1b",2,3,4,4a",5,6,7 CB840666.1 (EST) 
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Table C – U2AF
35
-RS2 (ZRSR2) 
 
Organism - Gene name 
Chr position 
Strand (Assembly) 
Splicing pattern 
(orf in bold) mRNA  Accession 
1,2,3a',3,4,5,6,7,8,9,10,11 NM_005089.2 (RefSeq) 
1,2,3a',3,3B BC065719.1 (mRNA) 
1,2,3a',3,3A DA173194.1 (EST) 
1,2,3,3A DA383795.1 (EST) 
1,2,3,4,5,6,7,8 CN289520.1 (EST) 
1,2a',2,3a',3,4 BE619312.1 (EST) 
1A,2,3,4,5,7 DA261525.1 (EST) 
Human - ZRSR2 
chrX:15718308-15751385 
'+' strand (hg18) 
 
 
 
 
2A,3a',3,4 CA425173.1 (EST) 
1,1A*,1A',1B*,1B',2,3a',3,4,5,6,7,8,9,10,11 NM_009453.2 (RefSeq) 
1,1A*,1A',1B*,1B',2,3a',3,4,5,5_6 NM_178794.3 (RefSeq) 
1,1B',2,3a',3 CJ149312.1 (EST) 
1A',1B',2,3a',3,4 CK623156.1 (EST) 
6,7,8,9,10,10_11 BU614769.1 (EST) 
3_4,4,5,5_6 BQ745328.1 (EST) 
1B',2,3 BB578434.1 (EST) 
7_8,8,9,9_10 CN700280.1 (EST) 
5_6,6,7,7_8 CB521832.1 (EST) 
Mouse - Zrsr2 
chrX:159279548-159302782 
'-' strand (mm9) 
 
 
 
 
 
1B'_2,2,3a',3,4,5 BU530520.1 (EST) 
Chicken - ZRSR2 
chr1:125314753-125330984 
'-' strand (galGal3) 
1,2,3,4,5, 
   2,3,4,5,6,7,8, 
             5,6,7,8,9,10,11 
composed from  
CR354065.1 (mRNA) 
CV890012.1 (EST) 
BU464289.1 (EST) 
1,2,3,4 EB909890.1 (EST) 
Zebrafish - ZRSR2 (duplicated 
gene) 
chr11:11601277-11611649 
chr11:11390562-11401670 
'-' strand (Zv6) 7,8,9,10,11 CT639411.2 (EST) 
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Appendix G - Method PCR validation of human U2AF35 novel isoforms 
 
Method of RT-PCR validation performed by Joana Borlido 
 
cDNA synthesis was carried out on Human Universal RNA (Stratagene) using Superscript 
II reverse transcriptase (Invitrogen). Primers were designed by using the computer software 
Primer Express (Applied Biosystems, Foster City, CA) and primer concentrations were 
optimized for each amplicon using Human Universal RNA as a template. The 
oligonucleotide used for each set of primers are listed in Table G1; the  concentration of  
primers used in the reaction was of 900nM. All reactions were performed in the ABI7000 
Sequence Detector (Applied Biosystems, Foster City, CA). The amplification products 
were then separated in a 2% agarose gel containing 0.5 µg/ml of ethidium bromide (EtBr) 
and quantified by ethidium bromide fluorescence in a Phosphorimager detector (Amersham 
Pharmacia Biotech).   
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Table G1 - Oligonucleotide sequence and concentration of primers used in RT-PCR 
 
Protein      
(Gene 
Symbol) 
Accession 
Number 
Amplicon 
size (bp)  Primer Sequences 
Forward, 5’- GCCAGACCATTGCCCTCTT -3’ 
NM_006758.2 
(RefSeq) 126 Reverse, 5’- CCTCCTCAAAAAACTCATCATAGTGTT -3’ 
Forward, 5’- GGCTGACGGCTCACACTGT -3’ 
NM_001025203.1 
(RefSeq) 71 Reverse, 5’- CCTCCTCAAAAAACTCATCATAGTGTT -3’ 
Forward, 5’- AGGCAGCCGGTGCCGT -3’ 
U2AF35 
(U2AF1) 
BG612658.1 
(EST) 75 Reverse, 5’- TTTCTGTAAAAACCTCCTCAAAAAACTC -3’ 
Forward, 5’- GTGAGCTGTCTCCTGTCACTGACT -3’ 
NM_001040425.1 
(RefSeq) 69 Reverse, 5’- GGGTACATTCCCCCATCTCAT -3’ 
Forward, 5’- AGGCTGTGCACGGGAATG -3’ 
NM_144987.2 
(RefSeq) 111 Reverse, 5’- GACCTGCGCCTGGGTC -3’ 
Forward, 5’- CTCTGCCTCCCAGAGATGGG -3’ 
BU608847.1 
(EST) 68 Reverse, 5’- TGACCTGAGGTCCGGAGTTC -3’ 
Forward, 5’- GCAACCTCTGCCTCCCAGTA -3’ 
U2AF26 
(U2AF1L4) 
DB338076.1 
(EST) 76 Reverse, 5’- GAGCCTGAGGTCCGGAGTTC -3’ 
Forward, 5’- TTTCCCGAGAAACCAAGCC -3’ 
NM_005089.2 
(RefSeq) 98 Reverse, 5’- CCTGAGTCTCTCAGTCGAGCAA -3’ 
Forward, 5’- ATCGTGGGCATGGAGGATGT -3’ 
DA261525.1 
(EST) 94 Reverse, 5’- GCGCACCAGGAAGGAATG -3’ 
Forward, 5’- GTTGGGATTACAGACACGCA -3’ 
U2AF35-R2 
(U2AF1L2) 
CA425173.1 
(EST) 74 Reverse, 5’- TGCTGGAAGTGCTCTCAAGAAG -3’ 
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6. SUPPLEMENTARY DATA 
Supplementary data is found on the CD  
 
Tables 
SupplemetaryTable1.doc 
SupplementaryDataFile1_2000HumanMuscleGenes.xls 
SupplementaryDataFile2_Tables443MuscleGenes_U06hs48.xls 
SupplementaryDataFile3_Tables420SplicingFactors_U06hs48.xls 
 
 
Publications 
Article_Mollet et al 2006.pdf 
Article_Pacheco et al 2006.pdf 
Article_Mollet et al 2008.pdf 
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ABBREVIATIONS 
BLAT – Blast Like Alignment Tool 
CPAN - Comprehensive Perl Archive Network 
EST – Expressed Sequence Tag 
mRNA – messenger RNA 
RT-PCR – Reverse Transcriptase –Polymerase Chain Reaction 
SQL – Standard Query Language 
UCSC – University of California Santa Cruz 
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